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ABSTRACT

TEMPORAL NEUROMUSCULAR ALTERATIONS OF THE QUADRICEPS
AFTER UNILATERAL ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION
Objective: The primary aim of this research was to examine the temporal pattern
of neuromuscular quadriceps deficits in both the involved and uninvolved limbs of
patients assigned to the control group after anterior cruciate ligament
reconstruction (ACLr), by assessing quadriceps strength, voluntary activation,
and corticomotor excitability prior to surgery (baseline), three months after ACLr,
and six months after ACLr. A secondary aim of this research was to determine
whether quadriceps strength, voluntary activation, and/or corticomotor excitability
assessed in patients prior to ACLr and/or at three months after surgery, is
predictive of lower extremity postural control and/or self-reported function at six
months after ACLr. Lastly, a tertiary aim of this research was to determine if a 12week home-based neuromuscular electrical stimulation (Home-NMES) program
elicits greater bilateral improvements in quadriceps strength, voluntary activation,
and corticomotor excitability of patients at three and six months after ACLr
compared to a 12-week standard home-exercise program (control group).
Participants: Fifty patients scheduled to undergo unilateral ACLr were randomly
allocated to the home-NMES group (19 Female, 6 Male; age: 18.9 ± 5.4 years;
height: 170.8 ± 9.7 cm; weight: 74.6 ± 18.5 kg; 28.0±20.0 days-post-injury) or
control group (14 Female, 11 Male; age: 19.4 ± 4.5 years; height: 171.1 ± 11.5
cm; weight: 70.7 ± 11.9 kg). Methods: A randomized clinical trial design was
used in this study. Prior to ACLr, isometric quadriceps strength and voluntary
quadriceps activation were assessed in both limbs of patients, and corticomotor
excitability was assessed in the involved limb. Three days after ACLr, both
groups were instructed to begin their allocated interventions. The Home-NMES
group administered NMES to their involved limb’s quadriceps three sessions a
day for 15 minutes, and five days a week for 12 weeks using a portable NMES
device. The control group was treated according to the current standard-of-care,
but they were also instructed to perform volitional isometric quadriceps
contractions for the same duration and frequency as the Home-Based NMES
protocol. The outcomes measures were reassessed in both groups at three and
six months post-ACLr. Main Outcome Measures: Quadriceps strength and
voluntary activation were assessed using maximal voluntary isometric
contractions and the superimposed burst technique, respectively. Normalized
ii

peak knee extension torque and central activation ratio were used to quantify
isometric quadriceps strength and activation, respectively. Corticomotor
excitability was evaluated with transcranial magnetic stimulation, and quantified
with active motor threshold). The Y-balance test anterior reach (YBT-A) and
Knee Injury and Osteoarthritis Outcome Score (KOOS) were used to assess the
patients lower extremity knee function at six months post-ACLr. Statistical
Analyses: Specific Aim 1: A 2x3 (limb x time) mixed model, ANOVA with
repeated measures was performed in the control group to assess differences
between the involved limb and the uninvolved limb for isometric quadriceps
strength, and voluntary quadriceps activation over time. A one-way mixed model,
ANOVA with repeated measures was performed in the control group to assess
differences in corticomotor excitability over time. Post-hoc comparisons were
performed when appropriate. Specific Aim 2: Separate, mixed model, linear
regression analyses were performed in the control group (involved limb) to
determine the effect that the neuromuscular quadriceps outcome measures
assessed at baseline and 3 months post-ACLr, had on lower extremity knee
functional outcome measures assessed at 6 months post-ACLr. Specific Aim 3: A
2x2x3 (group x limb x time) mixed model, ANOVA with repeated measures was
performed to assess group differences between the involved limb and the
uninvolved limb in isometric quadriceps strength, and voluntary quadriceps
activation over time. A 2x3 (group x time) mixed model, ANOVA with repeated
measures was performed to assess group differences in corticomotor excitability
over time. Post-hoc comparisons were performed when appropriate. Results:
Aim 1: Patients demonstrated lower quadriceps strength on their involved limb
compared to their uninvolved limb at baseline, three months post-ACLr, and six
months post-ACLr. Quadriceps strength progressively decreased in the involved
limb of patients from baseline to 3 months post-ACLr, baseline to 6 months postACLr, and increased from 3 months to 6 months post-ACLr. Quadriceps strength
was also decreased in the uninvolved limb of patients from baseline to 6 months
post-ACLr. ). Irrespective of when it was assessed, voluntary quadriceps
activation was higher in the involved limb of patients compared to their
uninvolved limb. There were no changes in corticomotor excitability of the
involved limb over time. Specific Aim 2: The quadriceps strength of patients at
three months post-ACLr had a significant positive effect on their 6-month YBT-A
performance KOOS score. ). Neither voluntary quadriceps activation or
corticomotor excitability or AMT (at baseline or 3-month post-ACLr) had a
significant effect on any of the 6-month lower extremity functional outcome
measures. Specific Aim 3: Irrespective of limb or when it was assessed,
quadriceps strength was higher in the control group compared to the HomeNMES group. Both groups demonstrated lower quadriceps strength on their
involved limbs compared to their uninvolved limbs at baseline, three months
post-ACLr, and six months post-ACLr. Quadriceps progressively decreased in
the involved limbs of both groups from baseline to three months post-ACLr and
baseline to six months post-ACLr, and increased from three months to six
months post- ACLr. At baseline, voluntary quadriceps activation was higher in the
involved limbs of both groups compared to their uninvolved limbs. There were no
iii

group differences or changes over time observed in the involved limb of both
groups with corticomotor excitability. Conclusion: Although quadriceps weakness
is more apparent in the involved limb of patients after ACLr, the quadriceps
strength of their uninvolved limb was also affected. Clinicians are encouraged to
not rely on a quadriceps strength limb symmetry index when making return-sportdecisions for their patients after recovering from ACLr. The quadriceps in the
uninvolved limb of patients demonstrated more inhibition, which may explain the
quadriceps strength deficits observed in the uninvolved limb of patients following
ACLr. To reduce the risk of subsequent injury upon return-to-sport and protect
against the development of knee OA, we recommend that clinicians incorporate
bilateral interventions aimed at restoring quadriceps strength and disinhibiting the
quadriceps. Intensive quadriceps strengthening should be performed in the early
stages of ACLr rehabilitation, so that lower extremity function can be improved in
patients later on. Lastly, the effectiveness of home-based NMES as a modality
for restoring quadriceps strength and activation in patients after ACLr is
inconclusive. Home-based NMES provides patients with the ability to receive
higher doses of NMES to the quadriceps; but its effectiveness may be limited by
low contraction intensities and poor treatment compliance in patients.
Keywords: anterior cruciate ligament reconstruction, quadriceps, neuromuscular,
electrotherapy

Conrad M. Gabler
April 29th, 2016
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CHAPTER 1: INTRODUCTION

1.1

BACKGROUND
Anterior cruciate ligament (ACL) injuries are one of the most common

knee-joint injuries seen in orthopaedics, with up to one quarter of a million of
these injuries occurring in the United States each year.1 The majority of ACL
injuries occur in young athletes who participate in high-risk sports, such as
football, soccer, basketball, and skiing. ACL reconstruction (ACLr) is the
recommended treatment for patients diagnosed with ACL injuries in effort to
restore knee-joint stability, preserve the menisci, and allow patients to return to
their desired levels of physical activity. The Centers for Disease Control and
Prevention estimated that over 100,000 ACL surgeries are performed annually.2
However, there are several postoperative side effects observed in patients
following ACLr that must be considered.
Compared to healthy individuals, patients who have had previous ACLr
have demonstrated decreased functional performance,3-10 and reported reduced
levels of function and quality of life.8,9,11,12 Schmitt and colleagues8 reported that
in patients who were cleared to return to sport after unilateral ACLr demonstrated
greater limb asymmetry on functional hop test, and lower self-reported function
compared to healthy athletes of similar age, height, and weight. In addition,
unilateral ACLr has been repeatedly shown to alter lower extremity biomechanics
in patients during walking,13 running,14,15 and jumping/landing tasks.16-20 Lastly,
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ACLr does not protect patients from the development of knee osteoarthritis (OA),
an unforgiving and incurable disease that is associated with both disability and
mortality.21,22 Within the first decade after ACLr, it has been reported that over
one third of patients develop knee OA, and this prevalence approaches 50% by
the second decade.23 Furthermore, patients who undergo ACLr are found to have
a 29% higher odds of developing knee OA compared to those who are ACLdeficient.23
Perhaps the most apparent side effect that is observed in patients after
ACLr is a persistent quadriceps strength deficit in the involved limb. Although
quadriceps weakness is also present in patients after ACL injury, it is further
exacerbated after they undergo ACLr.3,24-31 Studies have reported quadriceps
strength deficits in patients beyond 12 months and up to 20 years after
ACLr.5,11,25,32-50 Kuenze et al.48 recently compared the quadriceps strength limb
symmetry indices (LSI) of 22 patients who were an average of 2.5 years removed
from primary ACLr, and 24 matched, healthy controls. They reported significant
group differences in quadriceps strength, with the healthy controls demonstrating
nearly symmetrical quadriceps strength (LSI = 97 ± 14%), and the ACLr patients
still exhibiting persistent asymmetry beyond 2 years after surgery (LSI = 85 ±
21%). Furthermore, growing evidence demonstrates that the quadriceps strength
deficits observed in patients after unilateral ACLr are not specific to the involved
limb, but are observed in the uninvolved limb as well.32,42,45,51,52 Chung et al.45
recently assessed the temporal changes in bilateral quadriceps strength of 75
patients up to 24 months after unilateral ACLr, and compared their values to 75

‐2‐

matched, healthy controls. As expected, the quadriceps strength on the involved
limb was significantly lower than that of the uninvolved limb at each postoperative
time point leading up to 24 months (p < 0.05), but when these values were
compared to that of the healthy control group, both the involved and uninvolved
limbs of the ACLr group demonstrated significantly lower quadriceps strength at
each time point. Although a LSI is typically used to quantify quadriceps strength
deficits in the involved limbs of patients after ACLr, reports such as these
suggest that using the uninvolved limb as the reference may deceive clinicians
by underestimating the true magnitude of quadriceps weakness that is present.
Therefore, it may be more beneficial for clinicians to individually compare the
postoperative quadriceps strength of both limbs to the quadriceps strength of the
uninvolved limb measured prior to ACLr.
Restoring quadriceps strength in patients after ACLr is a primary focus for
clinicians during rehabilitation, due to the association quadriceps weakness has
with the aforementioned side effects of ACLr. A number of studies have
demonstrated the negative effect quadriceps weakness has on functional
performance and self-reported function in patients after ACLr.3,7-9,11,28,39,48,53-65
Quadriceps strength has been shown to predict 25% (r2 = 0.25) of the variance in
single-leg hop distance,54 and over 60% (r2 = 0.61) of the variance in selfreported function of patients with a prior history of ACLr.61 Several studies have
also demonstrated that quadriceps weakness contributes to the biomechanical
alterations observed during dynamic tasks.54,63,66-72 Ithburn and colleagues63
recently conducted a study comparing the quadriceps strength and single-leg

‐3‐

drop-landing biomechanics of 93 patients who were eight months post-ACLr, and
47 age-matched healthy controls. They subdivided patients into high-strength
and low-strength groups, and then compared the biomechanical data between
the three groups. They not only found that both the ACL groups demonstrated
greater knee-joint biomechanical asymmetries during landing compared to the
healthy controls, but that these asymmetries were even more pronounced in the
low-strength ACLr group compared to the high-strength ACLr group.
Perhaps the most detrimental effect quadriceps weakness has is on the
knee-joint health of patients after ACLr. During normal gait, three to four times of
an individual’s bodyweight is transmitted through their knee-joint.73 To limit
excessive joint loading, the quadriceps serve as the primary shock absorber for
the knee-joint. During ground contact (weight acceptance), the quadriceps
eccentrically contract to absorb the majority of external forces at the knee.73-75 As
a result, the forces transmitted through the knee-joint become dissipated, and
minimal stress is placed on articular cartilage.76,77 Conversely, weakness of the
quadriceps would cause higher loads to be transmitted at the knee-joint, and
expose the articular cartilage to more contact. Therefore, it has long been
hypothesized that quadriceps weakness contributes to the onset and progression
of knee OA in patients following ACLr.
Within the past decade, several studies have been able to support this
hypothesis through longitudinal investigations.78-83 Tourville and colleagues79
prospectively assessed tibiofemoral joint space narrowing and isokinetic knee
extension torque (KET) in 38 patients prior to ACLr and 4 years postoperatively.
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After follow-up testing, the authors separated patients into narrow and normal
joint space groups based upon their 4-year radiographs, and compared the ACLr
patients’ quadriceps strength to that of 32 healthy controls. At baseline, the
quadriceps strength in both ACLr groups was lower than that of healthy controls.
However, the peak KET of the narrow ACLr group’s was also significantly lower
than that of the normal ACLr group. Four years after ACLr, the quadriceps
strength of the normal ACLr group improved and was not significantly different
compared to healthy controls, while the narrow ACLr group’s quadriceps strength
remained lower than both the normal ACLr group and healthy controls.
Furthermore, a recent systematic review and meta-analysis reported that patients
who exhibit early quadriceps weakness have a 65% higher odds of developing
knee OA years later (OR = 1.65).78
In addition to the quadriceps strength deficits that are observed in patients
after ACLr, there are concurrent neural alterations occurring throughout various
levels of the central nervous system that result in neural quadriceps dysfunction
(NQD). The most evident type of NQD that patients exhibit following ACLr is the
inability to voluntary activate the quadriceps on the involved limb.32,34,51,84-86 This
decreased voluntary activation can be explained by a diminished ability to fully
recruit the motor units innervating the quadriceps and a reduced motor neuron
firing frequency.87 Healthy individuals without a history of knee injury or surgery
have the ability to volitionally activate at least 95% of the available motor units
innervating the quadriceps.88 Therefore, a volitional activation of 95% has been
generally accepted as the cutoff value for determining whether or not a patient
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has neural inhibition of their quadriceps after ACLr.89,90 Like quadriceps
weakness, quadriceps inhibition has been reported to exist bilaterally in patients
after unilateral ACLr, with the nonsurgical limb being equivalent to that of the
surgical limb. 32,51,91
One of the more recent types of NQD that has been observed in patients
after ACLr is a modified corticomotor excitability associated with the
quadriceps.34,51,84 Corticomotor excitability is typically assessed by applying
transcranial magnetic stimulation (TMS) to the area of the motor cortex where the
quadriceps are most represented, and measuring the resulting neuromuscular
responses at the quadriceps through surface electromyography (EMG).92-95 As
opposed to quadriceps weakness and inhibition, modifications in corticomotor
excitability are not observed immediately after unilateral ACLr.51 Lepley and
colleagues51 longitudinally assessed the changes in corticomotor excitability of
20 patients before and after undergoing unilateral ACLr. When compared to
healthy controls, no differences in corticomotor excitability were found
preoperatively or at two weeks postoperatively, but it was lower in patients at six
months post-ACLr. However, it remains unknown whether changes in
corticomotor excitability occur in patients during the first several months following
ACLr, demonstrating the need for more longitudinal studies to assess this
outcome.
1.2

SIGNIFICANCE
After knee-joint injury and/or surgery, the knee becomes immobilized due

to pain and swelling, causing the quadriceps to atrophy and weaken. As
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mentioned above, quadriceps weakness can lead to altered lower extremity
mechanics and reduced function, which may predispose patients to future injury
such as knee OA. However, the problem is that a majority of studies assessed
the correlation between quadriceps strength and observed sequelae (i.e., altered
biomechanics, reduced function, knee OA, etc.) in patients cross-sectionally after
they returned to sport activity, and were unable to determine whether earlier
quadriceps strength deficits explained the sequelae observed in patients later on
after ACLr. Answering this question would provide further evidence for clinicians
to focus on quadriceps strengthening in patients during the early stages of ACLr
rehabilitation.
NQD has been thought to be a driving factor behind the cyclical sequelae
(see Figure 1.1).96 NQD has been shown to explain nearly half of the variance in
quadriceps strength of patients after ACLr.97 Therefore, NQD is thought to
contribute to altered lower extremity biomechanics, reduced function, and early
knee OA that are observed in patients with quadriceps weakness. However, little
to no research has been able to confirm the effect of NQD on these
postoperative sequelae. Furthermore, since NQD is believed to limit the ability of
patients to regain quadriceps strength after ACLr, postoperative rehabilitation
protocols should involve methods to properly target NQD. Traditional
rehabilitation protocols that consist of isometric or concentric modes of exercise
to enhance quadriceps strength in patients after ACLr have been largely
ineffective.98,99 This led to the introduction and development of disinhibitory
interventions. Disinhibitory interventions consist of therapeutic modalities that
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Figure 1.1. Cyclical sequelae of knee-joint injury/surgery. An adapted paradigm
from Stokes and Young, 1985, Clinical Science, 67, 7-14.96

have been shown to successfully mediate NQD in patients with a history of kneejoint injury/surgery by targeting its underlying mechanisms.100-102
Neuromuscular electrical stimulation (NMES) is a motor-based modality
which elicits muscle contractions by directly activating the intramuscular nerve
branches through surface electrodes at the skin.103 NMES has been well
established in the literature as an effective modality for restoring quadriceps
strength in patients after ACLr.70,104-110 Although these strength improvements
can be easily attributed to the muscle hypertrophy,111-115 it is believed that neural
adaptations elicited by NMES are partly responsible for the increases in muscle
strength.111-113,116,117 However, there is conflicting evidence concerning the
disinhibitory effects of NMES on removing NQD in patients after knee
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injury/surgery. Several studies have reported improvements in the voluntary
quadriceps activation of patients with NMES interventions.116,118-122 Stevens et
al.118 assessed the effect of a quadriceps exercise program supplemented with
NMES for patients after total knee arthroplasty. Compared to those patients who
did not receive supplemental NMES, the group who received NMES with
exercise demonstrated significant improvements in voluntary quadriceps
activation at three weeks, six weeks, and six months postoperatively.101 Other
studies have negated the disinhibitory effects of NMES,123-128 but no study has
investigated the disinhibitory effect of NMES in patients after ACLr. Furthermore,
portable NMES units have demonstrated promising results in regard to improving
outcomes.129-131 The higher volume of NMES combined with the convenience of
home-based NMES, make these units an attractive modality for postsurgical
patients. Therefore, research is needed to assess the effect of home-based
NMES on improving neuromuscular quadriceps function in patients after ACLr.

1.3

SPECIFIC AIMS
1. To examine the temporal pattern of neuromuscular quadriceps
deficits in both the involved and uninvolved limbs of the patients
assigned to the control group after ACLr, by assessing
quadriceps strength, voluntary activation, and corticomotor
excitability prior to ACLr (baseline), three months after ACLr, and
six months after ACLr. We hypothesized that quadriceps strength
and voluntary activation would be lower in the involved limb compared
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to the uninvolved limb at each time point. We believed this because
previous reviews have demonstrated side-to-side quadriceps strength
differences in patients after ACLr at similar time points.98,132 Secondly,
we expected that quadriceps strength and voluntary activation would
decrease in the involved limb at three months post-ACLr compared to
baseline, and return to baseline values at six months post-ACLr. We
believed this because neuromuscular quadriceps function has been
found to be more affected within the first few months after ACLr
compared to ACL injury,3,24,27,31,133 and it begins to return to
preoperative levels around six months post-ACLr.24,51 We expected
that the corticomotor excitability of the involved limb’s quadriceps
would progressively decrease over time, and be most pronounced at
six months in accordance with the recent findings from Lepley et al.51
Lastly, we expected that the quadriceps strength and voluntary
activation of the uninvolved limb to progressively decrease over time,
because recent studies have shown that these two measures are
decreased in both limbs of patients after unilateral ACLr.34,42,45,51,84,91

2. To determine whether quadriceps strength, voluntary activation,
and/or corticomotor excitability assessed in patients prior to
surgery and/or at three months after ACLr, can predict lower
extremity postural control and/or self-reported function at six
months post-ACLr. We hypothesized that the patients’ quadriceps
strength and activation assessed at baseline and three months after
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ACLr would significantly influence the lower extremity postural control
and self-reported function at six months post-ACLr. We believed this
because these measures are sensitive to change within the first few
months after ACL injury and reconstruction,3,24,27,31,133 and they have
previously been reported to affect knee function in patients.53-55,6062,72,134

Secondly, we expected that corticomotor excitability would have

an insignificant influence on these same outcomes, mainly because
this measure has been found to be less affected within the first few
months after ACL injury and reconstruction.51

3. To determine if a 12-week home-NMES program elicits greater
bilateral improvements in quadriceps strength, voluntary
activation, and corticomotor excitability of patients at three and
six months after ACLr compared to a 12-week standard homeexercise program (control group). We hypothesized that patients
who performed the home-NMES program would demonstrate greater
bilateral improvements in quadriceps strength, voluntary activation,
and corticomotor excitability at both three and six months post-ACLr
compared to patients in the control group. We believed this because of
the previous literature that has demonstrated neuromuscular
improvements in the quadriceps of patients after NMES
interventions,105,106,118,122 the evidence of NMES targeting cortical
areas of the brain,116,135-137 and the phenomenon of cross-education
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that has been observed in the contralateral limb after ipsilateral NMES
treatments.111,138,139
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CHAPTER 2: REVIEW OF LITERATURE

2.1

INTRODUCTION
2.1.1 Evidence of Quadriceps Weakness
Quadriceps weakness is the most prevalent neuromuscular deficit

observed in the involved limbs of patients following ACL injury and ACLr. The
incidence and progression of quadriceps weakness has been well documented in
the literature.3,5,8,11,24-49,51,52,56,57,59,64,65,86,91,98,132,133,140-179 As a result, quadriceps
weakness has become an expected side effect of knee-joint trauma amongst
clinicians. Although ACLr is the recommended treatment to restore knee-joint
stability and improve function in patients with ACL injuries, it is not an effective
treatment for restoring quadriceps strength. In fact, quadriceps weakness is
further exacerbated in patients after ACLr compared to when they were without
an intact ACL (ACL-deficient).3,24-31 Moreover, the amount of quadriceps
weakness a patient exhibits prior to ACLr has been reported to be directly related
to the magnitude of quadriceps strength that will be further lost after
ACLr.27,56,64,147 Therefore, it is important for clinicians to focus their rehabilitation
on restoring quadriceps strength in patients both before and after ACLr.
Quadriceps strength is typically assessed by having the patient perform a
maximal voluntary contraction of the quadriceps during an open kinetic chain,
knee extension task. This can be performed either isometrically (fixed knee-joint
angle) or isokinetically (fixed angular velocity), with peak KET being the primary
measure of interest (measured in Nm or ft·lbs). An LSI is commonly used to
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quantify quadriceps weakness in patients after ACLr, which involves dividing the
peak KET produced in the involved limb by the peak KET produce in the
uninvolved limb (often reported as a percentage). Previous literature reviews
have reported that the average quadriceps strength LSI observed in patients
after ACLr was less than 80% at six months post-ACLr,98,132 and less than 90%
at 12 months post-ACLr.132 A criterion that is regularly used by clinicians when
determining whether a patient is ready to return to activity/sport after ACLr, is if
their quadriceps strength LSI is equal to or greater than 90%.8,28,68,180,181
However, most patients are discharged from rehabilitation and receive medical
clearance to return to their pre-injury physical activities or sports between six and
12 months after their ACLr.
This incongruity is most likely the result of the clinical methods used to
assess quadriceps strength in these patients. An isokinetic dynamometer is
referred to as the “gold standard” tool for measuring KET attributed to quadriceps
strength. However, these devices are rarely available in physical therapy clinics
due to their high financial cost. Therefore, most clinicians resort to manual
muscle tests or leg extension machines, which can compromise the validity and
reliability of the quadriceps strength assessment. In addition, quadriceps strength
LSI is known to be affected by angular velocity used during isokinetic
assessments. Several studies have reported insufficient quadriceps strength
symmetry (LSI ≤90%) in patients after ACLr when testing (concentrically) at an
angular velocity of 60°/s, but when testing at angular velocities of 120°/s or
faster, these same patients were able to meet the criterion (LSI
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≥90%).30,31,57,132,133,142,168,178,179 Most recently, Hsiao et al.31 assessed quadriceps
strength LSI in patients after ACLr using a variety of angular velocities (isokinetic)
as well as knee-joint angles (isometric). When compared to the pre-ACLr values,
significant decreases in quadriceps strength LSI were only observed at the
slower angular velocities (concentric at 50°/s and 100°/s) and the larger knee
flexion angles (70° and 90°). Although this phenomenon has yet to be fully
understood from a physiological standpoint, it must be considered by clinicians
when performing quadriceps strength assessments on these patients. Current
evidence suggests that quadriceps strength should be tested isometrically at 7090° of knee flexion,31 and/or isokinetically at an angular velocity of 60°/s
(concentric) in order to detect asymmetries in patients following ACLr.98,132
The length of time quadriceps weakness has been found to persist in
patients following ACLr is of equal concern. Studies have reported quadriceps
strength deficits in patients beyond 12 months and up to 20 years after
ACLr.5,11,25,32-50 Kuenze et al.48 recently compared the quadriceps strength LSI of
22 patients (average of 2.5 years removed from primary ACLr), and 24 matched,
healthy controls of comparable age, height, and weight (p >0.05). After assessing
isometric quadriceps strength (90° of knee flexion) bilaterally in both groups, they
reported significant group differences in quadriceps strength LSI (p = 0.03). The
healthy controls demonstrated nearly symmetrical quadriceps strength (LSI = 97
± 14%), whereas the ACLr patients still exhibited persistent asymmetry beyond
two years after surgery (LSI = 85 ± 21%). The persistent quadriceps weakness
that is observed in patients with a history of ACLr is likely the result of a
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combination of multiple factors. First, this may mean that patients are being
released from rehabilitation prematurely and the current quadriceps
strengthening interventions used in rehabilitation are not efficacious. Secondly,
patients may have achieved the recommended 90% LSI for quadriceps strength
at their date of clearance to return to activity/sport, but they failed to maintain that
symmetry years after their ACLr. Lastly, patients may have developed sequelae
such as patellofemoral pain or early knee osteoarthritis, which have also been
associated with quadriceps strength deficits.59,182
It must be mentioned that the attenuation of quadriceps strength that has
been consistently observed in the involved limbs of patients after unilateral ACLr,
has also been reported in these patients’ uninvolved limbs.32,42,45,51,52 Although
more research is needed to understand the manifestation of contralateral
quadriceps weakness in patients after unilateral ACLr, the available evidence
relative to this matter is sufficient to deserve clinical consideration. Chung et al.45
recently assessed the temporal changes in bilateral isokinetic quadriceps
strength (concentric at 60 deg/s) of 75 patients at three, six, 12, and 24 months
after unilateral ACLr. In addition, they compared the peak KET values of the
ACLr patients to 75 healthy controls who were of equal age, sex, height, weight,
and pre-injury physical activity level (via Tegner activity scale). In the ACLr
group, the uninvolved limb’s peak KET was significantly higher than that of the
involved limb at three (266.1 ± 43.7 Nm vs. 178.8 ± 51.2 Nm), six (276.4 ± 42.7
Nm vs. 224.2 ± 58.5 Nm), 12 (276.7 ±44.9 Nm vs. 235.4 ± 56.9 Nm), and 24
months (276.6 ± 42.8 Nm vs. 242.8 ± 55.5 Nm) after ACLr (p < 0.05). However,
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when these values were compared to that of the healthy control group (290.9 ±
40.1 Nm), both the involved and uninvolved limbs of ACLr group demonstrated
significantly lower peak KET at each follow-up time point (p < 0.05). Evidence
such as this suggests that using the uninvolved limb as the reference when
assessing quadriceps strength in patients after unilateral ACLr may
underestimate the magnitude of quadriceps strength deficits. Therefore, the
quadriceps strength LSI could mask true quadriceps weakness and deceive
clinicians when making the decision to return patients to their pre-injury
activity/sport after ACLr. For example, a patient may demonstrate greater than
90% quadriceps strength LSI, but if the quadriceps strength of their uninvolved
limb has also declined since the initial ACL injury, then the recovery of
quadriceps strength on the involved limb may be overestimated by an LSI.
Clearing a patient to return to their pre-injury activity/sport prior to
restoring bilateral quadriceps strength may place both of their limbs at risk for
subsequent knee-joint injury, and expose the knee to increased contact forces
due to the decreased force absorption capabilities from the quadriceps. To
unmask the quadriceps strength deficits in the involved limbs of patients and
account for the potential deficits of their uninvolved limbs, clinicians are
encouraged to not depend on an LSI when assessing the recovery of quadriceps
strength in patients after unilateral ACLr. Alternatively, it is recommended that
clinicians compare the bilateral peak KET data of their ACLr patients to those of
healthy individuals who are of similar age and stature (preferably normalized to
bodyweight: Nm/kg or Ft·lbs/lbs). If data from healthy individuals are not
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available to clinicians, the second best alternative is to compare the patients’
postoperative bilateral quadriceps strength to the preoperative quadriceps
strength of their uninvolved limbs after the initial ACL injury. Although acute ACL
injury is known to elicit deficits in ipsilateral quadriceps strength, there is no
evidence to suggest that acute ACL injury affects quadriceps strength in the
contralateral limb. Using these alternative comparison strategies provides
clinicians with a clearer representation of quadriceps strength recovery in the
involved limbs of patients after ACLr, and allows clinicians to determine if
postoperative quadriceps weakness is present in the uninvolved limbs so that
adjustments can be made in rehabilitation to correct bilateral quadriceps strength
deficits.
2.1.2 Consequences of Quadriceps Weakness
Given the ubiquitous nature of quadriceps weakness in patients who have
undergone ACLr, and its tendency to remain years after surgery, it is important to
understand the consequences of persistent quadriceps weakness. Since the
quadriceps are the largest muscle group of the lower extremity, which function to
facilitate movement and absorb external forces, it is expected that weakness in
this muscle group would lead to functional limitations in patients after ACLr. The
following section will discuss the consequences of quadriceps weakness on the
functional performance, self-reported function, lower extremity biomechanics,
knee-joint health, and general health of individuals.
Functional Performance
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Single-leg hop (SLH) testing is one of the more common methods used by
clinicians to assess lower extremity functional performance in patients after ACLr.
This testing consists of either a single hop for distance,183-185 a timed 6-meter
hop,183 a straight triple hop for distance,185 a cross-over triple hop for distance,185
or a combination of the four. SLH testing is regularly used in conjunction with
quadriceps strength testing for return to activity/sport decision making, with the
same criteria (≥ 90% LSI) being used to determine a patient’s physical readiness
to return to their pre-injury level of physical activity. In fact, growing evidence has
shown that quadriceps strength and SLH performance is higher (or more
symmetrical) in patients who return to activity/sport after ACLr compared to those
who do not.180,186,187
Numerous studies have reported that quadriceps weakness negatively
affects a patient’s performance on SLH tests after ACLr.3,7-9,28,39,53-59 Keays et
al.28 assessed the isokinetic peak KET (concentric at 60 and 120 deg/s), single
hop for distance, triple hop for distance, and performance on several agility tests
in 31 patients before unilateral ACLr and at their 6-month postoperative followup. The authors then sought to determine whether quadriceps strength was
correlated with functional performance before and after ACLr. Before ACLr,
significant correlations were observed between isokinetic quadriceps strength (at
both speeds) and performance on single (60 deg/s: r = 0.55, 120 deg/s: r = 0.53;
p < 0.01) and triple hop tests (60 deg/s: r = 0.55, 120 deg/s: r = 0.59; p < 0.01).
However, significant correlations were reported for the agility tests at six months
after ACLr (60 deg/s: r = 0.47 – 0.53, 120 deg/s: r = 0.46 – 0.52; p ≤ 0.01), and
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stronger correlations were also observed between quadriceps strength and the
single (60 deg/s: r = 0.66, 120 deg/s: r = 0.74; p < 0.00) and triple hop tests (60
deg/s: r = 0.62, 120 deg/s: r = 0.74; p < 0.001). This study not only demonstrated
the relationship between quadriceps strength and lower extremity functional
performance, but that this relationship is even stronger in patients following ACLr.
A recently published study by Palmieri-Smith and colleagues54 reported that
isokinetic quadriceps strength LSI (concentric at 60 deg/s) significantly predicted
25% (r2 = 0.25; p < 0.002) of the SLH for distance LSI in patients six to eight
months removed from ACLr.
There is also some evidence to suggest that postoperative quadriceps
strength is related to vertical jump height in patients after ACLr.4,7 Laudner et al.4
recently assessed isokinetic peak KET (concentric at 60 and 300 deg/sec), and
both single and double leg vertical jump height in 26 patients who were an
average of eight (7.8 ± 1.9) months post-ACLr and 26 healthy controls (matched
by height and weight). The bilateral differences in single leg vertical jump height
and peak KET (at both speeds) were significantly greater in patients than in the
healthy controls (p = 0.001). Furthermore, they found that isokinetic peak KET
was significantly correlated with both single (60 deg/s: r = 0.71, 300 deg/s: r =
0.74; p < 0.05): and double leg (60 deg/s: r = 0.64, 300 deg/s: r = 0.63; p < 0.05)
vertical jump height in patients. This data suggest that quadriceps weakness not
only mitigates single-leg jump performance in the horizontal direction, but in the
vertical direction as well.
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Altogether, this evidence demonstrates the importance of restoring
quadriceps strength in patients after ACLr in regards to improving lower extremity
functional performance and preparing them to return to activity/sport. Therefore,
clinicians should continue to emphasize quadriceps strengthening in the later
stages of rehabilitation to facilitate improvements in lower extremity function.
Self-Reported Function
Self-reported function is another outcome used by clinicians to determine
how well patients perceive their knee-joint pain, symptoms, and function following
ACLr. It is used to determine how successful ACLr and postoperative
rehabilitation are as treatments for ACL injuries. Questionnaires are used to
assess self-reported function and collect data on patients before and/or after
ACLr. The questionnaires that are currently used to assess self-reported function
in patients who have undergone ACLr are the International Knee Documentation
Committee (IKDC) form and Knee Osteoarthritis Outcome Score (KOOS). The
IKDC is a valid and reliable questionnaire for assessing self-reported function in
patients after ACL injury or reconstruction.188,189 The KOOS consists of 18
questions that pertain to knee-joint symptoms, and performance during dynamic
and daily activities. Excellent validity and reliability has been reported for the
KOOS in both ACL injury and ACLr patient populations.190-193 It consists of 42
questions that are categorized into five domains: knee-joint symptoms, knee-joint
pain, function with activities of daily living, function with sports/recreation, and
quality of life. Both the IKDC and KOOS (total) are scored on a 0-100 scale, with
100 representing the highest self-reported function. However, clinicians are
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urged to analyze and interpret each domain of the KOOS separately. Therefore,
each KOOS domain is typically scored separately on a 0-4 scale and
transformed into a percentage (0-100%).
Both the IKDC and KOOS,8,48,55,60-63 as well as other questionnaires
pertaining to self-reported function (Cincinnati Knee Score, Lysholm, and Tegner
activity scale),11,39,64,65 have been shown to be related to quadriceps strength of
patients after ACLr. Perhaps the most impressive study that supported this
relationship was that done by Pietrosimone and colleagues.61 They assessed
isometric peak KET (at 90° of knee flexion) and IKDC scores in 15 patients who
were an average of 54.4 (± 40.9) months removed from ACLr, and performed a
linear regression analysis to determine the amount of variability in self-reported
function that could be explained by their quadriceps strength. They discovered
that isometric quadriceps strength predicted over 60% (r2 = 0.61; p = 0.01) of the
variance in the IKDC scores of patients who have a history of ACLr. This finding
demonstrates that the majority of self-reported function (via IKDC) in patients
after ACLr can be explained by their quadriceps strength, and that quadriceps
weakness can severely limit these patients’ perceived function.
Lower Extremity Biomechanics
Assessing a patient’s lower extremity biomechanics after ACLr is also
important to determine whether there are kinematic and/or kinetic patterns that
give insight into specific weaknesses or place patients at risk for subsequent
injury. 3-D motion analyses are known as the gold standard for assessing
biomechanical patterns in individuals. They can provide information relative to
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joint angles, joint moments (internal and external), and vertical ground reaction
forces during various dynamic tasks (i.e., walking, running, jumping, etc.).
Although 2-D motion analyses are less expensive and can provide similar
information, they do not possess the same level of validity and reliability as 3-D
motion analyses. Therefore, a 3-D motion analysis is typically used by
researchers when assessing lower extremity biomechanics in patients before
and/or after ACLr.
Unilateral ACLr has been repeatedly shown to alter lower extremity
biomechanics in patients during walking,13 running,14,15 and jumping/landing
tasks.16-20 However, several studies have demonstrated that quadriceps
weakness contributes to the biomechanical alterations observed during these
tasks.54,63,66-72 Ithburn and colleagues63 recently conducted a study comparing
the isometric quadriceps strength LSI (at 60° of knee flexion) and single-leg droplanding biomechanics of 93 patients (mean age, 17.3 years) who were eight
months post-ACLr, and 47 age-matched healthy controls (mean age, 17.0 years).
After assessing the quadriceps strength of the ACLr group, they subdivided
patients into high-strength (≥ 90% LSI) and low-strength (< 80% LSI) groups, and
then compared the biomechanical data between the three groups (high-strength
ACLr, low-strength ACLr, and healthy control). They reported that both ACL
groups demonstrated greater knee-joint biomechanical asymmetries during
landing compared to the healthy controls. Specifically, decreased knee flexion
excursion (low-strength, p < 001; high-strength, p = 0.02) and peak internal knee
extension moments (low-strength, p < 001; high-strength, p < 0.01), and peak
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increased trunk flexion angle (low-strength, p < 001; high-strength, p = 0.03)
were observed in the involved limbs of the ACLr groups. However, knee flexion
excursion (p = 0.03) and peak internal knee extension moments (p = 0.03) were
further decreased, and peak trunk flexion angle was increased (p < 0.01) in the
involved limbs of the low-strength ACLr group compared to the high-strength
ACLr group. The authors also performed a linear regression analysis, and
reported that isometric quadriceps strength LSI was a significant predictor for
knee flexion excursion (r2 = 0.12, p < 0.001), peak internal knee extensor
moment (r2 = 0.10, p < 0.001), and peak trunk flexion angle (r2 = 0.15, p < 0.001).
Similar results have been previously reported by Lewek et al.68 They discovered
that quadriceps strength LSI in patients after ACLr significantly predicted peak
knee flexion angles (r2 = 0.25, p < 0.05) and peak internal knee extension
moments (r2 = 0.38, p < 0.01) during a jogging task.
In another study by Schmitt et al.,67 they reported that external
biomechanical forces are also distributed differently between the limbs of patients
at the time of return to activity/sport after unilateral ACLr. Similar to Ithburn et
al.,63 they divided patients into high (≥ 90% LSI) and low-strength (< 85% LSI)
groups, and compared biomechanical data to that of an age-matched, healthy
control group. However, instead of performing single-leg landing task, the
participants performed a double-leg drop vertical jump task. Compared to the
high-strength ACLr and healthy control groups, the low-strength ACLr group
demonstrated greater asymmetry in peak external knee flexion moments (p <
0.001, p < 0.001, respectively), peak vertical ground reaction forces(p < 0.001, p
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< 0.001, respectively), and peak loading rates (p < 0.01, p < 0.05, respectively).
Specifically, all three biomechanical measures were significantly lower in the
involved limbs and higher in the uninvolved limbs of the low-strength ACLr group.
There were no significant differences between the high-strength ACLr group and
healthy control group in regards to biomechanical limb symmetries (p < 0.05).
Knee-joint excursion and internal knee extension moments are
biomechanical measures that are believed to be controlled through an eccentric
contraction of the quadriceps.68 Therefore, a reduction of these two measures
may be an indicator of quadriceps weakness. The increased trunk flexion angle
observed in ACLr patients is said to be a compensatory biomechanical strategy
to accommodate for quadriceps weakness by shifting ground reaction forces
anterior to the knee.16 Furthermore, the asymmetrical distribution of external
forces between limbs of patients who exhibit quadriceps weakness after ACLr
has been theorized to place both knee-joints at risk for subsequent knee-joint
injury.67,194 While the ipsilateral quadriceps weakness exhibited in patients after
unilateral ACLr may decrease their ability to absorb shock at the surgical kneejoint, their increased reliance on the contralateral limb may also overload the
nonsurgical knee-joint. Although ACLr alone has an effect on lower extremity
biomechanics, quadriceps weakness seems to further contribute to
biomechanical alterations in these patients.
Knee-Joint Health
The development of knee OA is a common side effect in patients who
sustained ACL injuries.195,196 Although ACLr is a successful treatment for
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restoring knee-joint stability in these patients, it is largely ineffective at preventing
the development of knee OA. Within the first decade after ACLr, it has been
reported that over one third of patients develop knee OA, and this prevalence
approaches 50% by the second decade.23 Furthermore, patients who undergo
ACLr are found to have a 29% higher odds of developing knee OA compared to
those who are ACL-deficient.23 These statistics are interesting given that ACLr
has also been shown to exacerbate quadriceps weakness in patients who
sustain ACL injuries, which is why many researchers have hypothesized
quadriceps weakness to be a risk factor for the onset and progression of knee
OA in these patients.73-75,197
During normal gait, three to four times the bodyweight of a healthy
individual is transmitted through their knee-joint.73 To limit excessive joint loading,
the quadriceps serve as the primary shock absorber for the knee-joint. During
ground contact (weight acceptance), the quadriceps contract eccentrically to
absorb the majority of external forces at the knee.73-75 As a result, the forces
transmitted through the knee-joint become dissipated, and minimal stress is
placed on articular cartilage.76,77 Therefore, weakness of the quadriceps would
likely cause higher loads to be transmitted at the knee-joint, and expose the
articular cartilage to more contact. Two studies76,198 used a femoral nerve block
to temporarily paralyze the quadriceps of healthy individuals, and assessed the
change in loading rate at the knee during gait. After quadriceps paralysis, the
loading rate at the knee during heel-strike increased to more than twofold in
these individuals. The authors concluded that the increase in knee-joint loading
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was a direct reflection of the inability of the quadriceps to absorb external forces
during weight acceptance.
Since quadriceps weakness was first hypothesized to be related to the
onset and progression of knee OA, considerable research has been devoted to
determining the legitimacy of this relationship. As of today, there are numerous
studies that have been able to establish an association between quadriceps
weakness and knee OA in patients.78-83,182,199-214 Slemenda and colleagues212
were one of the first groups to demonstrate the integral role quadriceps strength
has on lowering the risk of knee OA in patients. They assessed isokinetic KET
(concentric at 60 deg/s) and radiographic tibiofemoral knee OA in 462 individuals
who were over the age of 65 years. Those individuals with Kellgren-Lawrence
grades greater or equal to 2 were classified as having knee OA, and those who
graded less than 2 were classified as healthy controls. Compared to the healthy
controls, those individuals with radiographic knee OA had approximately 20%
less quadriceps strength (p < 0.01). In addition, they reported that for every 10
ft·lb increase in isokinetic KET, there was a 20% lower odds of radiographic knee
OA (OR = 0.80, CI = 0.71-0.90) and 29% lower odds of symptomatic knee OA
(OR = 0.71, CI = 0.59-0.87). Thus, higher quadriceps strength served as a
protector against knee OA in older individuals. These results were later
supported by Baker et al.,210 who reported high isometric KET (at 90° of knee
flexion) to be a significant protector against mixed knee OA (tibiofemoral and
patellofemoral) in patients who were 60 years or older (OR = 0.4-0.5, CI = 0.30.8).
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However, the limitation of these two studies is that their assessments were
cross-sectional, which is the case for the majority of studies in this area.199203,205,207-209,211,213,214

In other words, these studies are unable to discern whether

OA precedes quadriceps weakness, or quadriceps weakness precedes OA.
Therefore, longitudinal follow-up studies are ideal for determining the true effect
quadriceps weakness has on the onset and progression of knee OA. There have
been a handful of longitudinal studies that have been able to demonstrate that
quadriceps weakness is a significant contributor to the onset of knee OA in
patients.78-83,212 Tourville and colleagues79 assessed tibiofemoral joint space
narrowing and isokinetic KET (concentric at 60 deg/s) in 38 patients prior to ACLr
(baseline) and four years postoperatively. After follow-up testing, the authors
separated patients into narrow and normal joint space groups based upon their
4-year radiographs. They also compared the ACLr patients’ quadriceps strength
to that of 32 healthy controls of similar age, body mass index, and physical
activity level. At baseline, the quadriceps strength in both ACLr groups was lower
than that of healthy controls (p < 0.001). However, the quadriceps strength of the
narrow ACLr group’s peak KET was also significantly lower than that of the
normal ACLr group (p = 0.04). Four years after ACLr, the quadriceps strength of
the normal ACLr group (95 ± 10.3% LSI) improved and was not significantly
different compared to healthy controls (99 ± 11.6% LSI, p > 0.05), while the
narrow ACLr group’s quadriceps strength (83 ± 23.1% LSI) remained lower than
both the normal ACLr group (p = 0.04) and healthy controls (p = 0.01). A more
recent systematic review and meta-analysis by Oiestad et al.78 reported that
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initial quadriceps weakness increased the odds of patients developing knee OA
(radiographic and/or symptomatic) by 65% (OR = 1.65, CI = 1.23-2.21). While
this study concluded that quadriceps is a significant risk factor of knee OA, their
analyses only consisted of five longitudinal studies.82,83,212,215,216
Compared to the handful of longitudinal studies that have been able to
support that the onset of knee OA in patients is related to a history or quadriceps
weakness, there are even fewer longitudinal studies available that demonstrate
that quadriceps weakness influences the progression of knee OA.204,206 Both
studies assessed initial isokinetic peak KET (concentric at 60 deg/s) in patients
diagnosed with knee OA, and divided them into tertiles according to quadriceps
strength (low, med, and high strength). At 30-month follow-up, the severity of
knee OA was assessed in both studies to determine whether initial quadriceps
strength contributed to the progression of knee OA. In the earlier study, Amin and
colleagues206 reported that compared to the patients in the lowest tertile of
quadriceps strength at baseline, the patients in the highest tertile had a 60%
lower odds of progressive patellofemoral osteoarthritis 30 months later (OR =
0.40, CI = 0.2-0.9). A later study, by Segal et al.,204 reported that women in the
lowest tertile of quadriceps strength at baseline had a 69% odds of having
tibiofemoral joint-space narrowing at their 30-month follow-up (OR = 1.69, CI =
1.26-2.28). Although these results are impactful, more studies are needed to
confirm the influence quadriceps weakness has on both the onset and
progression of knee OA in patients.
General Health
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In addition to quadriceps weakness being associated with poor knee-joint
health, there is also some evidence showing that quadriceps weakness affects
the general health of individuals.217-220 The progressive loss of quadriceps
strength over a period of 11 years has been reported to increase the risk of
fragility fracture in men and women who are over 60 years of age.217
Furthermore, quadriceps strength has been shown to protect against mortality in
patients with chronic obstructive pulmonary disorder because it is believed to
improve their exercise capacity.218 Evidence such as this portrays the importance
of restoring quadriceps strength in patients after ACLr in order to improve their
quality of life and longevity.

2.2

EXPLAINING QUADRICEPS WEAKNESS
Although age, physical activity level, and surgical factors can affect

quadriceps strength in patients after ACLr, there are several neuromuscular
changes that occur in the quadriceps that can explain the persistent quadriceps
weakness observed in this patient population. The remainder of this review will
be devoted to the providing evidence on the neuromuscular changes that occur
in the quadriceps after ACLr, understanding the mechanisms and ramifications of
these changes, and discussing the disinhibitory interventions that can be used to
correct these changes and restore quadriceps strength in patients after ACLr.
2.2.1 Modified Quadriceps Morphology
Evidence of Quadriceps Atrophy
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Along with quadriceps weakness, atrophy of the quadriceps can be just as
evident on the involved limbs of patients following unilateral ACLr. Quadriceps
atrophy has been consistently reported in the literature for patients who have
sustained an ACL injury and/or have undergone subsequent ACLr. Thigh
circumference,47,221-226 quadriceps cross-sectional area (CSA) and volume are all
measures that have been shown to decrease following knee-joint trauma in these
patient populations.33,47,52,91,169,170,225,227-235 Quadriceps CSA and volume are
typically assessed using magnetic resonance imaging (MRI) or computed
tomography (CT), whereas thigh circumference is typically assessed using a
cloth tape measurer. Of these measures, quadriceps CSA and volume are the
gold standard for assessing quadriceps atrophy, because unlike thigh
circumference, they can partition out adjacent musculature, bone, and adipose
tissue. However, the elevated financial costs associated with using an MRI or CT
to assess quadriceps CSA and volume are not as economically or clinically
feasible as a thigh circumference assessment. A tool that may provide a middleground between sensitivity and economy when it comes to assessing quadriceps
atrophy is that of diagnostic ultrasound. Diagnostic ultrasound has recently been
shown to detect differences in muscle thickness at the quadriceps of patients
after ACLr.236 Its lower cost compared to an MRI and CT, combined with its
higher sensitivity compared to thigh circumference make diagnostic ultrasound
an attractive alternative tool, yet more research is needed to determine the
validity and reliability of diagnostic ultrasound for the assessment of quadriceps
atrophy.
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Although it is the recommended treatment for restoring knee-joint stability
in patients who have sustained ACL injuries, unilateral ACLr does not seem to be
an effective treatment to attenuate quadriceps atrophy. Lindstrom et al.230
recently assessed quadriceps CSA (combining the four quadriceps muscles) in
male and female patients who had a history of ACL-deficiency and underwent a
subsequent unilateral ACLr. Prior to surgery, the quadriceps CSA was
significantly smaller on the involved limb (males: 616.5 ± 24.4 cm2, females:
441.1 ± 12.5 cm2) compared to the uninvolved limb (males: 638.4 ± 21.7 cm2,
females: 474.4 ± 12.7 cm2; p < 0.001) of patients. Quadriceps CSA was
reassessed in patients one year after unilateral ACLr, and significant quadriceps
atrophy was still observed in the involved limb (males: 616.7 ± 24.7 cm2, females:
433.9 ± 18.6 cm2) when compared to the uninvolved limb (males: 644.7 ± 20.7
cm2, females: 473.5 ± 17.9 cm2; p < 0.001). Several studies have supported
these findings, demonstrating ipsilateral quadriceps atrophy in patients who are
one year or more removed from unilateral ACLr.47,221,227,236 In fact, Arangio et
al.47 reported differences in quadriceps CSA (averaging the four quadriceps
muscles) between limbs in patients who were an average of four years (48.7
months) removed from unilateral ACLr (involved: 51.3 ± 1.3 cm2, uninvolved:
55.8 ± 1.27 cm2; p < 0.001).
Interestingly, significant quadriceps atrophy has not been consistently
observed in patients who are ACL-deficient.231 Within the past decade, several
studies have been performed to determine whether or not differences in
quadriceps atrophy exist between ACL-deficient patients who are classified as

‐ 32 ‐

non-copers and those classified as copers.228,231,232 Non-copers represent the
majority of ACL-deficient patients. They are defined as patients who report
recurrent episodes of knee-joint instability and reduced physical function.
Therefore, these patients often undergo ACLr to restore knee-joint stability and
improve their physical function. Conversely, copers represent a small cohort of
ACL-deficient patients who are able to maintain their pre-injury physical function,
without experiencing episodes of knee-joint instability.237-240 Copers are said to
adopt neuromuscular strategies that effectively compensate for their ACLdeficiency, and allow them to return to their pre-injury levels of physical function
without requiring ACLr.231,238,240 A study done by Williams et al.231 compared
quadriceps volume and CSA between ACL-deficient non-copers, ACL-deficient
copers, and healthy controls. In ACL-deficient non-copers, quadriceps volume (p
= 0.003) and CSA (p = 0.017) were significantly smaller on the involved limb
compared to the uninvolved limb. However, between-limb differences in
quadriceps volume and CSA were not observed in either the ACL-deficient
copers or healthy controls. When comparing quadriceps volume and CSA limb
symmetries (involved/uninvolved) between the three groups, quadriceps volume
was significantly smaller in the ACL-deficient non-copers (0.90 ± 0.09) compared
to both the ACL-deficient copers (1.01 ± 0.16) and healthy controls (1.01 ± 0.06).
These findings suggest that ACL-deficient copers not only adopt neuromuscular
strategies to maintain physical function, but they are able to avoid the
development of significant quadriceps atrophy. Therefore, the ability of ACLdeficient copers to bypass ACLr may also help to reduce their risk of developing
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quadriceps weakness and atrophy that are commonly observed in patients after
ACLr.
Evidence of Fiber-Type Changes
Along with muscle atrophy, variations in muscle fiber type have also been
demonstrated in the quadriceps of patients following ACL injury or ACLr. Skeletal
muscles consists of two primary muscle fiber types: slow-twitch muscle fibers
(type I) and fast-twitch (type II) muscle fibers. Type I muscle fibers are slowoxidative fibers, and they are believed to be responsible for muscle endurance
and posture maintenance due to their high resistance to fatigue. Type II muscle
fibers can be subdivided into fast-oxidative-glycolytic fibers (type IIa) and fastglycolytic fibers (type IIx). Both of these type II fiber subtypes are less resistant to
fatigue than type I fibers, but type IIa fibers are more resistant to fatigue than
type IIx fibers due to their oxidative characteristics. As a whole, type II fibers are
believed to be responsible for rapid and powerful muscle contractions, with type
IIx being the faster of the two subtypes.
The gold standard for analyzing skeletal muscle fiber types in humans is
by taking muscle biopsies and performing immunohistochemical analyses.
Muscle biopsies of the quadriceps are typically performed on patients during their
arthroscopic ACLr, where muscle samples can be taken from the vastus medialis
oblique and/or vastus lateralis muscles while the patient is under anesthesia.
These muscle samples are then cross-sectioned and mounted on glass slides.
Immunohistochemical analyses are performed to differentiate muscle fiber types
under the microscope. This involves staining the muscle samples with antibodies

‐ 34 ‐

so that the myosin heavy-chain isoforms associated with slow-twitch and fasttwitch muscle fibers can be correctly identified. Since most quadriceps muscle
biopsies are taken from patients during their ACLr procedure, the majority of
these data has come from patients with an ACL-deficiency.235,241-244 Both slow
and fast twitch fibers have been reported to be atrophied in the quadriceps of
patients who have previously sustained and ACL injury.235,241-244 However, the
majority of the evidence demonstrates that type II fibers within the quadriceps are
selectively atrophied more than type I fibers in this patient population.241-243
An alternative method that has been used to assess skeletal muscle fiber
type changes within the quadriceps of patients after ACL injury and ACLr is EMG
median frequency analyses. Although this method is a more crude assessment
of muscle fiber type compared to a muscle biopsy, it is much less invasive and
more comfortable for patients. A Fast Fourier Transform analysis is performed to
convert the EMG signals during an MVIC into a frequency domain, and a power
density spectrum is calculated. The power density spectrum is then divided into
two regions of equal power to determine the median frequency of motor unit
action potentials within the muscle/s of interest. Type I motor units innervate type
I (slow-twitch) muscle fibers, and type II motor units innervate type II (fast-twitch)
muscle fibers. Type I motor units fire at a lower frequency than Type II motor
units, and are the first to be recruited during a voluntary muscle contraction.
Therefore, assessing the median frequency of the quadriceps during an MVIC
provides information regarding the distribution of muscle fiber types in patients
after ACL injury or ACLr, and whether they differ from healthy individuals. Due to
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its noninvasiveness, EMG median frequency analyses can conveniently be
performed on patients before or after they undergo ACLr. Therefore, as opposed
to muscle biopsies, there is much more data from EMG median frequency
analyses on patients following ACLr. Furthermore, the evidence has
demonstrated a distinct pattern of lower EMG median frequency in the
quadriceps on the involved limbs of patients who are ACL-deficient and/or have
undergone ACLr.56,65,86,223 Drecshler et al.86 compared EMG median frequencies
in the quadriceps of patients post-ACLr to those of healthy (sport-matched)
controls. They reported a significantly lower mean EMG median frequency in the
ACLr group compared to the control group at both one and three months after
ACLr (p < 0.05). Other studies have reported reduced quadriceps EMG median
frequencies in the involved limbs of patients who were six months or longer
removed ACLr compared to their uninvolved limbs.56,65 The reduced quadriceps
EMG median frequency observed on the ACLr limb suggests that type II motor
units are less activated in these patients, and that the EMG median frequency is
predominately represented by the activation of type I motor units. This
interpretation may help to explain the findings from the aforementioned muscle
biopsy studies as to why type II muscle fibers are selectively atrophied in the
quadriceps of patients.
Mechanisms of Modified Quadriceps Morphology
Muscle atrophy can be commonly categorized into two types: disuse
atrophy and neurogenic atrophy. Disuse atrophy, given its name, is caused by a
period of physical inactivity that results in muscle wasting. This type of atrophy is
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commonly seen in patients who are bedridden, or in those who undergo period of
joint immobilization, where the surrounding joint musculature is neglected and
atrophies. Neurogenic atrophy is more serious than disuse atrophy because it
involves the nerve supplying innervation to the involved muscle. Neurogenic
atrophy occurs when there is an injury, or disease, of the innervating nerve
resulting in an inhibition of the muscle and subsequent atrophy. Disuse atrophy is
the type of atrophy that is most likely present in patients following ACLr; however,
neurogenic atrophy may also be involved due to the NQD observed in these
patients; at topic which will be discussed later in this chapter.
Research efforts of the 21st century have made substantial progress in
uncovering the complex physiology behind muscle atrophy and hypertrophy.
Both muscle atrophy and hypertrophy are found to involve multiple signaling
pathways and molecular mediators, but in general, these processes are
regulated by protein turnover within the muscle fibers.245-247 With muscle
hypertrophy, the diameter of muscle fibers are increased through protein
synthesis (or decreased protein degradation) and the addition of contractile
proteins (in parallel) within muscle fibers. Conversely, muscle atrophy is the
result of protein degradation (or decreased protein synthesis), which elicits a
breakdown of these contractile proteins, and ultimately, a reduction in the
diameter of muscle fibers. A recent study by Mendias et al.26 sought to assess
the fluctuations in pro-atrophy biomarkers circulating in the blood of patients both
before and after ACLr. Blood draws were performed on 18 patients prior to
surgery and multiple time points after ACLr (3 days, 2 weeks, 5 weeks, 12
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weeks, 18 weeks, and 26 weeks). The primary pro-atrophy biomarkers of interest
were myostatin and transforming growth factor-β. Both of these cytokines have
been shown to directly induce muscle atrophy and reduce muscle force
production.246,248 The authors reported elevated levels of myostatin in patients at
three days post-ACLr, and elevated levels of both myostatin and transforming
growth factor-β at 2-weeks post-ACLr. Both myostatin and transforming growth
factor-β returned to baseline levels at 5-weeks post-ACLr, and they remained
stable until 26 weeks post-ACLr. These results indicate that ACLr has an acute
excitatory effect on these pro-atrophy biomarkers, which may explain why these
patients have persistent quadriceps atrophy and difficulty restoring quadriceps
strength.
The mechanisms behind the muscle fiber type variations observed in the
quadriceps of patients after ACL injury and/or ACLr is less understood. Stockmar
et al.241 assessed the metabolic profiles (oxidative vs. glycolytic activity) within
the vastus medialis oblique muscle biopsies of six patients with ACL-deficiency in
addition to immunohistochemical analyses. They reported a decreased muscle
fiber diameter that was similar between type I (88.7%, p < 0.008) and type II
muscle fibers (85.9%, p < 0.015) within the quadriceps on the involved limb
compared to the uninvolved limb. However, a reduction in glycolytic activity and
an oxidative shift was observed within the muscle fibers of the vastus medialis
oblique on the involved limb compared to the uninvolved limb. This oxidative shift
suggests that a number of type II (fast twitch) muscle fibers either shifted to a
type IIa (fast-oxidative) profile, or they transformed into type I (slow twitch)
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muscle fibers (less likely). Either way, the fast force production of the quadriceps
was sacrificed in these patients.
An alternative (and perhaps combined) mechanism that may explain the
differences in muscle fiber type behavior observed within the quadriceps of
patients after ACL injury and/or ACLr, is a reduced sensitivity of Ia afferents
located at the muscle spindles. Adequate feedback from Ia afferents is necessary
for the recruitment of high-threshold (type II) motor units at the quadriceps.249-252
Therefore, an attenuation of Ia afferent feedback from the muscle spindles within
the quadriceps, may contribute to the selective atrophy of type II muscle fibers
that has been reported in these patients due to the prolonged inhibition of type II
motor units. Reduced Ia afferent sensitivity within the muscles spindles of the
quadriceps is believed to be the result of gamma loop dysfunction and/or
presynaptic inhibition that occurs in patients after ACL injury and ACLr. Gamma
loop dysfunction is believed to occur in these patients as a result of damage to
the mechanoreceptors located within the knee-joint capsule and ACL. The
afferent feedback from these knee-joint mechanoreceptors are thought control
the activation of gamma motor neurons located within the spinal cord that
function to regulate the tautness of the muscle spindles. The extensive work
done by Konishi and colleagues52,221,253 has confirmed the presence of gamma
loop dysfunction in the quadriceps of patients who have undergone unilateral
ACLr. By delivering a vibratory stimulus to the patellar tendon, a reduction in
quadriceps strength is observed in healthy individuals due to slackening of the
muscle spindles and desensitization of Ia afferents, which inhibits their ability to
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recruit type II motor units. However, when the same vibratory protocol is
performed on patients after ACLr, the force producing capability of their
quadriceps is unchanged compared to their pre-vibratory state. These findings
suggest that gamma loop dysfunction exists within the quadriceps of these
patients because the damage done to knee-joint mechanoreceptors disrupts
gamma motor neuron activation, leading to a persistent slackening of muscles
spindles and a desensitization of Ia afferents. As a result, the ability of these
patients to recruit fast force producing, type II motor units is reduced, and
selective atrophy of type II muscle fibers may be observed due to prolonged
disuse.253
Pre-synaptic inhibition is a potential mechanism for the quadriceps
inhibition that is commonly observed in patients after knee-joint trauma, but it
may also contribute to selective atrophy of type II muscle fibers within the
quadriceps. Pre-synaptic inhibition pertains to a diminished synaptic feedback
from Ia afferents that prevent the activation of alpha motor neurons within the
spinal cord. It is believed to be induced by a repetitive activation of Ia
afferents,254 which depletes the amount of neurotransmitters released at the
spinal cord.255-257 Interestingly, the depolarization of joint afferents has also been
shown to influence the pre-synaptic behavior of Ia afferents.258-260 Therefore, it is
possible that ACL injury and/or ACLr induces pre-synaptic inhibition due to the
disruption of knee-joint mechanoreceptors. If this is true, then pre-synaptic
inhibition may work in conjunction with gamma loop dysfunction as a
mechanisms of the selective atrophy of type II muscle fibers observed within the
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quadriceps of these patients. A further description of the neurophysiology behind
gamma loop dysfunction and pre-synaptic inhibition will be discussed later in this
chapter.
Ramifications of Modified Quadriceps Morphology
The quadriceps weakness that is observed in the involved limb of patients
following ACLr may be partially attributed to these morphological changes that
occur within quadriceps. Since muscle hypertrophy improves muscle force
output, it is logical to assume that muscle atrophy would lead to strength deficits.
Several studies have confirmed the relationship between quadriceps atrophy and
quadriceps strength in patients with ACL-deficiency232 or in those who have
undergone ACLr.40,47,57,91,230 A recent study by Thomas et al.91 assessed
isometric quadriceps strength (at 90° of knee flexion) and quadriceps CSA in 20
patients who were recently cleared to return to full physical activity after
undergoing unilateral ACLr (Mean ± SD = 212.89 ± 31.62 days post-ACLr). Both
quadriceps strength (148.39 ± 37.91 Nm vs. 212.98 ± 62.57 Nm; p < 0.001) and
quadriceps CSA (68.81 ±17.8 cm2 vs. 81.1 ± 21.58 cm2; p < 0.001) were
significantly decreased on the surgical limbs of patients compared to their nonsurgical limbs. The authors then used a linear regression analysis to determine
the association between quadriceps atrophy and quadriceps strength in these
patients. The analysis revealed that quadriceps CSA explained nearly 31% of the
variance in isometric quadriceps strength in patients following ACLr (r2 = 0.307; p
= 0.011).
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Furthermore, the amount of quadriceps atrophy observed in patients after
ACLr has also been correlated with functional tests commonly used by clinicians
to determine an athlete’s readiness to return to sport.230 Lindstrom and
colleagues230 assessed quadriceps CSA and one-leg hop function in 37 patients
prior to unilateral ACLr and at one year following surgery. Quadriceps CSA was
significantly smaller in the involved limb than the uninvolved limb at both preACLr (involved/uninvolved = 0.96 ± 0.01; p < 0.001) and one year post-ACLr
(0.95 ± 0.02; p < 0.001), with no significantly changes being observed across
time. One-leg hop distance improved from pre-ACLr to post-ACLr in both the
involved (102.6 ± 7.0 cm to 136.9 ± 6.9 cm; p < 0.001) and uninvolved limbs
(123.4 ± 6.7 cm to 146.7 ± 6.5 cm; p < 0.001) of patients, with improvements in
the involved limb being greater than the uninvolved limb (p = 0.001). The most
interesting finding was the significant correlations observed between quadriceps
CSA and one-leg hop function of patients. At one year post-ACLr, the
involved/uninvolved quadriceps CSA ratio were strongly correlated with one-leg
hop distance involved/uninvolved leg ratio (r = 0.63; p < 0.001), triple-hop
distance involved/uninvolved leg ratio (r = 0.68; p < 0.001), and 6-m timed-hop
involved/uninvolved leg ratio (r = 0.7; p < 0.001). Therefore, the negative effect
that quadriceps atrophy has on a patient’s quadriceps strength after ACLr may
translate to decreased performance during physical activities that involve
explosive movements.
There is much less evidence demonstrating the association between
muscle fiber type changes and quadriceps strength in patients after ACL injury
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and/or ACLr. This is largely due to the difficulty of translating microscopic cellular
changes to a macroscopic level. However, the available evidence on the
ramifications of EMG median frequency changes in quadriceps of these patients
does hold some merit. In an older study by McNair and Wood,261 they assessed
for differences in quadriceps EMG median frequency between patients with ACLdeficiency who demonstrated different quadriceps strength profiles. Seventeen
patients with chronic ACL-deficiency were separated into minimal quadriceps
weakness and maximal quadriceps weakness groups. After analyzing each
patient’s quadriceps EMG median frequency (vastus lateralis) on their involved
limb, a significantly higher EMG median frequency was observed in the minimal
quadriceps weakness group compared to the maximal quadriceps weakness
group (p < 0.05). The authors concluded that the group differences were due to a
greater degree of type II muscle fiber atrophy present within the maximal
quadriceps weakness group. A later study by McHugh and colleagues56 found
that preoperative quadriceps EMG median frequency was moderately correlated
with postoperative isometric quadriceps strength in patients who were six months
removed from ACLr (r = 0.54, p < 0.001). Surprisingly, this same study found
preoperative quadriceps EMG median frequency to be significantly correlated
with one-leg hop distance in patients at six months post-ACLr (r = 0.35; p < 0.05).
These findings are supported by a more recent study that reported moderate
correlations between knee function (via Cincinnati Knee Score) and EMG median
frequency limb symmetries (involved/uninvolved) of the vastus lateralis (r = 0.48;
p = 0.018) and vastus medialis oblique (r = 0.67; p = 0.001) muscles in thirteen
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athletes who were six to nine months removed from unilateral ACLr an cleared to
return to sport.65 More studies are necessary to determine the global impact
muscle fiber type changes have on both the quadriceps function and lower
extremity function of patients following ACLr.
2.2.2 Neural Quadriceps Dysfunction
Evidence of Quadriceps Inhibition
In addition to the morphological alterations taking place in the quadriceps
after ACLr, there are concurrent neural alternations occurring both within the
quadriceps and throughout various levels of the nervous system. The most
evident neural deficit observed in patients after ACLr is their inability to voluntary
activate the quadriceps on the involved limb.32,34,51,84-86 The decrease in voluntary
activation can be explained by a diminished ability to fully recruit the motor units
innervating the quadriceps and a reduced motor neuron firing frequency.87
Healthy individuals without a history of knee injury or surgery have the ability to
volitionally activate at least 95% of the available motor units innervating the
quadriceps.88 Therefore, a volitional activation of 95% has been generally
accepted as the cutoff value for determining whether or not a patient has neural
inhibition of their quadriceps following ACLr.89,90
Force-based measurements are the preferred method for assessing
voluntary muscle activation in a healthy or pathological population.262,263 As an
individual performs a maximal voluntary isometric contraction (MVIC) of their
quadriceps, supramaximal, electrical stimulation is percutaneously applied over
the femoral nerve trunk or intramuscular nerve branches to elicit a superimposed
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twitch. An individual’s voluntary quadriceps activation level is determined by
assessing the extent in which the electrical stimulation increases their peak KET
during a MVIC (typically expressed as a percentage).262,263 Theoretically, if the
electrical stimulus evokes little to no increase in KET during the MVIC, then that
participant is considered to have full quadriceps activation (≥95%).90,264
Conversely, if there is a large increase in torque after the electrical stimulus has
been delivered to the quadriceps, then it is assumed that the participant has
some level of inhibition present at their quadriceps (<95% of quadriceps
activation).90,264
Decreased volitional quadriceps activation that is present in patients
following ACLr can be labeled as either arthrogenic muscle inhibition (AMI) or
quadriceps activation failure (QAF). Arthrogenic, in its Greek form, translates to
“generated (-genic) from the joint (arthro-)”. Thus, the term AMI pertains to
inhibition of surrounding joint musculature that is due to the distention or damage
present within the joint.265 AMI of the quadriceps can be observed in patients
immediately after ACL injury or reconstruction even though there is no structural
damage imposed to the muscle or innervating nerve. AMI has been theorized to
be a reflexive neural phenomenon that is organically built in as a protective
mechanism after joint injury.96 In other words, AMI is intended to prevent
individuals from causing further joint damage after initial injury by inhibiting the
primary muscle acting on the involved joint.
AMI has been known primarily as a lower extremity event occurring in
those muscles involved in weight bearing tasks. The majority of AMI has been
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observed in the muscles surrounding the knee or ankle after joint-injury.172,266-270
While it is well known that the quadriceps are the main upper-leg muscle group to
become inhibited after knee-joint injury, the lower-leg muscles most inhibited
after ankle-joint injury are less specific. Of the muscles surrounding the anklejoint, the tibialis anterior and fibularis (peroneals) muscles have been found to
demonstrate AMI the most in patients with chronic ankle instability or acute ankle
sprain,268-270 but there is no consensus on which muscle group is predominantly
inhibited. An explanation of why AMI is less specific after ankle-joint injury versus
knee-joint injury may be due to the structural differences between the two joints.
The knee-joint (tibiofemoral joint) is primarily a hinged-joint constructed for the
movements of flexion and extension. Since the neuromuscular function of
quadriceps are a key component during weight-bearing activities, it is intuitive
that they are the primary upper-leg muscle group to fall prey to AMI after kneejoint injury. Conversely, the ankle-joint is actually made up of two joints: a hingedjoint (talocrural joint) that allows for ankle plantarflexion and dorsiflexion, and a
condyloid-joint that allows for ankle inversion and eversion. Therefore, the multijointed structure of the ankle-joint may explain why more than one lower-leg
muscle group demonstrates AMI after ankle-joint injury.
QAF is similar to AMI in that it pertains to quadriceps inhibition observed in
patients after knee-joint trauma. However, the term QAF is used to describe
those patients who persistently exhibit quadriceps inhibition long after the joint
damage has subsided. There have been several studies that have reported
persistent quadriceps inhibition in patients who are more than two years from
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ACLr.32,34,84,97,271 In a recent study by Pietrosimone et al.,34 they reported residual
neural quadriceps deficits present in patients who were an average of 4 years
(48 ± 36.2 months) removed from unilateral ACLr. They discovered that the
patients’ ability to voluntary activate the ipsilateral quadriceps remained inhibited
(88 ± 12%) and was significantly lower than that of healthy controls 4 years postACLr. At this time period after ACLr, it is expected that patients’ should be
relatively asymptomatic unless they have developed a subsequent knee-joint
pathology. Therefore, using QAF instead of AMI to describe these patients is
more appropriate because their quadriceps inhibition is no longer arthrogenic in
nature, but a habitual inhibition. There is less evidence for QAF than there is for
AMI, but this is mainly due to the longer follow-up studies that are needed to
capture QAF. In addition, it is difficult to find patients with true QAF, because
many patients who have a history of knee-joint injury or surgery express lingering
orthopaedic symptoms and/or go on to develop subsequent knee-joint
pathologies (i.e., anterior knee pain, early-onset OA, etc.). In this scenario, AMI is
still considered to be the culprit of the quadriceps inhibition observed in these
patients because their knee-joints are currently symptomatic and/or re-injured.
The evidence supporting the existence of quadriceps inhibition in patients
following ACLr has been well documented over the past 15 years with the use of
the aforementioned force-based measurements. Prior to this time period, it was
well established that the incidence of a knee-joint injury such as an ACL injury
elicits a neural inhibition of the quadriceps on the involved limb.90,264,267
Therefore, it is logical to assume that the surgical knee-joint trauma imposed by
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ACLr would resemble the neural inhibition observed in the quadriceps after the
initial ACL injury. Urbach and colleagues32 were the first to demonstrate true
neural inhibition (<95% voluntary quadriceps activation) in the quadriceps of
patients after ACLr using the IT technique. They longitudinally assessed the
voluntary quadriceps activation in 12 patients with ACL injuries prior to ACLr, and
assessed the same sample of patients two years after having undergone ACLr.
The mean (± SD) quadriceps activation of the patients prior to ACLr was 74.9%
(± 3.5). At two years after ACLr, the patients’ quadriceps activation improved to
85.3% (± 2.5), demonstrating that neural activation had recovered, but an
inhibition of approximately 15% still remained.
An observation that most researchers did not foresee when first assessing
voluntary quadriceps activation in patients after unilateral ACL injury or ACLr was
the presence of quadriceps inhibition in the contralateral (uninvolved) limb. A
bilateral quadriceps activation deficit after ACL injury and subsequent ACLr has
been consistently reported in the literature and is now considered to be a natural
neural response in patients after unilateral knee-joint injury.32,51,90,91,145,172
Furthermore, the amount of neural inhibition present within the quadriceps of the
contralateral limb has been reported to be equivalent to that of the ipsilateral
(involved) limb following unilateral ACLr. In a recent study by Thomas et al.,91
voluntary quadriceps activation was assessed bilaterally in the limbs of patients
who were seven months removed from ACLr. The mean voluntary quadriceps
activation level of the patients’ involved limbs was 87% (± 12), while the
uninvolved limbs demonstrated a quadriceps activation level of 85% (± 14).
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Therefore, the joint trauma present within the surgically reconstructed knee-joint
of these patients was modulating the neural quadriceps activation of their healthy
limb to the same extent as the quadriceps of their reconstructed limb. Scientists
have yet to fully explain the reason for the bilateral neural quadriceps inhibition
observed after unilateral ACLr. The most popular explanation is that of a neural
crossover effect that occurs in the central nervous system due to altered afferent
information being transmitted from the involved knee-joint.42,145,272 Due to this
bilateral deficit, physicians are cautioned when using a patient’s uninvolved limb
as a comparison when assessing the recovery of neuromuscular quadriceps
function in the involved limb and making return-to-activity decisions after ACLr.
Consequently, physicians should be advised to consider a healthy-matched
control as a comparison, and clinicians should place further attention on the
uninvolved limb during the rehabilitation of patients following ACLr.
Evidence of Reduced Spinal-Reflexive Excitability
Another neural deficit that has been observed in patients following ACLr is
a reduction in spinal-reflexive excitability at the quadriceps.34,51,273 The gold
standard for accessing the spinal-reflexive excitability of a muscle is the Hoffman
reflex (H-reflex) technique.274,275 In its basic form, the H-reflex is the electrical
variant to the mechanically induced stretch-reflex.274 However, the H-reflex
technique better isolates the monosynaptic reflex and allows for more specific
assessment of spinal-reflexive activity. Unlike the stretch-reflex, the H-reflex
technique bypasses the muscle spindle by applying a submaximal electrical
stimulus at the muscle’s peripheral nerve. The stimulation of the nerve activates
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Ia afferent (sensory) fibers that transmit signals to the spinal cord, causing a
depolarization of alpha motor neurons (aMN) and efferent (motor) fibers.274,276-278
The end result is myoelectric response observed at the muscle, labeled as the Hreflex. A muscle’s H-reflex activity is quantified via voltage amplitudes on surface
EMG. A reduced H-reflex that is observed in the quadriceps of patients following
ACLr signifies that there are inhibitory mechanisms present within the spinal cord
that are partially responsible for the NQD.259,260,265,279 Therefore, the quadriceps
H-reflex has become a valuable measure for accessing the spinal-reflexive
behavior in patients before and/or after they have undergone ACLr.
Although the H-reflex has been used in research for over a century,280
there have only been a handful of studies that have used the H-reflex to assess
the spinal-reflexive excitability of the quadriceps in patients following
ACLr.34,51,84,97,273,281 The majority of quadriceps H-reflex assessments have been
reported in studies that used an artificial knee effusion model by injecting saline
fluid into the knee-joint capsule of healthy participants.259,260,282-284 It has been
well established that artificial knee-joint effusion inhibits the quadriceps H-reflex
in healthy individuals. This is a widely accepted model for demonstrating the
neural effect that knee-joint effusion has on spinal-reflexive excitability, but it fails
to represent the additional structural damage, inflammation, and pain that is
present after true knee-joint trauma such as ACLr. Therefore, the few studies that
have assessed the quadriceps H-reflex in patients after ACLr are particularly
important to understanding the impact that the surgery has on spinal-reflexive
excitability.
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There have been a total of six published studies that have assessed the
quadriceps H-reflex in patients following ACLr.34,51,84,97,273,281 Of these six studies,
Lepley et. al.,51 were the only group to demonstrate a reduced quadriceps Hreflex in the involved limbs of patients post-ACLr compared to a healthy control
group. Conversely, there were also two separate studies that have reported an
increased quadriceps H-reflex in ACLr patients compared to healthy controls.34,97
The primary difference between these two studies and the aforementioned study
is the timing of when the postoperative H-reflex assessments were performed.
The two studies that reported an elevated quadriceps H-reflex performed their
assessments on patients who were an average of four years removed from
ACLr.34,97 Whereas, the patients in the study by Lepley et al., performed H-reflex
assessments only two weeks after undergoing ACLr.51
These findings demonstrate that there may be a difference in spinalreflexive excitability of patients who are in the acute stage after ACLr compared
to those who are in the chronic stage after ACLr. Studies that have used the
artificial knee effusion model concur that quadriceps H-reflex is acutely
suppressed following knee-joint trauma because they reported reductions in the
quadriceps H-reflex immediately after injecting the knee-joint capsule with saline
fluid.259,260,282-284 Artificial knee effusion models cannot support the elevated
spinal-reflexive excitability observed in the quadriceps patients who are in the
chronic stage after ACLr because the majority of the patients do not present with
knee-joint effusion. It has been theorized that heightened spinal-reflexive
excitability observed in these patients after ACLr may be a neural adaptation that
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progressively develops to compensate for their persistent quadriceps
dysfunction.
It must be noted that half of the studies which have assessed spinalreflexive excitability in patients after ACLr did not report significant differences in
H-reflex compared to healthy controls.84,273,281 This demonstrates that the
science is still far away from determining if and how spinal-reflexive excitability is
modulated after ACLr in humans, and additional studies assessing the
quadriceps H-reflex in these patients are needed to progress this area of
research. It is important to determine if the spinal-reflexive excitability is
suppressed in patients after ACLr because it not only impedes their recovery of
neuromuscular function, but it may put them at risk for future injury. A reduced
spinal-reflex may hinder a patient’s neuromuscular system to appropriately
respond to environmental stimuli. For example, if this patient were walking and
experienced an external perturbation causing their surgical knee to collapse into
knee flexion, their quadriceps may not appropriately contract in response to
being rapidly stretched due to the reduced spinal-reflexive excitability. Therefore,
the patient may be at a higher risk for straining a muscle or falling.
Evidence of Corticomotor Excitability Alterations
One of the more recent neural adaptations that is beginning to gain
traction in this area of research is the modified cortical activity that is observed in
patients after ACLr. Specifically, corticomotor excitability associated with the
quadriceps has been shown to be altered in patients following unilateral
ACLr.34,51,84 Corticomotor excitability is typically assessed by applying single-
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pulse transcranial magnetic stimulation (sTMS) to the area of the primary motor
cortex where the majority of the MNs projecting to quadriceps via the
corticospinal tract are represented, and measuring the subsequent motor evoked
potential (MEP) observed at the quadriceps through surface EMG.92-95 The
corticomotor excitability measures most commonly used with sTMS are motor
thresholds and MEP recruitment curves. Both of these measures provide slightly
different information, yet complement each other in regards to the corticomotor
excitability of the MNs in the motor cortex representing a given muscle group.
Motor thresholds are believed to reflect membrane excitability and local density
of a central core of pyramidal neurons and interneurons.92,95,285 As the activation
threshold of these neural elements increases, more sTMS output is needed for
the motor threshold to be reached. Therefore, an increased motor threshold is
interpreted as a decreased corticomotor excitability in that region of the motor
cortex. MEP recruitment curves are thought to demonstrate the extent in which
the alpha-motor neuron pool is activated with increasing sTMS intensities, as well
as the spatial distribution of neural elements within a region of the motor
cortex.94,286,287 The steepness of the MEP recruitment curve is attributed to the
extent of motor representation for a given muscle group (steeper the curve =
greater representation of muscle group, and vice versa).
The majority of studies assessing corticomotor excitability in patients after
ACLr have used motor thresholds to quantify the magnitude and/or change of
excitability in the area of the motor cortex represented by the
quadriceps.34,51,61,84,97,288 As opposed to the aforementioned types of NQD,
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modifications in corticomotor excitability relative to the quadriceps of patients do
not seem to arise until at least six months after unilateral ACLr.51 Lepley and
colleagues51 have provided the only research to date that has longitudinally
assessed the changes in corticomotor excitability of patients before and after
undergoing unilateral ACLr. Bilateral assessments of motor thresholds of the
quadriceps were measured in 20 patients over three time points: five weeks prior
to ACLr, two weeks post-ACLr, and six months post-ACLr. Prior to surgery, there
were no differences in motor thresholds between limbs or when compared to
healthy controls. The motor thresholds were significantly increased
(corresponding to decreased corticomotor excitability) in both limbs two weeks
after ACLr, but were no different compared to the control group. However, the
motor thresholds in both limbs were significantly higher than the healthy controls
at 6 months post-ACLr, as well as when compared to the threshold values
expressed before surgery and two weeks post-ACLr. The corticomotor excitability
of the patient’s uninvolved limbs seemed to follow the same time trajectory after
unilateral ACLr as the surgical limb, which further supports the existence of a
neural cross-over effect. These patients not only demonstrated a reduced
corticomotor excitability associated with the quadriceps of patients recovering
after ACLr, but these attenuations were not truly evident until 6 months after
surgery. The absence of corticomotor excitability attenuations after acute kneejoint disruption is not completely unexpected. In a previous study by Lepley et
al.288, an artificial knee-joint effusion elicited an immediate reduction in voluntary
quadriceps activation, while it failed to attenuate corticomotor excitability. These
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findings suggest that more time is needed for neural changes to be observed in
supraspinal regions of the nervous system compared to spinal regions.
Two additional studies have reported decreases in corticomotor excitability
in relation to the quadriceps of patients following unilateral ACLr,34,84 but their
motor threshold assessments were conducted years after the patients underwent
surgery. However, both of these studies reported significant differences between
limbs at this extended time point, with lower corticomotor excitability being
exhibited in the quadriceps of the surgical limb.34,84 This finding suggests that
although the corticomotor excitability of the contralateral quadriceps
demonstrates similar reductions as the ipsilateral quadriceps after unilateral
ACLr, this neural deficit may not persistent for as long in the contralateral limb
and it naturally recovers. An alternative theory is that the corticomotor excitability
of the contralateral limb is improved over time after unilateral ACLr because
patients tend to place more reliance on this limb during ambulatory tasks.
Conversely, the mechanics and postural control of the surgical limb is modified in
patients after unilateral ACLr, which may explain the cortical reorganization and
reduced corticomotor excitability of the ipsilateral quadriceps. More prospective
studies assessing longitudinal corticomotor excitability in patients recovering from
ACLr are needed to better determine when these neural alterations begin to
arise, and understand how long they tend to persist and/or resolve in both limbs.
Timeline of Neural Quadriceps Dysfunction post-ACLr
The temporal manifestation of NQD that is observed in ACL-injured
patients before and after they have undergone ACLr has yet to be fully
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understood and agreed upon among researchers. However, a general timeline of
the neural quadriceps deficits observed after ACLr can be developed via a
thorough review of the literature. The evidence regarding the onset and
progression of quadriceps inhibition that is observed in patients after ACL injury
and reconstruction is the most mixed in the literature compared to the other
neural quadriceps deficits. This can be partially attributed to the different
techniques used to assess voluntary quadriceps activation. As mentioned
previously, the SIB and IT techniques are the most common methods for
assessing quadriceps activation, but each uses a different equation to calculate
activation, and can therefore provide slightly different information in regards to
the amount of inhibition present within the quadriceps of these patients.
Significant deficits in bilateral voluntary quadriceps activation (54-83%)
has been reported patients after ACL injury,32,51,99,145,264,266,289 but some studies
have reported quadriceps activation levels in these patients approaching those of
healthy individuals (~ 95%).24,27,89,172,290 Likewise, deficits in bilateral voluntary
quadriceps activation (75-88%) have been reported in patients after
ACLr,27,32,34,48,91,97,291,292 while other studies have reported little to no voluntary
quadriceps activation deficits in patients after ACLr (~95%).24,51,55,86,290,293,294 This
mixed evidence may be solely due to differences in measurement techniques
used to assess voluntary quadriceps activation. However, it may also be due to
differences in when voluntary quadriceps activation was assessed in patients. In
general, the majority of studies that reported deficits in voluntary quadriceps
activation,32,34,48,97,99,264,292 assessed patients who were more than one year
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removed from ACL injury or reconstruction; whereas the majority of studies that
reported little to no deficits in voluntary quadriceps
activation,24,27,51,55,86,89,172,232,290 assessed patients who were less than eight
months removed from ACL injury or reconstruction. It can be expected that some
level of quadriceps inhibition is present in patients immediately after ACL injury
and reconstruction based on the principles of AMI. During this acute state of joint
trauma, the effusion, pain, and inflammation present within the knee-joint is
sufficient to inhibit the involved limb’s quadriceps, and cross-over to the
uninvolved limb as well. However, force-based measures of voluntary quadriceps
activation are typically contraindicated in the involved limb of patients within the
first two months after ACL injury and reconstruction due to increased pain,
inadequate range-of-motion, and/or post-surgical guidelines that are enforced to
protect the graft from being stressed prematurely (post-ACLr only). AMI of the
quadriceps seems to resolve during the first few months after ACL injury and
reconstruction, with voluntary quadriceps activation approaching near normal
levels in patients at one year post-injury/surgery. However, voluntary quadriceps
activation seems to relapse into an inhibited state years later. This delay in
quadriceps inhibition may described as presence QAF, or it could be quadriceps
inhibition that is due to the insidious onset of a subsequent knee-joint pathology,
such as knee OA. Like patients after ACL injury or reconstruction, patient with
knee OA have been reported to exhibit bilateral deficits in voluntary quadriceps
activation.295 However, further research is need to explore this theory, and to
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determine whether deficits in voluntary quadriceps activation after ACL injury and
reconstruction are truly time-dependent.
The time course of spinal-reflexive alterations that occur in patients before
and after ACLr has been described more consistently throughout the literature.
Lepley et al.51 has been the only study to assess the H-reflex in patients both
before and after ACLr. Compared to their preoperative assessment, the Hreflexes of patients two weeks after undergoing unilateral ACLr was lower in both
limbs; therefore, implying that the joint damage caused by the surgery attenuated
spinal-reflexive excitability to a greater extent than the ACL injury itself. This
observation is similar to the differences seen in patients’ voluntary quadriceps
activation before and after ACLr, with the surgery inflicting more quadriceps
inhibition than the injury. Unlike the time course observed with quadriceps
inhibition after ACLr, the recovery of spinal-reflexive excitability in patients seems
to be more rapid. Studies have found that the quadriceps H-reflex of patients
three to six months after ACLr is not only higher than that of more acute
assessments (2-4 weeks post-ACLr),51,273 but it is no different than that of healthy
matched controls as well. Furthermore, four years removed from ACLr, patients
have higher spinal-reflexive excitability than healthy individuals.34,84 These
findings demonstrate that although the quadriceps H-reflex is reduced bilaterally
in patients acutely following unilateral ACL injury and ACLr, it seems to rapidly
recover and heighten over time. This heightened spinal-reflexive excitability
observed in patients who are years removed from ACLr may serve as a
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compensatory mechanism for the additional neuromuscular deficits that are
exhibited in these patients.
There have not been enough longitudinal studies to draw a conclusion on
the time course of corticomotor excitability alterations in patients after ACL injury
and reconstruction. However, a general pattern of time can begin to be observed
by combining studies that have assessed corticomotor excitability. Corticomotor
excitability changes have been demonstrated bilaterally in patients after unilateral
ACLr,34,51,84,97 but these changes have not been apparent until at least six
months post-surgery.51 Corticomotor excitability in the uninvolved limb has been
shown to return to baseline in patients who are over a year removed from
unilateral ACLr, whereas the corticomotor excitability in the surgical limb remains
decreased.34,84 Decreased corticomotor excitability is one of the few neural
quadriceps deficits that has been shown to remain in patients after ACLr.
However, the clinical importance of corticomotor excitability and the effect it has
on the recovery of quadriceps function in patients after ACLr has yet to be
determined. Therefore, more research is needed to determine the temporal
behavior of cortical excitability and how it contributes to other neuromuscular
quadriceps deficits observed in patients after ACLr.
The corticomotor excitability changes that have been reported in patients
prior to ACLr is not as clear as what has been reported after ACLr. Lepley et al.51
assessed corticomotor excitability in patients who were five weeks from initial
ACL injury. The motor thresholds of these patients were no different between
limbs or when compared to healthy controls, signifying that corticomotor
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excitability was unaffected by the acute knee-joint injury. An earlier study
conducted by Heroux and Tremblay296 reported opposing findings in a group of
ACL-deficient patients. They bilaterally assessed corticomotor excitability
associated with the quadriceps of 10 patients who previously sustained a
unilateral ACL injury without undergoing subsequent ACLr. They found the motor
thresholds of the injured limb to be significantly lower (higher corticomotor
excitability) than that of the uninjured limb, whereas no differences were
observed between limbs in the healthy control group. Although these findings
contradict those of Lepley et al.,51 there are two methodological differences that
may explain their lack of agreement. To begin with, Heroux and Tremblay296
assessed motor thresholds with the patients’ quadriceps being in a relaxed state,
while Lepley et al.296 assessed motor thresholds during a slight quadriceps
contraction (5% of MVIC). This procedural variation between studies may have
influenced the dependent variables enough to result in conflicting results. The
second and more promising explanation is that the patients were assessed at
different time points after initial ACL injury. As stated above, Lepley et al.51
assessed preoperative corticomotor excitability at an average of five weeks after
ACL injury; where, Heroux and Tremblay296 assessed patients who were nearly
two years (median = 22 months) removed from ACL injury. Therefore, the
heightened corticomotor excitability demonstrated in the involved limb of patients
who participated in the study by Heroux and Tremblay may have been a result of
time itself. The authors hypothesized that because their patients were ACLdeficient for an extended period of time, more cortically-driven control over the
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knee musculature was required to manage the external demands of daily
activities and maintain knee-joint stability.296 Therefore the increased
corticomotor excitability associated with the injured limb’s quadriceps may serve
as a coping mechanism for individuals with ACL-deficiency.
Although a general timeline can be developed to portray the expected
onset and duration of the aforementioned neural quadriceps deficits in patients
following ACLr, clinicians must interpret it with caution. Like any disease, there
will be outliers that fall outside the expected, “normal” timeframe of symptoms.
Therefore, clinicians must remember to take an individualistic approach when
treating neural quadriceps deficits in patients after ACLr. These deficits may
manifest and progress differently between patients, making it important for
clinicians to treat patients until neural quadriceps function is restored. The
presence of bilateral neural quadriceps deficits in patients after unilateral ACLr
provides additional justification for clinicians to incorporate both limbs when
designing rehabilitation protocols, and to not rely on a bilateral comparison alone
when making return-to-activity decisions. Comparing a patient’s post-operative
neuromuscular function to that of a healthy, matched control is preferred when
determining readiness to return-to-activity. Furthermore, there are multiple
factors that contribute to the persistent quadriceps weakness observed in
patients after ACLr. Once NQD has been resolved in patients, clinicians should
continue to target any structural modifications that remain within the quadriceps
in efforts to restore the muscle mechanics and strength to a healthy state.
Mechanisms of Neural Quadriceps Dysfunction
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The underlying mechanisms of NQD are multi-faceted, and there has
been a growing body of research within the past decade dedicated to exploring
this area. Since NQD was first determined to be a natural condition that occurs in
patients after ACLr, researchers have developed and tested theories in attempts
to explain the neurophysiology behind the observed neural quadriceps deficits.
Because of this research, understanding of NQD has evolved and improved over
the years. Therefore, the neural mechanisms that have been most supported by
research will be highlighted and described in this review.
Before the mechanisms of NQD can be discussed, it is important to
establish an understanding of the various sensory receptors located within the
knee-joint. These sensory receptors are commonly divided into two main groups,
those that are innervated by larger, myelinated afferents, and those that are
innervated by small, unmyelinated (or lightly myelinated) afferents.102,297 Large,
myelinated afferents hold precedence over small, unmyelinated (or lightly
myelinated) afferents due to their lower activation thresholds and higher
conduction velocities. Therefore, the hierarchy of knee-joint afferents can be
appreciated by their numerical classification type.
Type Ia and Ib afferents are at the top of the large, myelinated afferent
group because they have the largest fiber diameters and highest conduction
velocities. Type Ia afferents innervate muscle spindles and are depolarized after
a rapid muscle stretch. Type Ib afferents innervate Golgi tendon organs and are
typically depolarized following a strong muscle contraction. Type II afferents also
fall under the large, myelinated afferent group, and are depolarized by
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mechanical pressure and tension.297-299 In the muscle, type II afferents innervate
intrafusal fibers (nuclear chain) and respond to stimuli in the absence of muscle
length changes (non-adaptive). Since they respond to instantaneous muscle
length and not change, they are thought to contribute to an individual’s joint
position sense. The sensory receptors innervated by Type II afferents include
Ruffini endings, Pacinian corpuscles, and Golgi-like endings. Although they have
also been found to exist in the human knee-joint, the proportion of Type II
afferents in the knee-joint is unknown and is believed to be relatively small based
on data from animal studies.298
Type III and IV afferents fall under the small, unmyelinated (or lightly
myelinated) variety, and they innervate the second group of knee-joint
receptors.297,298,300 The articular branch of the tibial nerve is the largest articular
nerve supplying the human knee-joint.300 Of the sensory fibers comprised in the
articular branch of the tibial nerve, 70% of them are reported to be Type IV
afferents.300 Both Type III and IV afferents innervate free nerve endings
possessing high activation thresholds, which respond to strong mechanical,
thermal, or chemical stimuli. Therefore, the primary function of Type III and IV
afferents is believed to be nociceptive in nature. However, animal studies have
found that a portion these afferents can be activated by non-painful, passive
knee-joint motion, suggesting that these findings may be observed within the
human knee-joint as well.301
Gamma Loop Dysfunction
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The gamma loop comprises the monosynaptic reflex and is thought to be
dysfunctional within the quadriceps of patients after ACLr.133,150,221,253 The
function of the gamma loop is to monitor the rate of change in a muscle’s length
and recruit high-threshold (type II) aMNs during an MVIC. Gamma motoneurons
(yMNs) within the spinal cord regulate the tautness of the muscle spindles within
the intrafusal fibers of skeletal muscle. The tautness of the muscles spindles
correspond to the sensitivity of the Ia afferents. As a muscle is rapidly stretched,
the muscles spindles depolarize Ia afferents, which transmit signals to the spinal
cord to activate aMNs and induce a reflexive contraction within the muscle. The
sensitivity of the Ia afferents at the muscle spindles also dictate the recruitment of
high-threshold motor units during an MVIC.249-252,302 Therefore, it is considered to
be physiologically impossible to recruit type II aMNs during an MVIC without a
functional gamma loop.
Joint afferents are thought to influence aMN recruitment by controlling the
activity of yMNs within the spinal cord.303 Therefore, damage to the
mechanoreceptors within the knee-joints of patients after ACLr could be
responsible for the observed gamma loop dysfunction. The mechanoreceptors
located within both the knee-joint and ACL are thought to directly influence the
activation of the yMNs associated with the muscle spindles located within the
quadriceps.303 After the ACL has been ruptured and subsequently reconstructed,
the consequent damage to the mechanoreceptors attenuates the activity of
yMNs, and the recruitment of high-threshold aMNs is inhibited due to the reduced
sensitivity of Ia afferents. Thus, the persistent quadriceps weakness that is
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exhibited in patients following ACLr has been partially attributed to gamma loop
dysfunction.133,150,221,253 Furthermore, the selective atrophy of type II muscle
fibers combined with the lack of force attenuation after quadriceps fatiguing
exercise,56,65,86,292,304 which have been observed in these patients, may be
explained by Ia desensitization.
Dr. Yu Konishi has done the majority of work in this area, and his research
largely supports the above hypothesis.133,221,253,272,305 In one of his earlier
studies,305 he worked to determine the effect that altered knee-joint afferents had
on neuromuscular quadriceps function. His group assessed MVIC and EMG
activity of the quadriceps in three groups: patients with ACL deficiency, healthy
participants with anesthetized joints (via lidocaine injection), and in healthy
controls. These neuromuscular assessments were performed both before and
after each group had vibratory stimuli applied to their infrapatellar tendon. In the
control group, the prolonged tendon vibration caused an immediate reduction in
both MVIC and EMG activity. However, the same vibratory protocol failed to elicit
neuromuscular reductions in both the ACL-deficient and anesthetized groups.
Exposing the tendon to a prolonged vibration creates a physiological, habitual
response within the gamma loop by increasing the activation threshold of yMNs,
slackening the muscle spindles, decreasing the sensitivity of the Ia afferents, and
consequently inhibiting the activation of high threshold (type II) aMNs.250,252,306,307
At the same time, the prolonged vibratory stimulus is thought to further reduce
the sensitivity of Ia afferents by increasing their respective activation thresholds
and/or depleting neurotransmitters at their terminal endings;307 thus, preventing
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the recruitment of type II aMNs. As a result, the reduced neuromuscular output
from the quadriceps is the expected response after prolonged infrapatellar
tendon vibration. Conversely, the lack of reduced neuromuscular output
observed in the quadriceps of the ACL-deficient and anesthetized groups postvibration indicated that gamma loop dysfunction was present in those individuals,
confirming the hypothesis that altered afferent signaling from within the knee-joint
disrupts gamma loop function. Although physiology of gamma loop dysfunction
can be debated, some researchers believe that damage to the ACL causes a
reduction in excitatory feedback from ligamentous mechanoreceptors to yMNs
and/or supraspinal centers which diminishes the alpha-gamma coactivation
during and MVIC.264,303,305,308 However, the sparse innervation of sensory
receptors within the ACL compared to other knee-joint structures has raised
uncertainty.298,299 An alternative theory that may also work in conjunction is that
the afferent discharge of nociceptive originating from the knee-joint after trauma
contributes to gamma loop dysfunction. Animal studies have discovered that prior
depolarization of Type IV afferents within the knee-joint suppresses any ensuing
excitatory feedback from other sensory receptors to yMNs.309 In order for this
theory to gain legitimacy, these findings must be replicated in humans.
There have been several follow-up studies that have been able to
reproduce the above findings within the quadriceps of an ACLr patient
population.133,150,221,253 Similar to the bilateral quadriceps inhibition that is
observed in patients after ACLr,90,145,266 gamma loop dysfunction has been found
to exist bilaterally in the quadriceps of patients following unilateral ACLr.221
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However, the gamma loop dysfunction in the contralateral quadriceps was only
present for 12 months post-ACLr, whereas this dysfunction persisted in the
ipsilateral quadriceps beyond 18 months. It is thought that the disruption of
afferent signaling present in the ipsilateral knee-joint after ACLr has an effect on
both spinal and supraspinal centers.221,272,303 As a result, the gamma loop
dysfunction observed in the contralateral quadriceps after unilateral ACLr may be
due to descending inhibitory signals projecting towards the contralateral limb.
Furthermore, Konishi and colleagues133 recently compared the extent of
gamma loop dysfunction between patients with unilateral ACL ruptures, patients
with unilateral ACLr, and healthy controls. The MVIC and EMG activity was
significantly decreased after infrapatellar vibration in the control group’s involved
quadriceps. However, these same neuromuscular measures remained
unchanged post-vibration in both limbs of the ACL-ruptured group and ACLr
group. Although the percentage change in MVIC and EMG activity between the
ipsilateral quadriceps of both groups was not significantly different, the ACLruptured group’s contralateral quadriceps showed a greater change than that of
the ACLr group’s contralateral quadriceps. This finding suggests that ACLr
further disrupts gamma loop function of the contralateral quadriceps compared to
an ACL rupture. Therefore, the initial ACL rupture induces bilateral gamma loop
dysfunction in the quadriceps of patients, but the invasion of additional knee-joint
structures (i.e., skin, capsule, menisci, etc.) via surgery further compounds the
dysfunction present within the contralateral quadriceps via central
mechanisms.133,303,310 The duration gamma loop dysfunction persists after ACLr
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remains unknown because there has not been another study that has assessed
this outcome in patients who are beyond 18 months post-ACLr. Since gamma
loop dysfunction tends to linger in patients after ACLr, it may explain the
persistent quadriceps weakness and QAF observed in this patient population as
well.
Nonreciprocal (Ib) Inhibition
Nonreciprocal (Ib) inhibition pertains to the group of interneurons located
in lamina VI and VII of the spinal cord.311 This group of interneurons receives
input from the Ib afferents transmitted from Golgi tendon organs (GTOs) that
originate within the musculotendinous junction. GTOs are proprioceptive sensory
receptors that function to monitor changes in muscle tension.312 As a muscle
begins to contract, the tension at the musculotendinous junction increases,
causing a deformation of the GTOs housed within the junction.313 The
deformation of GTOs elicits a depolarization of Ib afferents which propagate
signals to the spinal cord. Ib afferents then synapse with Ib inhibitory
interneurons, that also project information to supraspinal centers, and an
inhibitory reflex is elicited at the muscle.313,314 This inhibitory reflex suppresses
efferent activity to promote elongation of the muscle,315 and is best characterized
as a sudden relaxation of a muscle after experiencing a state of high tension.
Interestingly, Ib interneurons have also been found to receive input from a
variety of knee-joint afferents. Through the use of animal models, researchers
have been able to demonstrate that a polysynaptic pathways exists between
knee-joint afferents and Ib interneurons.316,317 This research has been supported
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in humans through the work of Iles and colleagues.318 They used an artificial
knee-joint effusion model by infusing saline into the knee-joint capsules of
healthy individuals. Through the use of a spatial facilitation technique, they
concluded that capsular pressure caused by the effusion depolarized type II
afferents and triggered nonreciprocal (Ib) inhibition of the quadriceps H-reflex. It
remains unknown whether pathways also exist between type III and IV knee-joint
afferents and Ib interneurons in humans, but nonreciprocal (Ib) inhibition is still
considered to be a potential mechanism of the NQD observed in patients after
ACLr.102
Flexion Reflex
The presence of AMI in the quadriceps of patients after knee-joint injury
has been well supported throughout the literature. However, several studies have
also reported increased neural activity in the hamstrings of these patients,319-321
described as a flexion reflex. The flexion reflex is characterized as a facilitation of
flexor muscles and an inhibition of extensor muscles after joint injury.322 Although
it is considered to be a natural phenomenon, the neural pathways associated
with the flexion reflex have not been fully explored. Wide dynamic range (WDR)
interneurons are thought to play a key role in mediating the flexion reflex.323,324
These interneurons originate in lamina V of the spinal cord and receive
nociceptive input from a variety of peripheral receptors, including free nerve
endings within knee-joints.325 The influx of inflammation and pain that is present
after knee-joint injury activates free nerve endings, triggering a discharge of input
from type III and IV afferents to the WDR interneurons. As inflammation and pain
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continue to reside in the knee-joint, the free nerve endings and WDR
interneurons become hyperexcitable, and their activation thresholds are
lowered.301,326-328 Not only does this result in a persistent hypersensitivity to
noxious stimuli at the knee-joint, but a heightened response to mechanical (nonnoxious) stimuli at the joint. This phenomenon is described as a pain
sensitization. Specifically, peripheral sensitization pertains to the hypersensitivity
of free nerve endings located within the involved joint,301,326,327 whereas central
sensitization pertains to the WDR interneurons.328 Peripheral sensitization can be
observed in patients who exhibit painful reactions to movement with their
involved knee-joint, which would otherwise not be perceived as painful.301,326,327
Central sensitization is a much more complex and widespread condition due to
the involvement of WDR interneurons. Patients with central sensitization not only
exhibit painful reactions to movement with their involved knee-joint, but nonnoxious stimuli from adjacent regions such as the quadriceps are perceived as
painful.328 Therefore, WDR interneurons are believed to contribute to persistent
NQD observed in patients after unilateral ACLr, most likely by mediating the
flexion reflex.102
The flexion reflex was first demonstrated in animal studies which
assessed the neuromuscular behavior of the extensor and flexor musculature
surrounding the knee-joint after induced knee-joint trauma.329-331 Furthermore,
the flexion reflex has been found to be present following activation of the
mechanoreceptors within the ACL of animals. Raunest et al.330 reported
increased EMG amplitudes of the knee flexor muscles, and suppressed
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amplitudes in the knee extensor muscles of sheep after shear forces were
applied to the ACL. These findings demonstrate that the mechanoreceptors and
corresponding afferents within the ACL have both inhibitory and excitatory
influences on the neural activity of the quadriceps and hamstrings, respectively.
Although the flexion reflex is well supported in animal studies, the
evidence of a flexion reflex in humans is less abundant. However, human studies
have shown enhanced activity in the hamstrings of patients with knee-joint
injuries compared to healthy controls.319-321 Additionally, the activity of the
hamstrings have been shown to be heightened in patients after ACL injury.320
The hamstrings function synergistically with the ACL to control anterior tibial
translation in the knee-joint; therefore, it is intuitive that their activity be
heightened after ACL injury as a strategy to maintain knee-joint stability. The
flexion reflex has also been shown to be reestablished in patients after ACLr. By
electrically stimulating the ACL grafts of patients with an arthroscopic technique,
Tsuda et al.332 reported that the majority of patients demonstrated increased
EMG activity in the hamstrings, suggesting that the ACL grafts underwent
sensory re-innervation. The results justify the existence of the flexion reflex in
humans, and support that it may also be a potential mechanism of NQD in
patients after ACLr.
Pre and Post-synaptic Inhibition
Interneurons account for the majority of all neurons that are located in the
spinal cord, and they are key component of the spinal circuitry. The basic
function of an interneuron is to relay information between ascending and
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descending pathways, as well as to other interneurons. However, interneurons
also play an integral role in transmitting excitatory and inhibitory signals to
interneurons, aMNs, and yMNs.333,334 Therefore, it is believed that a portion of
NQD that is observed in patients after ACLr is attributed to the
neurophysiological behavior of interneurons. Specifically, NQD observed in
patients is thought to be a result of inhibitory mechanisms that occur at the presynaptic afferent terminals (pre-synaptic inhibition),259,260,265 and/or at the postsynaptic cleft between interneurons and MNs (post-synaptic inhibition).335-337
Both of these mechanisms are believed to be under the supraspinal control,
which influence activity via descending pathways.256,338
Pre-synaptic inhibition is attributed to a decrease of neurotransmitters
released from Ia afferent terminal endplates.255-257 Prior activation of the
monosynaptic reflex has been shown to dampen the release of neurotransmitters
at the pre-synaptic cleft, resulting in an inhibition of the reflex pathway.254,339 The
attenuated Ia afferent discharge caused be pre-synaptic inhibition may also
contribute to the aforementioned gamma loop dysfunction.102 However, the
neurophysiological factors that are specifically responsible for pre-synaptic
inhibition are not completely understood. It is thought to involve an interference of
the calcium influx at the Ia afferent terminal, possibly due to inhibitory,257 GABAergic interneurons. Calcium plays a key role in the binding of vesicles containing
neurotransmitters, which are carried across the pre-synaptic cleft to the
interneuronal membrane so that vesicular exocytosis can occur and signals can
be transmitted to the appropriate neurons.257
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The depolarization of joint afferents has also been shown to influence presynaptic inhibitory mechanisms.258-260 Therefore, it can be assumed that kneejoint injury triggers pre-synaptic inhibition through the disruption of joint
mechanoreceptors. Palmieri et al.260 tested this hypothesis by using an artificial
knee-joint effusion model in healthy individuals. To determine the effect of kneejoint effusion on spinal-reflexive excitability, Hmax amplitudes were assessed
before and after saline infusion. In addition, they used a modified H-reflex
protocol,340 which consists of applying two stimuli (15% of Mmax) to the femoral
nerve at an 80ms interpulse interval, and then evaluating the H-reflex amplitude
elicited from the second stimulus (conditioned reflex) relative to the H-reflex
elicited by the first stimulus. If the conditioned reflex is of a lower amplitude, it is
referred to as the paired reflex depression and represents the modulation of
processes controlling rate-dependent reflex depression and the influence of the
reflex activation history. Compared to conditioned reflexes elicited prior to
undergoing artificial knee-joint effusion, both the Hmax and conditioned reflexes
observed post-effusion were significantly lower, suggesting that pre-synaptic
mechanisms contribute to the reduced spinal-reflexive excitability after knee-joint
injury.260 However, these results should be interpreted with caution due to
methodological limitations.
Antidromic signals from efferents have been shown to attenuate the
excitability of aMNs in the spinal cord.337 This phenomenon is defined as postsynaptic (recurrent) inhibition, and it is caused by the activation of recurrent
collaterals in the spinal cord that excite a specific group of inhibitory interneurons
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known as Renshaw cells.335,336 While pre-synaptic inhibition is specific to the
synapse of Ia afferents,255 post-synaptic inhibition has a more widespread
inhibitory effect on neuronal synapses in the spinal cord. The activation of
Renshaw cells not only leads to an inhibition aMNs,335,336 but it has also been
shown to affect Ia inhibitory interneurons and yMNs;341-343 therefore, making
post-synaptic inhibition a potential contributor to gamma loop dysfunction. The
net result of post-synaptic inhibition is the reduction of efferent activation in a
muscle and its synergists, as well as an excitation of its antagonists.259,265
However, more research is needed exploring post-synaptic inhibition in humans
for it to be considered as a legitimate mechanism of NQD in patients after ACLr.
Supraspinal Mechanisms
The underlying mechanisms of NQD that have been reviewed to this point
pertain to the spinal cord and peripheral nervous system. However, knee-joint
afferents project input to both spinal and supraspinal centers;344-346 thus, it is
probable that supraspinal mechanisms also contribute to the observed neural
dysfunction in patients after ACLr. In particular, supraspinal mechanisms are
thought to contribute to the persistent NQD that has been observed in these
patients, such as QAF and reduced corticomotor excitability.
Since alterations in corticomotor excitability associated with the
quadriceps have only recently been discovered in patients following unilateral
ACLr, the research exploring the cortical mechanisms behind this condition is in
its infancy. Corticomotor alterations are most likely the result of cortical
neuroplasticity after knee-joint trauma. After knee-joint trauma such as that
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caused by ACLr, there is an afferent discharge from the knee joint due to the
onset of effusion, inflammation, and pain. However, the knee-joint damage
elicited during the arthroscopic surgery likely damages (or destroys)
mechanoreceptors responsible for joint proprioception.345 Several studies have
reported joint position sense discrepancies in patients after ACLr that are thought
to be the result of damage to knee-joint mechanoreceptors.344,347-349 Therefore,
the deprivation of proprioceptive input to the somatosensory cortex may elicit
neuroplastic changes in the primary motor cortex pertaining to reduced
corticomotor excitability. These neuroplastic changes may involve a
reorganization of motor maps in the primary motor cortex, and/or a suppression
of corticomotor areas. Cortical reorganization is likely due to compensatory
movement strategies that are adopted in patients after ACLr. Numerous studies
have reported altered lower extremity biomechanics in patients after primary,
unilateral ACLr,17,350-352 which are thought to be strategies adopted by patients to
compensate for neuromuscular deficits, avoid exposing the reconstructed joint to
mechanical stress, or the result of pain and effusion. Alternatively, or perhaps
concurrently, these avoidance strategies my also result in a long-term depression
of corticomotor areas.353 From a simplistic point of view, as the involved limb’s
quadriceps continue to be underused in these patients, synapses begin to
deteriorate within the primary motor cortex, and their maps become invaded by
neighboring muscles; therefore contributing to reduced corticomotor excitability.
However, substantial research is needed to test these theories and determine the
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exact neural mechanisms of corticomotor alterations observed in patients after
ACLr.
The brainstem is also believed to contribute to the mechanisms of NQD in
patients after ACLr.102 The brainstem not only functions to regulate vitals such as
heart rate and respiratory rate, but it serves an important role in relaying input
from the spinal cord to the cerebrum and cerebellum, and vice versa. The
inflammation and pain that is present after joint injury greatly enhances
descending input from the brainstem (pain modulation),354-357 which can both
inhibit and facilitate mechanisms at the spinal cord. Based on current evidence,
knee-joint pathology is thought to be associated with brainstem dysfunction
specific to the modulation of WDR interneurons involved in the flexion
reflex.258,354,356 In addition, the QAF that remains in patients after ACLr has been
partly attributed to the brainstem’s influence on central sensitization of the WDR
interneurons.102 Nevertheless, supraspinal mechanisms play a significant role in
the NQD observed in patients after ACLr, and additional supraspinal regions
deserve to be explored to gain a better appreciation of their contributions.
Ramifications of Neural Quadriceps Dysfunction
The ramifications of NQD demonstrated in patients after ACLr are not as
well-known in the literature as that of quadriceps weakness. However, within the
past decade, clinical research has begun to uncover the contributions NQD has
on quadriceps strength, and the resulting consequences it has on physical
function and well-being of these patients. The following review will highlight the
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correlation and predictive ability of the aforementioned measures of NQD on
quadriceps strength, biomechanics, and patient-reported outcomes.
Quadriceps Strength
One of the most established relationships reported in the literature is that
between isometric quadriceps strength (MVIC) and voluntary quadriceps
activation (via SIB technique) in patients who have sustained knee-joint
trauma.86,97,232,358-364 Significant, strong correlations between these two
neuromuscular outcomes in patients post-ACLr have been consistently reported
across studies, with Pearson product correlation coefficients ranging from r =
0.67 to r = 0.8.86,97 Furthermore, voluntary quadriceps activation has been
reported to predict up to 87% of the variance in quadriceps MVIC via regression
analyses.358 The relationship between other measures of NQD (spinal-reflexive
excitability and corticomotor excitability) and quadriceps strength in patients after
ACLr has been underinvested, but recent evidence has shown that relationships
may exist.97,296
A study conducted by Lepley et al.97 investigated the predictive
capabilities of voluntary quadriceps activation, spinal-reflexive excitability, and
corticomotor excitability (AMT) on isometric quadriceps strength (MVIC) in
patients who have undergone ACLr. The authors performed the above
neuromuscular assessments on patients who were an average of four years
removed from primary, unilateral ACLr, and used multiple linear regression
analyses to determine the amount of variance in MVIC values that could be
explained by the variance in voluntary quadriceps activation, spinal-reflexive
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excitability and corticomotor excitability outcome measures. Prior to the
regression analyses, they examined correlations within the measures of neural
quadriceps function, and between the measures of neural quadriceps function
and quadriceps strength. As expected, a strong, positive correlation existed
between quadriceps activation and MVIC (r = 0.78; p < 0.001). There was also a
moderate, positive correlation between quadriceps H-reflex and MVIC (r = 0.66; p
< 0.05), and a moderate, negative correlation between quadriceps AMT and
MVIC (r = -0.64; p < 0.05). When all three neural quadriceps measures were
entered into the regression model, they were able to predict 49% of the variance
in isometric quadriceps strength of patients after ACLr (r2 = 0.49; p < 0.01).
However, quadriceps activation (r2 = 0.37; p < 0.001)) and spinal-reflexive
excitability (r2 = 0.1; p < 0.05) were the only variables that demonstrated
significant predictive capabilities, and quadriceps AMT only increased the
predictability of the regression model by 2% (r2 = 0.02; p = 0.4).
It should be noted that when correlations were assessed among the
neural quadriceps measures in this study,97 voluntary quadriceps activation and
AMT were the only measures to demonstrate a significant correlation (r = -0.64; p
< 0.05); whereas, insignificant correlations existed between quadriceps activation
and spinal-reflexive excitability (r = 0.44; p = 0.3), and spinal-reflexive excitability
and AMT (r = -0.4; p = 0.41). These findings imply that the insignificant
predictability of corticomotor excitability on quadriceps strength may be the result
of collinearity. Since voluntary quadriceps activation and corticomotor excitability
are both central measures of neural quadriceps function, it is intuitive that a
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correlation exist between the two, resulting in a potential overlap of their
predictive capabilities within the regression model. Conversely, the lack of
correlation between voluntary quadriceps activation and spinal-reflexive
excitability suggests that they assess different aspects of NQD; therefore, they
represent different pieces of the regression model in relation to predictive
capabilities on quadriceps strength. However, further research is needed to
explore the association of various neural quadriceps measures on quadriceps
strength in patients after ACLr.
Biomechanics
Researchers are just beginning to understand the implications of NQD on
lower extremity biomechanics following ACLr. To this date, the only publications
to investigate the effects of NQD on lower extremity biomechanics have been
from studies using an artificial knee-joint effusion model.282,358,365 Although the
artificial knee-joint effusion model is a supported method for inducing NQD,
which allows for a controlled assessment of its biomechanical consequences, its
clinical validity and generalizability to an ACLr patient population is limited.
Therefore, the results from these applied studies must be interpreted with
caution.
Several studies have reported altered lower extremity biomechanics after
artificially inducing effusions in the knee-joints of healthy individuals.282,358,365
Torry et al.365 was the first study to use an artificial knee-joint effusion model to
elicit quadriceps inhibition and investigate subsequent biomechanical gait
alterations. Compared to the pre-effusion state, the participants demonstrated
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increased flexion angles at both the knee and hip during the stance phase of gait.
However, there were opposing extensor moments between the knee and hip
during the effused state. Knee extensor moments decreased with larger kneejoint effusion indicating that less force from the quadriceps was being applied
across the knee-joint during the first half of stance. Conversely, hip extensor
moments increased during the first half of stance, suggesting a compensatory
strategy at the hip due to quadriceps inhibition.
Palmieri et al.282 used a similar artificial knee-joint effusion model as Torry
et al.,365 but instead of investigating the effect on gait biomechanics, they
assessed single-legged drop landing biomechanics. After saline infusion, there
was an immediate reduction in EMG activity of the vastus medialis oblique and
vastus lateralis; thus, resulting in a successful induction of AMI in the quadriceps.
Compared to a non-effused state, large knee-joint effusion (60 mL of saline)
elicited decreased knee-flexion angles, decreased knee-extension moments, and
increased vertical ground reaction forces in participants upon landing.
Furthermore, regression analyses revealed that quadriceps EMG activity
accounted for a significant portion of the variance in the knee-flexion angle (r2 =
0.29; p < 0.05), sagittal plane knee moment (r2 = 0.37; p < 0.05), and the vertical
ground reaction force (r2 = 0.83; p < 0.05). In a similar study,358 quadriceps
inhibition (via SIB technique) was reported to explain lower extremity
biomechanics during stair descent. Voluntary quadriceps activation significantly
explained the variance for both knee-extension moment (r2 = 0.29; p < 0.01) and
vertical ground reaction force (r2 = 0.25; p < 0.05). The biomechanical pattern
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that has been observed at the knee after joint effusion and quadriceps inhibition
is indicative of “quadriceps avoidance” strategy.282 As the involved limb accepts
full support of the body during landing or stair descent, the quadriceps work
eccentrically to attenuate forces at the knee-joint. Therefore, the observed
decrease in knee-flexion angle and knee-extension moment suggests that the
quadriceps are avoiding eccentric activity, which consequently allows for more
force to be transferred to the knee-joint as portrayed by the increased vertical
ground reaction force.
Based on the ramifications reviewed thus far, NQD may influence the
development and/or progression of knee osteoarthritis in patients after ACLr as
well. Quadriceps weakness,78,79,216 altered knee-joint biomechanics,366-368 and a
history ACLr have all been shown to be strongly associated with knee
osteoarthritis.23,369 Therefore, NQD has been hypothesized to increase the risk of
knee osteoarthritis in patients after ACLr.370 However, this connection has yet to
be supported by the literature, demanding the need for further research to be
done in this area. If researchers are able to establish this connection, the
inclusion of disinhibitory interventions in the rehabilitation of patients after ACLr
would be warranted to not only combat subsequent NQD, but protect against the
development of early knee osteoarthritis as well.
Self-Reported Knee Function
Perhaps the most clinically relevant relationship to discuss is that between
NQD and patient-reported outcomes (PROs) after ACLr. PROs are patientcentered assessments that provide insight into a patient’s perceived level
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function and quality of life after an injury or intervention. PROs are routinely
administered to patients following ACLr as a methodology to determine perceived
success. NQD may influence a patient’s perception of recovery after ACLr, and
therefore, may influence PROs.
The effect of NQD on PROs after knee-joint injury is beginning to be
revealed in realms of orthopaedic research.32,61,84,86,134 Voluntary quadriceps
activation has previously been reported to moderate the relationship between
quadriceps strength and function in patients with knee osteoarthritis.134 Fitzgerald
et al.134 assessed quadriceps activation and MVIC, and lower extremity function
(Western Ontario and McMaster Universities Osteoarthritis Index combined with
Get Up and Go test) in 105 patients with radiographically diagnosed knee
osteoarthritis. After performing regression analysis, the authors found that adding
the quadriceps activation by MVIC interaction to the regression model resulted in
the highest prediction of function (r2 = 0.22; p < 0.01); therefore, quadriceps
inhibition was believed to serve as a moderator between quadriceps strength and
function. For example, patients who exhibited higher levels of quadriceps
weakness and quadriceps inhibition, had lower levels of function than those with
comparable strength and less inhibition. Conversely, patients who exhibited
lower levels of quadriceps weakness and higher levels of quadriceps inhibition,
had higher levels of function compared to those of comparable strength and less
inhibition. Although the authors could not explain why stronger patients with more
quadriceps inhibition had higher levels of function, they hypothesized that if a
patient has good quadriceps strength, the presence or absence of quadriceps
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inhibition may not play an important role in affecting their function.134 If a patient
has enough strength to function well, they may not need to fully activate their
quadriceps. In contrast, if a patient has significant quadriceps weakness and
quadriceps inhibition, the combination of the two may be sufficient enough to
affect their function. Regardless, this was one of the first studies to demonstrate
the effect NQD has on a patient’s objective and subjective function after kneejoint injury, which has promoted the significance of restoring neural quadriceps
function in patients after ACLr.
To date, there have only been two known studies that have reported a
relationship between NQD and PROs in patients following ACLr.32,48 A
prospective study by Urbach et al.32 assessed the correlation between the
recovery of quadriceps activation and restoration of physical activity levels in
patients who have undergone ACLr. Voluntary quadriceps activation (via ITT
technique) and physical activity level (using the Tegner activity scale) were
longitudinally assessed in 12 patients prior to ACLr and at two years post-ACLr.
Significant improvements over time were reported for both outcomes, and a
strong correlation existed between the two (r = 0.71; p < 0.01), suggesting that
voluntary quadriceps activation has an influence on the restoration of physical
activity levels in patients following ACLr. In a more recent study by Kuenze et
al.,48 the authors used receiver-operator-characteristic (ROC) curves as a
method to establish clinical thresholds for neuromuscular measures of
quadriceps function associated with PROs in patients who were at least six
months removed from unilateral ACLr. Interestingly, they found that symmetrical
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voluntary quadriceps activation (limb symmetry index > 99.2%; area under curve
= 0.67) was more effective than ipsilateral quadriceps activation in identifying
patients with better patient-reported function post-ACLr, based on their total Knee
Osteoarthritis Outcome Score (KOOS total). The results from this study suggest
that near complete voluntary quadriceps activation limb symmetry may be an
additional indicator for clinicians to use when determining whether patients are
ready to return-to-activity following unilateral ACLr and rehabilitation.

2.3

ASSESSING NEURAL QUADRICEPS DYSFUNCTION
2.3.1 Voluntary Quadriceps Activation
Voluntary muscle activation represents both the extent of motor unit

recruitment, and the firing rate of motor units within a given muscle (or muscle
group); yet, it does not discern the two. Over the past half-century, force-based
measures have been the preferred method for assessing the voluntary muscle
activation in both a healthy and clinical population. The force-based assessment
of voluntary muscle activation was first described in 1928 by Denny-Brown,371
and was later tested in 1954 by Merton.372 By superimposing supramaximal,
percutaneous electrical stimuli to the adductor pollicis muscle during an MVIC,
Merton372 observed no differences in force output between superimposed twitch
and voluntary contractions from healthy participants. However, when the
participants were asked to perform submaximal muscle contractions, the
electrical stimuli evoked an increment in twitch force at the adductor pollicis. After
plotting the increment of the superimposed twitch force against the force
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produced a varying MVIC percentages, he observed a negative linear
relationship between the two variables. In other words, as participants
approached 100% MVIC, the increment in superimposed twitch force began to
diminish. It was determined that complete activation of a muscle can be achieved
in healthy individuals when maximal voluntary effort is provided. Conversely, a
visible increment in superimposed twitch force during maximal voluntary effort is
attributed either to fatigue (central and/or peripheral) or neural inhibition. These
results were confirmed in subsequent studies involving the biceps brachii,373,374
tibialis anterior.373,375 and quadriceps.376,377
More recent evidence has demonstrated that the ability of healthy
individuals to completely activate a muscle is less common than what was
originally reported by Merton. This discrepancy is mainly attributed to advances
in high resolution analyses of voluntary muscle activation. A voluntary quadriceps
activation level ≥ 95% has been consistently reported in research on healthy
(non-fatigued) individuals; thus, this level is often used as the standard in studies
investigating voluntary quadriceps activation in patients after ACLr.88 The
remaining motor units in the quadriceps that are commonly left inactivated (5% or
less) by healthy individuals are thought to represent a reserve within the central
nervous system that protects muscles from being overloaded. Furthermore, the
relationship between voluntary quadriceps activation and quadriceps strength
(relative to %MVIC) has been discovered to not be linear, but curvilinear.263,378 As
depicted in Figure 2.1, a sharp incline in quadriceps activation can be observed
at the initiation of an MVIC, but the curve then begins to level off at approximately
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50% MVIC, and it flattens as 100% MVIC is approached. Therefore, the
activation-strength curve is best explained by a 2nd order polynomial.263,378

%MVIC
Figure 2.1. Central activation ratio (CAR) data plotted as a function of the
percentage of maximum voluntary isometric contraction (% MVIC). The
relationship is curvilinear and best fit by a second-order polynomial. Taken from
Stackhouse SK, Dean JC, Lee SC, Binder-Macleod SA. Measurement of central
activation failure of the quadriceps femoris in healthy adults. Muscle Nerve.
2000;23:1706–1712.378
The following review will discuss the force-based techniques
corresponding procedures that are used to assess voluntary quadriceps
activation. This will include the recommended electrode placement, subject
positioning, and parameters for each technique. In addition, the reported
reliability of each technique will be discussed.
Procedures
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The force-based techniques that are most commonly used to assess
voluntary quadriceps activation are the interpolated twitch (ITT) technique and
the superimposed burst (SIB) technique.262,263 Both of these techniques consist
of supramaximal, percutaneous electrical stimulation being delivered to the
quadriceps to evoke an increase in torque while a subject performs an MVIC of
their quadriceps. With the ITT technique, a single stimulus or a pair of stimuli
(doublet) is applied over the femoral nerve trunk both at the peak of the subject’s
MVIC and while they are at rest (either 2-5 seconds before or after the MVIC).263
Applying an electrical stimulus to a relaxed muscle is a method adopted by the
ITT technique intended to assess the peripheral/morphological mechanisms of a
muscle or muscle group.294 This resting stimulus is commonly referred to as the
control twitch when quantifying a subject’s voluntary quadriceps activation with
the ITT technique, because it is used to normalize the superimposed twitch
torque increment observed during their MVIC. Conversely, the SIB technique
involves a single train of stimuli being applied over the muscle bellies of a
subject’s quadriceps (via intramuscular nerve branches) at the peak of their
MVIC.262
Due to the methodological differences between the SIB and ITT
techniques, separate calculations are used when quantifying voluntary
quadriceps activation with each technique. For the SIB technique, a central
activation ratio (CAR) is calculated by dividing the peak torque elicited during the
MVIC by the superimposed torque elicited by the train of stimuli (CAR =
[MVICTorque/SIBTorque] *100).262,378 For the ITT technique, percent activation
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(%ACT) is calculated by comparing the ITT torque increment elicited from the
single stimulus (or doublet) at peak MVIC to the control twitch torque elicited at
rest (%ACT = 1 – [ITTTorque/ControlTorque]*100).263,379 The SIB technique and CAR
are thought to specifically assess the neural mechanisms (i.e., descending aMN
recruitment) underlying voluntary quadriceps activation, whereas the ITT
technique and %ACT take into account both the neural and morphological (i.e.,
potentiation and series elastic components) mechanisms.294 It is important for
researchers not to intermix the procedures and equations associated with the
SIB and ITT techniques when assessing voluntary quadriceps activation in
attempt to protect the validity of these measures.380
Electrode Placement
For the SIB technique, two large electrode pads (self-adhesive or carbonimpregnated) are typically adhered to the participant’s skin at the proximal
(anode) and distal (cathode) aspects of the quadriceps, and bipolar stimulation is
used. The specific electrode placement can either be to a vastus muscle (vastus
lateralis and vastus medialis oblique) or rectus muscle (proximal and distal rectus
femoris) configuration. No differences in CAR have been discovered between
these two electrode configurations when using the SIB technique.381 The
electrode placement for the ITT technique is much more intricate compared to
the SIB technique. For the ITT technique, unipolar stimulation is used by
adhering a smaller (2x2 inch) active electrode (anode) at the superior-lateral
corner of the femoral triangle, and a dispersive electrode (cathode) at the distal
quadriceps or posteriorly at the gluteal fold. This electrode configuration is
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intended to target the femoral nerve during stimulation because it provides
innervation to the quadriceps. Finding the optimal location to stimulate the
femoral nerve can be difficult for the examiner; therefore, some researchers have
adopted an electrode configuration similar to that used with the SIB technique
when using the ITT technique. By placing the electrodes over the muscle bellies
of the quadriceps instead of over the femoral nerve, subjects have reported less
discomfort with percutaneous electrical stimulation,382 and higher reliability with
%ACT.263 However, using quadriceps stimulation over nerve stimulation with the
ITT technique can be challenged based on methodological grounds regarding its
validity. Specifically, twitch torque increments with the ITT technique are shown
to be higher with nerve stimulation compared to quadriceps, suggesting that a
single stimulus or doublet is not sufficient enough to activate the quadriceps with
quadriceps stimulation, and spatial recruitment of motor units at the quadriceps is
superior with ITT nerve stimulation.382 Therefore, femoral nerve stimulation is the
preferred electrode configuration when using the ITT technique to assess
voluntary quadriceps dysfunction.
Subject Positioning
The recommended subject positioning is identical for both ITT and SIB
techniques. When comparing isometric, concentric, and eccentric contraction
types in healthy individuals, isometric quadriceps contractions have
demonstrated highest voluntary quadriceps activation levels.383 Subjects are
seated on a dynamometer chair with their hip-joints fixed at 85° of flexion and the
knee-joint of interest fixed at 90° of flexion. Assessing voluntary quadriceps
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activation at 90° of knee-joint flexion has been shown to elicit the highest
quadriceps activation levels in healthy subjects;384-387 thus, optimizing the ability
to detect quadriceps inhibition in patients after ACLr. Furthermore, this angle is
believed to put less strain on the surgical grafts of patients who are recovering
from ACLr, because of the higher anterior shear forces that are generated from
the quadriceps at lower knee-joint angles.388,389
To help subjects achieve higher knee extension torques when performing
MVICs of their quadriceps, they are advised to rapidly push their lower leg
against the lever arm pad on the dynamometer at maximal effort, while the
examiner simultaneously provides verbal encouragement. In addition, it is
important to isolate the subject’s quadriceps during their MVIC. Utilizing torso
belts to secure the patient to a dynamometer chair helps subjects to maintain an
upright posture, which limits paraspinal activity during the MVIC.390 Subjects
should also be instructed to cross their arms over their chest during the MVIC to
prevent them from pulling on the chair with their arms.390 The ITT technique does
require subjects to completely relax their quadriceps when the control twitch is
applied. Surface EMG can be used to monitor myoelectric activity in the
quadriceps and ensure that subjects are fully relaxed prior to delivering the
control twitch.
Parameters
The stimulation parameters that are commonly used with ITT can be
observed in Table 2.1. To determine the stimulation intensity used with the ITT
technique, a control twitch test is commonly performed on subjects before
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Table 2.1. Interpolated Twitch Technique Parameters
Parameter
Common Range
# of Stimuli
2
Pulse Duration
0.05 – 1 ms
Interpulse interval
10 ms
Pulse Frequency
50 – 100 Hz
Voltage
400 V
performing ITT trials. The control twitch test consists of delivering a single or
paired (doublet) stimulus to the femoral nerve while the subject is at rest, and
incrementally increasing the amperage until there is a plateau in twitch torque.
The amperage (mA) that produced the highest resting twitch torque in the subject
is then used for their subsequent ITT trials. This amperage varies from subject to
subject because of the intrinsic differences in muscle morphology between
individuals. The control twitch test can be very tedious and uncomfortable for
subjects because they are receiving an indefinite number of stimuli at rest prior to
performing ITT trials. As a result, some researchers are beginning to promote the
use of a standardized amperage when assessing voluntary quadriceps activation
with the ITT technique.380,391 A recent study by Grindstaff et al.380 assessed
differences in control twitch torque at the quadriceps when using various
amperages. They reported that using an amperage of 450 mA was sufficient
enough to evoke maximum control twitch torque for the majority of participants,
whereas 500 mA achieved maximum control twitch torque for all participants.
Submaximal amperages have previously been shown to produce %ACT levels in
the quadriceps that are comparable to those observed with maximal
amperages.391 Amperages that are 50-90% of the intensity used to produce a
maximal control twitch torque have demonstrated valid %ACT levels at the
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quadriceps that are no different than those used with maximal amperages.391
Furthermore, Bampouras et al.391 reported that 50% of maximal amperage was
the lowest intensity to produce a valid %ACT level at the quadriceps, and it was
more comfortable for subjects based on a 10mm visual analog pain intensity
scale.
The number of stimuli delivered to the femoral nerve when assessing
voluntary quadriceps activation with the ITT technique has been a topic of debate
within the literature. A single stimulus, doublet, triplet, quadruplet, and quintuplet
have all been used to assess voluntary activation, but the differences in %ACT
between them are negligible.263,379,385 However, differences in twitch torque and
%ACT have been demonstrated when more than one stimulus is applied to the
femoral nerve.392-394 Compared to using a single stimulus, doublets have been
shown to increase superimposed twitch torque during an MVIC,263 improve the
reliability of both twitch torque and %ACT,392,394 and be less influenced by
potentiation.393 In addition, the post-MVIC control twitch has been recommended
over the pre-MVIC control twitch when assessing voluntary quadriceps
activation.395,396 During and after an MVIC of the quadriceps, it is expected that
the quadriceps will become potentiated, which increases the superimposed
twitch torques and control twitch torques evoked by electrical stimulation.
Therefore, the post-MVIC control twitch is recommended when calculating %ACT
of the quadriceps based on its validity.395-398 The post-MVIC control-twitch torque
has also been shown to be more reliable than the pre-MVIC control twitch
torque,395,396 which further supporting its use when calculating %ACT.
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The stimulation parameters that are commonly used with SIB technique
can be observed in Table 2.2. As mentioned previously, the SIB technique
consists of applying a train of (ten) stimuli to the quadriceps when the participant
reaches their peak torque during an MVIC. Providing a train of stimuli instead of
a single stimulus or doublet is more uncomfortable for subjects.380 When applying
electrical stimulation over the quadriceps with SIB technique, longer stimulation
durations are required to penetrate the muscle and evoke a greater summation of
motor units. The reason why the ITT technique does not require a train of stimuli
is because less electrical stimulation is required to activate the quadriceps via the
femoral nerve (nerve stimulation) compared to activating the quadriceps via its
intramuscular nerve branches (muscles stimulation).

Table 2.2. Superimposed Burst Technique Parameters
Parameter
Common Range
# of Stimuli
10
Train Duration
100 ms
Pulse Duration
0.2 - 0.6 ms
Pulse Frequency
100 Hz
Amperage
450 mA
Since a train of stimuli is more uncomfortable, researchers have explored the
parameters (train duration, pulse duration, pulse frequency, voltage) used with
the SIB technique to determine which parameters are the most comfortable for
subjects without compromising the validity of quantifying voluntary quadriceps
activation (CAR). Miller et al.399 discovered that a 50 ms train duration was more
comfortable for subjects compared to a 100 ms train duration, but the 100 ms
train duration evoked greater superimposed torque during MVIC and was less
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variable than the 50 ms train duration. However, previous studies have
determined train durations greater than 100 ms do not evoke further increments
in superimposed torque, and are therefore unnecessary to use with the SIB
technique.378,400,401 Pulse durations greater than 0.1 ms have also been found to
not change superimposed torque increments,399 which suggests that a pulse
duration of 0.1 ms is sufficient for the SIB technique. Two of the more
understudied SIB parameters are pulse frequency and stimulation intensity
(voltage). A pulse frequency greater than 50 Hz has been shown to produce a
similar quadriceps CAR to that of a 100 Hz pulse frequency, but 100 Hz is the
preferred parameter to facilitate motor unit summation and the recruitment of all
fiber types. Miller et al.400 tested stimulation trains at 50 V, 100 V, and 200 V to
determine which stimulation intensities evoke the largest superimposed torque
increments during an MVIC. They reported a significant difference in the
percentage of superimposed torque increments between the four voltages, with
150 V and 200 V evoking larger increments than 50 V and 100 V. However, there
was no difference in evoked torque increments between 150 V and 200 V,
implying that 150 V is a sufficient voltage for the SIB technique.
A point of concern with using either force-based technique to assess
voluntary quadriceps activation is that the superimposed stimulus must be
applied at the participant’s peak MVIC in order to provide a valid measure of
quadriceps activation. When force-based techniques were first introduced, the
superimposed stimulus was manually triggered once the examiner observed a
plateau in force on the oscilloscope. As you can imagine, this method is open to
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much human error and negatively affects both the validity and reliability of forcebased techniques. One method that has been used to standardize the delivery of
the superimposed stimulus is a time-based triggering technique. This involves
delivering the superimposed stimulus at a standard time point during the
participant’s MVIC. For example, the stimulus automatically triggered three
seconds after the onset of the participant’s MVIC. However, there is no way to
insure that the all participants achieve or sustain their peak torque during the
MVIC at three seconds, which again negatively affects the reliability and validity
of the measure. The most promising method for standardizing the onset of
stimulation is a torque-based triggering technique introduce by Krishnan et al.402
With torque-based triggering, the superimposed stimulus is applied at a specific
torque during the participant’s MVIC. To insure that the superimposed stimulus is
applied at the subject’s peak torque during their MVIC, several MVIC trials are
performed beforehand to determine the subject’s peak torque value. The
subject’s peak torque value is then used to trigger the superimposed stimulus
during their MVIC for the quadriceps activation trials. Torque-based triggering
has improved both the validity and reliability of force-based triggering techniques,
as well as limiting the number of times a participant is exposed to electrical
stimulation.402 However, torque-based triggering has only recently been adopted
in studies assessing voluntary quadriceps activation. Torque-based triggering
must become the gold standard with force-based assessments of voluntary
quadriceps activation in order for results to be fairly compared across studies and
generalizations to be legitimized.
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Reliability
The reliability of both the ITT and SIB techniques have high test-retest
reliability for the assessment of voluntary quadriceps activation in healthy
individuals.88,403-406 However, the majority of these studies assessed intrasession
reliability; whereas intersession reliability is of more clinical significance because
it demonstrates whether or not the force-based techniques are consistent
longitudinally. The intersession intraclass correlation coefficient (ICC) for the ITT
technique (using %ACT) has been reported to be high (ICC = 0.92 – 0.95), with a
low standard error of measurement (SEM = 1.0 – 2.84%) and minimum
detectable change (MDC = 2.8 – 6.6%).403,406 There has only been on study to
date that has assessed the intersession reliability of the SIB technique (using
CAR).404 The results demonstrated moderately-high reliability (ICC = 0.86), low
SEM (2%), and a low MDC (5.5%). These results suggest that both force-based
techniques have good reliability, and they can be used in longitudinal studies to
assess voluntary quadriceps activation. It should be noted that none of these
studies have assessed the reliability of either the SIB or ITT techniques in an
ACLr patient population. Although this is not absolutely necessary, determining
the ICC, SEM, and MDC of these techniques in an ACLr patient population would
ensure their reliability in a clinical population.
2.3.2 Spinal-Reflexive Excitability
In 1910, Paul Hoffmann introduced a method to noninvasively assess the
spinal stretch reflex,280 which was later named as the Hoffman reflex (Hreflex).275 The H-reflex serves as an electrical variant of the mechanically
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induced stretch reflex, but contrary to the stretch reflex, the H-reflex bypasses
the influence of the muscle spindles by directly activating their corresponding Ia
afferents.276 Therefore, the H-reflex is the preferred technique for assessing
monosynaptic spinal-reflexive behavior in muscles of humans. More specifically,
the H-reflex has been used extensively in orthopaedic research as a tool to
assess presynaptic inhibition279 and spinal-reflexive excitability277 in the
quadriceps of patients after ACLr,34,51,84,97,273,281 or following a disinhibitory
treatment.407-409
Within the past century, the methodology associated with the quadriceps
H-reflex has evolved to improve the validity and reliability of the technique. The
following review will discuss the most recent procedures that are associated with
the quadriceps H-reflex technique used to assess spinal-reflexive excitability.
This will include the recommended electrode placement, subject positioning, and
parameters for the H-reflex technique. In addition, the reported reliability of the
quadriceps H-reflex will be discussed. Please refer to Palmieri et al.274 for a more
in-depth review of H-reflex methodology.
Procedures
When assessing the quadriceps H-reflex, a percutaneous electrical
stimulus is applied over the femoral nerve, and the evoked myoelectric response
at the quadriceps is assessed through surface EMG. Since the stimulation is
being applied to a mixed peripheral nerve, both afferent and efferent fibers have
the potential to be depolarized.276 The activation threshold of afferent fibers is
lower than that of efferent fibers due to their larger diameter,410 meaning that Ia
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afferents are first to depolarize as the stimulation intensity is increased from
baseline. The stimulation of Ia afferent fibers within the femoral nerve causes
action potentials to be transmitted to the dorsal horn of the spinal cord, which
results in the depolarization of aMNs and transmission of action potentials to the
efferent fibers innervating the quadriceps. Once these action potentials reach the
neuromuscular junctions and depolarize the sarcolemma, an EMG twitch
response is observed at the quadriceps, defined as the H-reflex. Therefore, the
electrically-induced H-reflex measures the efficacy of synaptic transmission as
the stimulus travels from Ia afferents to the efferent fibers.274,277
As the intensity of the electrical stimulus is increased from baseline, the EMG
amplitude of the H-reflex reaches a peak amplitude, termed as Hmax, which is
believed to represent an individual’s spinal reflexive excitability. Continuing to
increase the intensity causes the H-reflex to begin to diminish until it is no longer
visible.411 However, while the H-reflex diminishes, an earlier muscle response,
called the M-wave, begins to appear on the EMG tracing, and its amplitude
steadily increases with the stimulus intensity until it eventually reaches a plateau
in amplitude, termed as Mmax

265,274

Mmax represents the maximum peripheral

activation of an individual’s motor units.279 The behavior of the H-reflex and Mwave is depicted in Figure 2.2.
The lower threshold of Ia afferents compared to efferent fibers explains
why the H-reflex is observed at lower stimulus intensities, and the M-wave only
appears at higher stimulus intensities, but it does not explain why the H-reflex
diminishes at higher stimulus intensities. As the stimulus intensity increases, the
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Figure 2.2. Hoffmann reflex (H-reflex) and muscle response (M-wave) pathways.
When a short-duration, low-intensity electric stimulus is delivered to the tibial
nerve, action potentials are elicited selectively in sensory Ia afferents due to their
large axon diameter (response 2). These action potentials travel to the spinal
cord, where they give rise to excitatory postsynaptic potentials, in turn eliciting
action potentials, which travel down the alpha motor neuron (aMN) axons toward
the muscle (response 3). Subsequently, the volley of efferent action potentials is
recorded in the muscle as an H-reflex. Gradually increasing the stimulus intensity
causes action potentials to occur in the thinner axons of the aMNs (response 1),
traveling directly toward the muscle and recorded as the M-wave. At the same
time, action potentials propagate antidromically (backward) in the aMN toward
the spinal cord (response 1) to collide with action potentials of the evoked reflex
response (response 3), thereby resulting in partial cancellation of the reflex
response. At supramaximal stimulus intensities, orthodromic (toward the muscle)
and antidromic (toward the spinal cord) action potentials occur in all MN axons;
the former gives rise to a Mmax, whereas the latter results in complete
cancellation of the H-reflex. Taken from Palmieri RM, Ingersoll CD, Hoffman MA.
The Hoffmann reflex: methodologic considerations and applications for use in
sports medicine and athletic training research. J Athl Train. 2002;39(3):268277.412
activation threshold for efferent fibers is met and signals are transmitted
bidirectionally to both the muscle (orthodromic) and the spinal cord
(antidromic).255,274,278 The orthodromic signals are responsible for introducing the
M-wave, whereas the antidromic signals collide with the efferent signals elicited
via Ia afferent activation and ultimately “cancel out” the H-reflex; therefore,
explaining why the H-reflex disappears at higher stimulation intensities. The
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length of time it takes for the electrical stimulus to elicit an H-reflex and M-wave
at a muscle (latency) is dependent on an individual’s limb length.413,414 For
example, the more distal the muscle of interest is from the point of stimulation,
the longer the H-reflex and M-wave latencies. Since the H-reflex travels both
afferent and efferent pathways, and the M-wave only travels the efferent
pathway, it is logical that the H-reflex latency is longer than that of the M-wave
latency. The average H-reflex and M-wave latencies at the quadriceps has been
reported to be approximately 17-22 milliseconds265,415 and 11 seconds,265
respectively. Refer to Figure 2.3 for further description of H-reflex pathways.

Figure 2.3. Recruitment curves of Hoffman reflex (H-reflex) and muscle
response (M-wave). Taken from Hopkins JT, Ingersoll CD. Arthrogenic muscle
inhibition: a limiting factor in joint rehabilitation. Sport Rehabil. 2000;9(2):135159.265
H-reflex amplitudes are known to vary between subjects,265,274 making it
difficult for researchers to compare their results with others studies, and reducing
the external validity of this measure. Therefore, it is highly recommended that
researchers normalize H-reflex amplitudes when reporting their results, so to
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allow for more valid comparisons between subjects and studies.265,274 The H:M
ratio is common method used to normalize H-reflex amplitudes,265 and it is the
preferred normalization method when H- reflex data is being collected
longitudinally.274 The H:M ratio of a given muscle is generated by dividing the
Hmax amplitude by the Mmax amplitude. Since the MMAX is thought to represent
maximum muscle activation, the H:M ratio can be interpreted as the proportion of
the aMN pool capable of being recruited via the monosynaptic pathway.274
However, the H:M ratio is based on the assumption that Mmax is a stable value.
The number of aMNs in the spinal cord are thought to remain the same over
time; thus, it is believed that the H:M ratio is a valid method for researchers to
use when normalizing H-reflex data.265
Electrode Placement
Unipolar stimulation is recommended to observe the H-reflex in absence
of the M-wave because it is thought to selectively activate Ia afferents at lower
thresholds.416,417 This involves placing the active electrode (cathode) directly over
the nerve supplying innervation to the muscle on interest, and the dispersive
electrode (anode) on the opposite side of the limb. It has been suggested that
this electrode configuration is better than a longitudinal arrangement because the
stimulus artifact is less, an anodal block is less likely to develop, and selective
stimulation of the nerve trunk is easier.417 However, if there are many nerves
located adjacent to the nerve trunk being targeted, bipolar stimulation should be
used to selectively activate the nerve trunk without stimulating any of the
surrounding nerves.416 With bipolar stimulation, both the anode and cathode are
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contained in one electrode, which allows the stimulation to be more precise. For
quadriceps H-reflex testing, the active electrode is placed at the superior-lateral
corner of the femoral triangle, and the dispersive electrode is placed posteriorly
at the gluteal fold. As mentioned previously, surface EMG is used to record the
H-reflex and M-wave amplitudes after stimulation. Bipolar electrodes (2 cm interelectrode distance) are adhered to the subject’s skin, over the corresponding
muscle belly and parallel with the muscle fibers.
Subject Positioning
Subject positioning is the most technical of the H-reflex testing
procedures. Factors such as eye movement,415 head position,415,418 joint
angles,419-422 remote muscle contractions,279,415,423 and muscle length424,425 have
been shown to affect H-reflex amplitude. As a result, H-reflex data can be highly
variable between subjects and between studies based on differences in subject
positioning.426,427 Therefore, specific guidelines pertaining to the testing position
of subjects have been promoted to control these factors and reduce H-reflex
variability. Specifically, it is recommended that subjects be positioned in a semireclined, supine position with their head and arms supported and their hands
being held at their side.417 The knee on the involved limb should be supported at
approximately 15° of flexion, and their heel should rest on a supportive foot
rest.428 The position of the extremities and angle of the joints should remain
constant throughout H-reflex testing,412,423,428 and the subjects should be
instructed to keep their eyes open and stare at the ceiling prior to nerve
stimulation.417
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Parameters
As mentioned above, the fiber diameter of Ia afferents is larger than that of
the efferents within a mixed nerve, making the rheobase (activation threshold)
lower for Ia afferents.429 Therefore, H-reflex of a given muscle can be provoked
at lower stimulation intensities. In terms of the duration of stimulus used with Hreflex testing, longer stimulus durations have been previously shown to
selectively activate Ia afferents;430 whereas, shorter durations preferentially
activate efferent fibers.429 A stimulus duration of 1 millisecond is suggested to
elicit an H-reflex.417 Lastly, the rest-period between the deliverance of stimuli
must be taken into consideration when testing the H-reflex in subjects. If stimuli
are delivered too closely within each other, the H-reflex amplitude can be
negatively affected. This is attributed to a neural phenomenon known as postactivation depression.431 After a stimulus is delivered to a nerve, the Ia afferents
become depolarized and neurotransmitters are released presynaptically to bind
with spinal interneurons, which then excite aMNs and evoke a neuromuscular
response (H-reflex). However, if a second stimulus is delivered before the
neurotransmitters are replenished in the Ia afferent endplate, the H-reflex
amplitude will be reduced. Therefore, as a method to avoid these effects of postactivation depression, stimuli should be delivered at an interval no less than 10
seconds apart.416,431
Reliability
Due to the variability that has been associated with H-reflex testing, it is
important for researchers to determine the test-retest reliability of the H-reflex

‐ 103 ‐

amplitudes, especially when it is being used as a repeated measure in
longitudinal studies. Ten to twenty measurements have been previously
advocated as the standard for finding the mean HMAX,417 but as little as 5
measurements has also been shown to produce sufficient reliability (ICC =
0.93).432 The intrasession reliability of the quadriceps H-reflex has been reported
to be very high (ICC = 0.96 – 0.97), with a low SEM (0.001) and MDC (0.002).428
However, only moderate levels of intersession reliability have been reported, with
the between-week reliability (4 weeks, ICC = 0.79 – 0.96)428 being lower than that
of the between-day reliability (5 days, ICC = 0.76).428,433 Consequently, the SEM
(0.01 – 0.06) and MDC (0.03 – 0.17) of the H-reflex are also higher when
assessed between testing sessions.428,433 It must be noted that quadriceps Hreflex reliability assessments (intrasession or intersession) have not been
conducted in an ACLr patient population; thus it is unknown whether ACLr
patients have more variable H-reflex amplitudes than that of healthy individuals.
2.3.3 Corticomotor Excitability
In 1980, Merton and Morton built a transcranial electrical stimulator (TES)
that could invasively stimulate areas of the human brain through an intact
scalp.434 By delivering a high-voltage shock above the area of the brain
represented by the primary motor cortex, a resulting muscle response, called a
motor-evoked potential (MEP), could be observed. This invention was a scientific
breakthrough in the field of neurology because it allowed scientists to assess the
neural activity of the human brain without disrupting superficial tissues. However,
the main problem with TES is that it is a painful for subjects due to its electrical
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properties. Thus, five years later, Anthony Barker developed an alternative
device that non-invasively stimulated areas of the brain, while providing little to
no discomfort to subjects.435 This invention is known as transcranial magnetic
stimulation (TMS). Since its inception, TMS has largely replaced TES and is
widely used to study both the neuroanatomy and neurophysiology of the human
brain. With TMS, large electrical current flows through a coil placed on the scalp,
generating a perpendicular magnetic field that penetrates through the scalp and
skull, and induces an electrical current flowing parallel to the superficial layers of
brain (see Figure 2.4).286,436,437 Since the electric current of TMS penetrates
through the scalp and skull, cutaneous pain receptors are not activated, resulting
in a relatively painless experience for the subject.438 This is contrary to TES
whose electrical current passes through the scalp and skull, and subsequently
activates pain receptors.436,439 Due to the high electrical impedance of the skull,
the current density required to successfully activate the cortical neurons using
TES is much higher than that of TMS. The combination of these factors is what
has made TMS the more popular tool of choice.
In addition, TMS and TES also activate the neurons within the cerebral
cortex differently. Since the electrical current of TMS flows parallel to the surface
of the brain, horizontally oriented neurons are preferentially activated, whereas
the TES flows in all directions, directly activating neurons at the axon hillock.436
Low-intensity TES causes a single descending volley, termed the D-wave (direct
wave), which bypasses the synaptic network within the cortex. When higher
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Figure 2.4. Illustration demonstrating the direction the electrical current flows in
the magnetic coil, the generated magnetic field, and the induced electrical current
in the brain. Taken from Hallett, M. Transcranial magnetic stimulation and the
human brain. Nature. 2000;406:147–150.437

intensities of TES are used, greater electrical fields are produced and indirect
trans-synaptic activation of pyramidal neurons occurs. This leads to a series of
descending volleys that follow the D-wave termed I-waves (indirect waves). In
contrast, the parallel nature of the TMS current commonly elicits I-waves due to
preferentially activated trans-synaptic pyramidal neurons;440 however, higher
intensities of TMS tend to also elicit D-waves at the corticospinal tract. The
summation of descending volleys travel to the anterior horn of the spinal cord
and depolarize the alpha motor neurons. This progressive depolarization
subsequently induces an action potential, resulting in a MEP within the targeted
muscle group.436
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Current TMS models are capable of inducing multiple types of pulses such
as single-pulse, paired-pulse, or repetitive. Single-pulse TMS is especially useful
for mapping cortical areas and assessing the integrity of the corticospinal
tract.94,441 and is generally used to assess corticomotor excitability via motor
thresholds and MEP amplitudes. Single-pulse TMS involves the delivery of one
monophasic magnetic stimulus to the brain and recording the resultant MEP.
This stimulation involves currents that rapidly rise and then decay slowly,
followed by a long duration low amplitude current of opposite polarity.436,442
Procedures
As TMS is delivered to an area of the motor cortex, the flow of ions
introduced by the electrical field alters the electrical charge of the cell membrane,
causing a depolarization and hyperpolarization of neurons.439 The passive ion
channels within the cell membrane make it permeable to these ions, which
increases membrane conductance. Experiments have shown that the electrical
field induced by TMS selectively activates neurons at lower threshold where the
axons terminate (or bend sharply).443,444 Hence, axons with larger diameters are
expected to be activated at lower TMS intensities. These neuroanatomical and
neurophysiological properties of TMS provide rationale for determining the area
(“hotspot”) of the motor cortex which elicits the highest MEP amplitudes for a
given muscle group. This “hotspot” theoretically represents the area of the motor
cortex under the stimulating coil where the electrical field is the strongest and
acts on the axon terminate (i.e., synapse).
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Motor threshold is defined as the lowest TMS output needed to elicit
specific MEP amplitudes at a target muscle group when applying a single-pulse
stimulus to the motor cortex.445 This measure is believed to reflect membrane
excitability and local density of a central core of corticospinal neurons
(specifically pyramidal neurons) and interneurons.285 Motor thresholds can be
assessed with the subject’s muscles in a relaxed or active state.442 MEP
amplitudes are typically larger in upper extremity muscles compared to lower
extremity muscles. Therefore, when assessing motor thresholds at the lower
extremity, subjects are commonly instructed to sustain a slight muscle
contraction (5-15% of maximal voluntary force) so to enhance MEP
amplitudes.442 This is known as an active motor threshold technique. Conversely,
a resting motor threshold technique (with the subject muscles relaxed) is often
acceptable to use for upper extremity muscles. The recommended MEP
amplitude for establishing resting motor thresholds is 50µv, and recommended
MEP amplitude for active motor thresholds is 100 µv.442
There are several methods that have been used to measure motor
threshold, but for the purpose of this review, the method used by the author will
be discussed.61,97,446 The first step is to identify the ‘hotspot” on the scalp where
the largest MEP amplitude is produced for the targeted muscle group using 50%
of TMS output. Once the “hotspot” is identified and marked (on a swim cap),
stimulus intensity should be increased or decreased in increments of 5% until the
recommended MEP amplitude is reached (50 or 100 µv). Once MEP amplitude
is reached, 5 out of 10 consecutive trials performed at that stimulus intensity
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should elicit MEPs at or above the recommended amplitude, and 6 out of 10
trials should fall below the recommended amplitude when the stimulus intensity is
decreased by 1% of TMS output. Multiple trials are performed to confirm the
motor threshold level can be trusted due to the inherent variability of MEPs.
Another measure that is used to assess global corticomotor excitability is
called a recruitment curve (or input-output curve). It represents gradually
increasing TMS intensity and recording the resultant change in MEP amplitude.
Increasing TMS output by increments of 10% motor threshold is one method that
has been used.288 MEP amplitudes are commonly expressed as a ratio between
MEP and the maximal M-wave (using peripheral nerve electrical stimulation) of
the targeted muscle. This stimulus-MEP relationship is then plotted to create a
recruitment curve. Although this measure is less understood, it is thought to
demonstrate the extent in which the alpha-motor neuron pool is activated with
increasing TMS intensities.287 Another hypothesis is that the progression of the
curve reveals other neurons outside the core group of neurons that are activated
as stimulation intensity is increases; thus, explaining the larger MEP amplitudes
observed at high TMS intensities.94,286
The MEP amplitude elicited through single-pulse TMS is thought to reflect
both the integrity and excitability of the corticospinal tract in relation to a targeted
muscle group.442,445 However, the absolute MEP amplitude consists of both
upper and lower motor neuron activity; thus, making it difficult to assess neural
activity at just the cortex. A solution to this problem was developed by Rossini et
al.442 who recommended correlating MEP amplitude evoked by TMS with the
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amplitude of the compound muscle action potential (or M-wave) via peripheral
electrical nerve stimulation. The equation involves dividing the MEP amplitude by
the M-wave amplitude, and then multiplying the product by 100 to provide an
MEP percentage (MEP%). This MEP% is said to estimate the portion of lower
motor neurons in the anterior horn of the spinal cord that are activated by TMS.
As the TMS intensity increases, MEP% of the targeted muscle group increases
accordingly. Upper extremity muscles demonstrate a steep TMS-MEP% slope,
while the MEP% in lower extremity muscles is more gradual as TMS intensity is
increased.447
Since its inception 30 years ago, uses for single-pulsed TMS have
continued to grow due to its noninvasive nature and clinical versatility. The
following review will discuss the most recent procedures that are associated with
single-pulsed TMS used to assess corticomotor excitability. This will include the
recommended coil placement, subject positioning, and parameters for singlepulsed TMS. In addition, the reported reliability of the motor thresholds and MEP
amplitudes will be discussed.
Coil Placement
MEP amplitude largely depends on the location of the TMS coil on the
scalp and the direction of the induced electrical field.448,449 With all TMS coiltypes, the current within the coils (as viewed from above) should be in a
clockwise orientation when stimulating the right hemisphere, and a
counterclockwise orientation when stimulating the left hemisphere.447 Therefore,
the directions of the induced electrical fields are flipped and the motor cortices of
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both hemispheres are being stimulated in a posterior-to-anterior fashion. This
posterior-to-anterior stimulation is found to be optimal for eliciting MEPs at low
thresholds over the motor cortex.436
When using figure-8 coil for focal TMS, the direction of the magnetic field
is perpendicular to the long axis of the coil. Therefore, large difference in elicited
MEP can be observed with different figure-8 coil orientations.450 For example,
when targeting the hand muscles in the motor cortex, the orientation of the
magnetic field should be perpendicular to the central sulcus,448 whereas the
orientation should be perpendicular to the longitudinal fissure when targeting leg
muscles.450 Furthermore, since the stimulation pattern of the figure-8 coil is more
focalized than the circular coil,450 MEPs are more prone to variability if its coil
placement is not standardized. This makes it important for examiners to find the
“hotspot” on the scalp and mark it so that the reliability of the evoked MEPs can
be improved.
Prior to performing assessments with TMS, the optimal site of cortical
stimulation should be determined in relation to the muscle group that is being
targeted. This “hotspot” corresponds to the location on the scalp that elicits the
highest peak-to-peak MEP amplitude of the targeted muscle.94,436,442 This
location is often determined by having the subject wear a swim cap on their head
that consists of two intersecting, perpendicular lines.94,442 The sagittal line should
run from the occiput to the tip of the nose, and the coronal line should run from
one external ear canal to the other. This orientation allows the lines to intersect at
the vertex of the skull. When targeting muscles of lower extremity (the
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quadriceps specifically), the first MEP should be recorded with the center of the
coil at the vertex (using 50% maximal stimulator output).288 This is in accordance
with the representation of the lower extremity in the primary motor cortex, as
demonstrated by the motor homunculus. It is important to note that the direction
of current flow in the coils (clockwise or counterclockwise) should be consistent
throughout testing.442 This is because the orientation of the induced electrical
field within the motor cortex is opposite of the coil’s current. Marking the current
direction on the coil’s frame helps to remind the examiner of the electrical field’s
orientation and the manner at which they are stimulating the motor cortex (i.e.,
posterior-to-anterior or anterior-to-posterior). After stimulating at the vertex, the
coil should be repositioned anteriorly and posteriorly (in 0.5-1cm increments) until
the highest peak-to-peak MEP amplitude is found.288,296 The coil may also be
repositioned lateral to the midline, on the cortical hemisphere contralateral to the
targeted limb to search for larger MEP amplitudes. Once the hotspot has been
located, a tracing of the coil should be drawn on the swim cap with a fine-point
ink pen or marker.94,436,442,451 This step allows for consistent coil placement
throughout a given testing session.
EMG is commonly used to record and measure the MEP elicited through
TMS. An output cable from a magnetic stimulator is connected to an EMG A/D
board, which in turn is connected to a computer. EMG software is then used to
monitor EMG activity of the targeted muscle/s, and record MEPs after TMS is
delivered. The temporal latency from the onset of stimulation to an MEP is longer
for lower extremity muscles (~100 ms) compared to upper extremity muscles

‐ 112 ‐

(~50 ms) due to the longer distance that is needed for the stimulus to travel.442
Therefore, the recording window of the software’s oscilloscope must be wide
enough to capture MEPs in the lower extremity (>80 ms). To prevent an MEP
from not being captured, an effective method is to use the TMS impulse to trigger
the onset of the recording window on the oscilloscope. This ensures that MEPs
are not recorded too early or too late, and allows both the stimulus and MEP to
be observed on the oscilloscope. Surface electrodes are used more often than
indwelling electrodes when recording MEPs. Bipolar surface electrodes should
be applied on the subject’s skin (shaved, abraded, and cleaned) overlying the
target muscle with a 2 cm inter-electrode distance, identical to the procedures
used when recording compound muscle action potentials or M-waves. Filtering
should be relatively open, with a low-pass filter recommended to minimize
stimulus artifacts caused by the TMS.442 MEP amplitudes are measured from the
highest to lowest peak of the MEP, and these values are commonly recorded in
microvolts (µv).
Subject Positioning
Subjects should be positioned comfortably in either an upright, seated
position or horizontal, prone position. The examiner must ensure that there is a
sufficient amount of head space for the coil to be appropriately positioned.436 The
position of the subject’s head and eyes should be constantly maintained, and the
examiner should instruct them to relax their body throughout the testing session
while still being alert. For those measurements that require a voluntary muscle
contraction during the TMS, subjects should maintain a constant level of
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contraction during stimulation trials, and be instructed to relax their muscle
between trails.446
The size of the MEP amplitude not only depends on the strength and
number of descending volleys induced through TMS, but also on the physical
state of the subject’s muscle. When a subject is in a relaxed state, higher
stimulation intensities are needed to elicit an observable MEP because more
descending volleys are needed for depolarization.442 On the contrary, if the
stimulus was delivered while a subject sustained a submaximal voluntary
contraction of the targeted muscle, a lower intensity would be needed to produce
an observable MEP due to the resting potential of the inactive motor neurons
being closer to threshold.442 In other words, when keeping stimulation intensity
constant, TMS delivered during a voluntary muscle contraction elicits a larger
MEP compared to that of a resting muscle because a portion of the muscle is
already primed. Voluntary muscle contractions are often used as a method to
both enhance MEP amplitudes and lower motor thresholds when assessing
muscle groups less responsive to TMS.442,452 Voluntary contractions have also
been found to shorten the MEP latency by 2-3 ms compared to relaxed muscle.
The reduced latency is suggestive of earlier lower motor neuron firing in
response to earlier I-waves and D-waves during the contraction.436 In addition,
voluntary muscle contractions not only make MEP amplitudes easier to observe,
but they have also been shown to improve the reliability of TMS measures by
exhibiting more consistent MEP amplitudes across multiple trials.453 Therefore,
having subjects perform a background voluntary muscle contraction at a constant
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submaximal level (5-10% of maximum contraction) while delivering TMS is
recommended to improve MEP measurement quality.
Parameters
Magnetic stimulators commercially used for TMS produce magnetic fields
from 1-2.5 Tesla that last 100 to 200 µs, and induce electrical fields in the cortex
of up to 150 V/m,439,442 and are be capable of reaching depths of 1.5-3 cm
beneath the scalp based upon which coil type is used. Circular, Figure-8, and
double-cone coils are the coil types routinely used for TMS. Circular (round) coils
induce a circular current that is maximal at the diameter of the coil (8-12
cm).436,442 As a result, no stimulation occurs at the center of the coil, making it
suitable for broad stimulation of the brain. For more focal stimulation, Figure-8
coils consisting of two adjacent coils with opposite current directions are
recommended. This flat coil configuration allows for a more pinpoint stimulation,
but lacks the strength to penetrate deeper cortical areas.436,442,454 The coil type
that provides both strong and focal stimulation is the double-coned coil. The
double-coned coil has the same configuration as the Figure-8 coil, except that
the two adjacent coils are angulated at 95° instead of being flat (180°). This
double-cone figuration increase the power at the intersection, while allowing the
stimulus to be focused simultaneous.286,442,455 While the circular and Figure-8
coils are suitable for eliciting MEPs in upper extremity muscles, the double-coned
coil is recommended for targeting muscles of the lower extremity.436
The amplitudes of MEPs increase as the TMS output intensity is
increased. This suggests that application of a stronger stimulus also recruits
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more upper and lower motor neurons. However, compared to the amplitudes of
M-waves elicited through peripheral electrical nerve stimulation, the MEP
amplitudes evoked by TMS are smaller in size. In fact, this stimulus-response
relationship for M-waves demonstrates a sigmoidal curve, while a gradual, linear
relationship is observed for MEPs with increasing TMS intensities. The stimulusresponse relationship has been found to vary considerably between subjects.
When the TMS intensity is standardized to individual MEP motor thresholds (i.e.,
120% motor threshold), significant differences between MEP amplitudes have
been observed between subjects.456 As a method to normalize MEP amplitudes
across individuals, a ratio of the MEP amplitude to the M-wave of the targeted
muscle group has been recommended.442 However, this MEP ratio has also been
shown to differ between subjects, 59,61 which may be due to the location of the
peripheral stimulus.59 Applying the electrical stimulation more proximally at the
nerve (i.e., sciatic nerve) may account for the dispersion that occurs when
applied more distally (i.e., peroneal nerve).457,458
Reliability
It is important to test the intersession reliability of corticomotor excitability
TMS measures in healthy subjects to determine whether they are both stable and
sensitive enough to detect changes over time in a pathological population or
treatment group. The majority of the reliability studies for MEP amplitudes and
motor thresholds have been performed in upper extremity muscles. Over a
timespan of 3-14 days, these studies have reported very high intersession
reliability for motor thresholds (ICC = 0.83 – 0.99),451,459 whereas the reliability for
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MEP amplitudes range from low to very high reliability (ICC = 0.5 – 0.99).451,460462

Recently, Livingston et al.451 assessed the intra-rater reliability of corticomotor

excitability measures in the hand muscles of 16 healthy subjects. Their subjects
attended 6 sessions over the span of 15 days, and both MEP% and resting motor
thresholds were assessed bilaterally during these sessions. They reported very
high intra-rater reliability with resting motor thresholds (ICC = 0.83 – 0.93), while
the reliability of MEP% was low to high (ICC = 0.28 – 0.72). Although both
corticomotor excitability measures appear to demonstrate adequate reliability in
the upper extremity, MEP amplitudes are more variable than motor thresholds,
and should therefore be interpreted with caution.
The intersession reliability of corticomotor excitability measures in lower
extremity muscles has been less explored compared to the upper extremity. Of
the few studies that have examined the reliability of corticomotor excitability
measures in lower extremity muscles, the intersession reliability for motor
thresholds was high to very high (ICC = 0.78 – 0.98),463,464 whereas the reliability
for MEP amplitudes range from very low to very high (ICC = -0.14 – 0.99).463-465 It
is important to note that the time between sessions for these studies was 10-56
days, and some of these studies included both healthy subjects and patients
(stroke and spinal cord injury).464,465 The most recent study by Luc and
colleagues463 assessed the intersession reliability of active motor thresholds and
MEP amplitudes in the vastus medialis oblique and peroneus longus (bilaterally).
Twenty subjects attended a baseline testing session and returned for follow-up
assessments at 2 and 4 weeks. MEP amplitudes were evaluated at multiple TMS
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intensities relative to the percentage of active motor thresholds (95%, 100%,
105%, 110%, 120%, 130%, and 140%). These amplitudes were also normalized
to the peripheral M-waves to obtain an MEP%. Both muscles demonstrated high
to very high intersession reliability at both day 14 (ICC = 0.78 – 0.96) and day 28
(ICC = 0.92 – 0.95). However, the reliability of MEP% was highly variable across
TMS intensities and between days (ICC = -0.14 – 0.99), demonstrating low to
very high intersession reliability. These findings for the lower extremity are in
agreement with what has been reported in upper extremity muscles. Motor
thresholds are more reliable than MEP amplitudes, and they should be
preferentially used when conducting longitudinal assessments of cortical
excitability in subjects.

2.4

DISINHIBITORY INTERVENTIONS FOR NEURAL QUADRICEPS

DYSFUNCTION
The influence quadriceps strength has on long-term health and function,
combined with the limiting effect NQD has on a patient’s ability regain quadriceps
strength using traditional quadriceps strengthening exercises, has prompted the
development and evaluation of interventions used to combat NQD exhibited in
patients after knee-joint injury/surgery. These interventions, termed disinhibitory
interventions, have grown in variety over the past decade, but not all of them
have demonstrated efficacy. Disinhibitory interventions can be categorized into
either sensory-based or motor-based modalities based on their treatment effects.
Sensory-based modalities serve to disinhibit efferent pathways of the quadriceps
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after knee-joint injury/surgery, by attenuating the influx of inhibitory afferent
stimuli arising from the involved knee-joint and/or overriding it with excitatory
afferent stimuli. Conversely, motor-based modalities serve to facilitate quadriceps
activation after knee-joint injury/surgery, by activating the intramuscular nerves
directly and/or targeting the supraspinal efferent pathways projecting to the
inhibited motorneuron pool.
The final section of this review will discuss the various sensory and motorbased modalities that have been used disinhibitory interventions, and their
effectiveness in mitigating NQD in patients with knee-joint pathology and/or
surgery.
2.4.1 Sensory-Based Modalities
Cryotherapy
Cryotherapy involves the application of cooling modalities (i.e. ice bag,
cold tub, etc.) to a site of musculoskeletal trauma. It is commonly applied after
acute musculoskeletal injuries to decrease cell metabolism, limit edema
formation, and control pain during the inflammatory phase.466 However,
cryotherapy has also been shown to possess disinhibitory capabilities.407,408,467471

Studies using artificial knee-joint effusion models were the first to demonstrate

disinhibition of the quadriceps by applying cryotherapy at the knee,408,470 but
there have been several studies since then that have replicated these outcomes
in patients with knee-joint pathology or surgery.407,467-469 Pietrosimone et al.469
assessed the disinhibitory effect of applying cryotherapy (crushed ice bags) to
the knees of patients with tibiofemoral OA and quadriceps inhibition (CAR <
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90%). Compared to the control group that did not undergo the cryotherapy, those
in the cryotherapy group had a significantly higher percent change in quadriceps
CAR after applying cryotherapy to their knees for as little as 20 minutes (5.75% ±
7.25 vs -3.5% ± 8.0, P < 0.01). Furthermore, a strong treatment effect size was
demonstrated in the cryotherapy group (Cohen’s D = 1.21, 95% CI = 0.28 –
2.05), implying that cryotherapy has both statistical and clinical significance as a
disinhibitory modality for patients who exhibit NQD after knee injury/surgery.
However, the maximum treatment duration of cryotherapy is limited (20-30
minutes) to protect against peripheral neuropathy, but the residual disinhibitory
effects of cryotherapy have been reported to last up to 30 minutes after the cold
modality is removed (attributed to rewarming).408,470,472 Therefore, the true
potential of cryotherapy is thought to “open” the efferent pathways of the
quadriceps at the beginning of a patient’s rehabilitation, so that the available
motoneurons can be “exploited” when they perform quadriceps strengthening
exercises.407 To test this hypothesis, Hart et al.407 conducted a randomized
clinical trial on patients with prior ACLr who presented with of quadriceps
inhibition (CAR ≤ 90%). The patients were randomized into 2-week interventions
consisting of either cryotherapy treatments, traditional quadriceps strengthening
exercises, or a combination of cryotherapy and exercises. Those patients in the
cryotherapy group applied ice bags to their involved knee-joints once a day (20
minutes/session) for two weeks, and the exercise group performed progressive
open and closed kinetic chain exercises each of the 14 days (1 hour/session).
Whereas, the cryotherapy+exercise group performed the same exercise protocol
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as the exercise group, but they applied the same cryotherapy protocol as the
cryotherapy group prior to exercising. The authors assessed peak isometric KET
(at 90° of knee flexion), voluntary quadriceps activation (using the SIB technique
and CAR), and spinal reflexive excitability (H:M ratio) in groups before and after
their 2-week interventions. Interestingly, the cryotherapy+exercise group was the
only group that demonstrated a statistically significant improvement in quadriceps
function after two weeks, and this was specific to peak isometric KET (pre = 1.6 ±
0.4 Nm/kg, post = 2.2 ± 0.7 Nm/kg, p = .002). Although voluntary quadriceps
activation did not achieve statistical significance in the cryotherapy+exercise
group, clinical significance was observed with the strong treatment effect size
(Cohen’s D = 1.4, 95% CI = 0.42, 2.4). These results suggest that cryotherapy
should be administered prior to exercise for patients who exhibit NQD, so that
they may take advantage of the available motoneurons when exercising their
quadriceps.
Transcutaneous Electrical Nerve Stimulation
Like cryotherapy, transcutaneous electrical nerve stimulation (TENS) is a
sensory-based modality originally intended to control arthrogenic pain through
principles of the gate control theory.473 Non-painful, cutaneous receptors are
innervated by large diameter, myelinated afferent fibers (type II/A-beta and III/Adelta); whereas, pain receptors are innervated by small diameter, unmyelinated
afferent fibers (type IV/C). When both of these fiber types are activated together,
the non-painful stimuli are preferentially interpreted by the central nervous

‐ 121 ‐

system, and the afferent signals arising from pain receptors become “gated” (via
presynaptic inhibition).
Although cryotherapy and TENS both use these principles to control pain,
they target different afferent structures. When cryotherapy is applied to a painful
joint (i.e., ice bag application), cutaneous thermoreceptors detect the abrupt
changes in skin temperature, causing type III (A-delta) fibers become activated.
As a result, these signals are transmitted to the central nervous system, and the
type IV (C) fibers become overridden.474 Depending on how long the cryotherapy
is applied, and the thickness of subcutaneous tissue superficial to the joint,
cryotherapy may also work to control pain by decreasing conduction velocities of
type IV fibers originating from nociceptors within the joint. On the other hand,
TENS selectively activates larger diameter, type II (A-beta) fibers.475,476 These
fibers innervate cutaneous mechanoreceptors that respond to touch/pressure.
Therefore, when TENS is applied to the skin surrounding a painful joint, the
stimuli arising from the TENS is favored by the central nervous system, and pain
is diminished due to the inhibition of type IV fibers.
Given their ability to control pain, it is intuitive to assume that cryotherapy
and TENS can disinhibit the quadriceps in patients after knee injury/surgery
because of the contribution knee-joint pain has with AMI (i.e., flexion reflex).
However, the majority of inhibitory mechanisms at the core of AMI are not driven
by arthrogenic pain, but by the disruption of joint mechanoreceptors instead.
Therefore, the gate control theory of pain does not explain why cryotherapy and
TENS have been shown to increase motor output of the quadriceps after artificial
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knee-joint effusion. Although some joint discomfort is expected after artificial
knee-joint effusion, the NQD that is observed in these subjects is primarily
caused by the disruption of joint mechanoreceptors via capsular distention. Since
cryotherapy and TENS have been shown to disinhibit the quadriceps after
artificial knee-joint effusion, they must also have the ability to target the inhibitory
mechanisms triggered by capsular distention (i.e. Ib inhibition, presynaptic
inhibition, and post-synaptic inhibition).
Similar to pain control, cryotherapy and TENS are believed to disinhibit the
quadriceps in different ways. Applying cryotherapy to a joint transmits excitatory
stimuli to the central nervous system through activation large diameter afferent
fibers, which in turn, facilitate the motorneuron pool projecting to the quadriceps.
In addition, cryotherapy has been shown to slow the nerve conduction velocity of
afferent fibers,477 and is hypothesized to slow the discharge rate of joint
mechanoreceptors if applied for a long enough duration.408 Previous reports have
demonstrated that intraarticular temperature can decrease during and after
application of cryotherapy to a joint.478,479 Oosterveld et al.479 reported a
decrease of 16.9°F in intra-articular temperature after a 30-minute cryotherapy
treatment. Even after the ice was removed, intra-articular temperatures continued
to decrease for up to 45 minutes. Therefore, by being able to reach the depth of
the knee-joint, cryotherapy can slow the discharge rate of joint
mechanoreceptors, which would attenuate the influx of afferent stimuli projecting
to the central nervous system, and disengage the inhibitory mechanisms.
Conversely, TENS has been reported to decrease presynaptic inhibition of Ia
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afferents through stimulation of cutaneous afferent fibers.339 It has also been
hypothesized that the afferent stimuli from TENS may inhibit the Ib inhibitory
interneuron, or excite the Ia excitatory interneuron, which would facilitate the
motoneuron pool.408 Furthermore, both cryotherapy and TENS have been
thought to disinhibit the quadriceps by triggering supraspinal centers that inhibit
Ib interneurons through descending pathways.408 Supraspinal centers are known
to regulate spinal reflexive activity to allow for controlled movement.355,356
Therefore, the overload of excitatory and inhibitory stimuli arising from the kneejoint during TENS or cryotherapy treatments, may force supraspinal centers to
intervene and control the efferent pathways projecting to the quadriceps.
The disinhibitory effect of TENS was first demonstrated during studies of
the mid-1980s.480,481 Arvidsson and Eriksson481 assigned 15 knee-surgery
patients (12 ACLr, 1 meniscectomy, 1 lateral release, 1 MCL repair) to groups
that consisted of either TENS or placebo-TENS interventions. In both groups, the
interventions were applied to the involved knee for 15-20 minutes post-surgery
(at rest). Integrated EMG of the quadriceps was assessed in patients before and
after the treatment sessions. Compared to baseline, integrated EMG significantly
increased by 305% in the TENS group after treatment, whereas no significant
changes were demonstrate in the placebo-TENS group. However, much like
what was realized with cryotherapy, the true disinhibitory potential of TENS is
maximized when used in conjunction with exercise.467,482
Pietrosimone et al.482 randomized 36 patients, with tibiofemoral OA and
quadriceps inhibition (CAR < 90%), into TENS+exercise, placebo-
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TENS+exercise, and exercise-only groups. The groups were matched by
voluntary quadriceps activation (CAR) and OA grade (Kellgren-Lawrence score).
All three groups performed a 4-week exercise program (3 sessions/week) that
consisted of progressive lower extremity range-of-motion and strengthening
exercises. Additionally, the TENS and placebo-TENS groups applied treatments
to their involved knees for eight hours per day when they were the most active.
Peak isometric KET (at 70° of knee flexion) and voluntary quadriceps activation
(using the SIB technique and CAR) were assessed in each group at baseline,
and at weeks two and four of their intervention program. There were no group
differences observed at baseline for both measures of quadriceps function.
Voluntary quadriceps activation were significantly higher in the TENS+exercise
group (CAR = 94%) than the exercise-only group at two weeks (CAR = 82%, p =
0.02), and significantly higher than the placebo-TENS+exercise group at four
weeks (CAR = 94% vs. 81%, p = 0.03). Peak isometric KET was higher in the
TENS+exercise group than the placebo-TENS+exercise group at both two (2.5
Nm/kg vs. 1.6 Nm/kg, p < 0.01) and four weeks (2.8 Nm/kg vs. 1.6 Nm/kg, p <
0.01), but not significantly higher compared to the exercise-only group (p = 0.09).
Although these results imply that the placebo-TENS and exercise-only
interventions possess disinhibitory effects, the clinical significance of the
interventions was better conveyed by observing the treatment effect sizes
(Cohen’s D). The TENS+exercise group demonstrated strong effect sizes for
peak isometric KET and voluntary quadriceps activation at weeks two (KET:
1.05, 95% CI = 0.16, 1.86; CAR: 1.93, 95% CI = 0.91, 2.83) and 4 (KET: 1.26,
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95%, CI = 0.35, 2.09; CAR: 1.81, 95% CI = 0.80, 2.68), while the placeboTENS+exercise group was the only other group to demonstrate at significant
effect size (though moderate) for voluntary quadriceps activation (0.88, 95% CI =
0.02, 1.68). This observation in the placebo-TENS+exercise group may have
truly been the result of the “placebo effect”.
Perhaps the most surprising result of this study was the disinhibition of the
quadriceps that was maintained in the TENS+exercise group following removal of
the TENS treatment. Although previous studies have claimed that disinhibition of
the quadriceps is negated after TENS is removed,408 this was the first study to
assess the disinhibitory effect of TENS when applied over a period of weeks.
Thus, the greater exposure to TENS may have generated a lasting disinhibitory
effect in their patients. The authors hypothesized that the greater exposure to
TENS may have facilitated synaptic plasticity within the motorneuron pool,483
which may allow a patient to access previously inhibited motoneurons after
TENS is removed.482 Hebbian theories suggest that postsynaptic neurons that
continually depolarize in response to excitatory presynaptic potentials may allow
for multiple postsynaptic neurons to depolarize together, even when the
postsynaptic neurons are not directly depolarized by presynaptic potentials.484
Therefore, after weeks of being able to access motor units of the quadriceps
through TENS, synaptic plasticity may have ensued within the motoneuron pool,
which allows them to depolarize simultaneously, regardless of the excitatory
presynaptic potential.482
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Previous reviews support TENS as not only the most effective sensorybased disinhibitory intervention, but the most effective disinhibitory intervention in
general.100,101 In one of my earlier publications, I developed a critically appraised
topic to determine whether TENS or cryotherapy was the more effective
disinhibitory modality for improving voluntary quadriceps activation (quantified via
CAR) in patients with knee-joint pathologies.100 I searched the literature to find all
of the studies that used TENS and/or cryotherapy as a disinhibitory interventions
for patients with knee-joint pathologies (i.e. osteoarthritis, ACL deficiency,
patellofemoral pain, etc.). A total of three randomized clinical trials satisfied my
eligibility criteria and were included in the review.467,469,482 To compare the clinical
effectiveness between TENS and cryotherapy, I extracted (or calculated)
Cohen’s D effect sizes (difference in mean CAR from baseline to posttest,
divided by the pooled standard deviation of the two means) for CAR from the
intervention groups of each study (see Figure 2.5). TENS consistently exhibited
stronger effect sizes than cryotherapy, and unlike cryotherapy, maintained
significant effect sizes at each post-treatment measurement time point. This
suggests that TENS may be the more clinically effective disinhibitory modality.
Furthermore, the clinical versatility of TENS is greater than cryotherapy. Unlike
cryotherapy, there is no limit to treatment duration or dosage with TENS, and
most all TENS units can be worn during exercise without obstructing movement.
Therefore, the strong disinhibitory effect and clinical versatility of TENS, gives it
an advantage over cryotherapy.
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Figure 2.5. CAR effect sizes with 95% confidence intervals: Diamonds with solid
error bars represent effect size point estimates for TENS interventions and 95%
confidence intervals, whereas circles with broken lines represent effect size point
estimates for cryotherapy and 95% confidence intervals. All point measures and
confidence intervals on the right of the vertical solid line represents beneficial and
statistically significant effects (confidence intervals do not cross 0), whereas the
left of the line represents non-beneficial and statistically insignificant effects.

Muscle Vibration
Although cryotherapy and TENS are considered to be the most effective
sensory-based disinhibitory interventions, muscle vibration is novel modality that
has demonstrated early promise, and is beginning to receive more attention in
the literature. Muscle vibration can be applied in two different modes: whole body
vibration (WBV) or local muscle vibration (LMV). WBV involves having individuals
stand on a vibratory platform, whilst performing stationary, closed kinetic chain
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exercises (i.e. squats). LBV, as the name implies, involves a portable, vibratory
device that is strapped to the muscle of interest while individuals perform lower
extremity exercises. Although both modes of muscle vibration are equally
effective at improving neuromuscular function,485 LBV is more cost-effective and
less restrictive to exercise type. Thus, LBV tends to be more clinically applicable
compared to WBV.
The neuromuscular effects of muscle vibration is founded on principles of
the tonic vibration reflex.486 By applying repetitive vibratory stimuli to a muscle,
the Ia afferents at the muscle spindles become highly excitable, which lead to a
heightened motor output of the muscle. Pollock and colleagues487 found that
immediately after muscle vibration, the recruitment threshold was lowered for
fast-twitch (type II) motor units and elevated for slow-twitch motor units. This
suggests that muscle vibration enhances neuromuscular function by specific
targeting motoneurons projecting to fast-twitch motor units. However, other
reports have shown that the neural effects of muscle vibration are not confined to
just motoneurons within spinal cord, but at the motor cortex as well.488,489 Mileva
et al.489 used TMS to assess the MEP amplitudes at the tibialis anterior muscle,
while their participants simultaneously underwent a WBV protocol (330 second
isometric squat). They reported MEP facilitation in all participants during the
WBV protocol. These results indicate that muscle vibration may improve
neuromuscular function by increasing corticomotor excitability.
Since muscle vibration has been shown to facilitate quadriceps activation
in healthy individuals,490-495 it seems logical that it would produce disinhibitory
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effects in patients after knee-joint injury/surgery. However, most of the current
literature involves determining the effects muscle vibration on quadriceps
strength,496,497 lower extremity function,498,499 and postural stability497,499,500 in
patients with knee-joint pathologies. Although these measures are important to
understanding the complete benefits muscle vibration, they do not provide
information in regard to its disinhibitory effect. Blackburn and colleagues485
recently sought to determine the disinhibitory effect of muscle vibration using an
artificial knee-joint effusion model. To induce AMI in the quadriceps, they injected
the knee-joints of 45 healthy individuals with 60 mL of saline. The individuals
were then randomized into WBV, LBV, or control groups. Each group performed
an isometric squat (40° of knee flexion), but the WBV and LBV (at the quadriceps
tendon) groups received simultaneous muscle vibration (30 Hz, 2g). Voluntary
quadriceps activation (via SIB technique and CAR) and peak isometric KET (60°
of knee flexion) were assessed in all groups at post-effusion and immediately
post-intervention. Artificial knee-joint effusion decreased voluntary activation
(CAR > 90%) and peak KET in all groups, and there were no significant
differences between the groups at post-effusion (p > 0.05). Significant
improvements in voluntary activation were only observed in the WBV (+11.4%, p
= 0.21), and LBV (+7.3%, p < 0.001) groups immediately post-effusion, but not in
the control group (+1.3%, p = 0.18). Compared to the control group (1.2%, p >
0.05), peak KET was also improved to a greater extent in the WBV (16.5%, p =
0.02) and LBV (23%) groups immediately post-intervention, but the LBV group
did not achieve statistical significance (p < 0.08). The immediate disinhibitory

‐ 130 ‐

effects of muscle vibration that were observed in this study provide further
support for this sensory-based modality as a disinhibitory intervention. However,
muscle vibration has yet to be investigated as a disinhibitory intervention for
patients with knee-joint pathology/surgery. Studying muscle vibration in a patientbased population will provide evidence-based justification for its use as a
disinhibitory intervention.
Lastly, heightened neuromuscular function has been reported to remain in
individuals up to 30 minutes after muscle vibration in healthy individuals.491
Cryotherapy and TENS are considered to be superior disinhibitory interventions
largely because of their residual effect on patients. Therefore, if the same
residual effects can be demonstrated in patients after muscle vibration, it will not
only promote its legitimacy as a disinhibitory intervention, but it will receive the
same respect as the above-mentioned sensory-based modalities
2.4.2 Motor-Based Modalities
Neuromuscular Electrical Stimulation
Neuromuscular electrical stimulation (NMES) is a motor-based modality
which applies a series of external stimuli to skeletal muscles through surface
electrodes at the skin. NMES is commonly prescribed for patients who exhibit
muscle dysfunction or weakness, as a method to reeducate muscle contraction
and/or augment muscle force. Unlike the physiology of a voluntary muscle
contraction, NMES elicits muscle contractions by directly activating the
intramuscular nerve branches.103 In addition, the temporal recruitment order of
motor units observed during NMES is believed to differ from that of the biological
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recruitment pattern. The biological recruitment pattern of motor units is
asynchronous, and based on the Henneman size principle,501 with smaller motor
units (type I) being recruited prior to larger motor units (type II). With NMES, this
recruitment is fairly synchronous,502 but larger motor units tend to be
preferentially recruited before smaller motor units due to their larger surface
area.115,503,504
NMES has been well established in the literature as an effective modality
for restoring quadriceps strength in patients after ACLr.70,104-110 Although these
strength improvements are easily attributed to the muscle hypertrophy that
develops during NMES interventions,111-115 it is believed that neural adaptations
elicited by NMES are partly responsible for the increases in muscle strength.111113,116,117

Initial increases in muscle strength during strength training have been

attributed to neural adaptations within the central nervous system;505-507 thus, it is
reasonable that the same effects would be observed during the early phase of an
NMES regimen. Studies assessing the therapeutic effect of NMES interventions
on healthy individuals, have demonstrated progressive increases in muscle
strength throughout the intervention period, with muscle hypertrophy only being
evident during the late phase of the intervention.111-114 Gondin and colleagues113
reported that after applying four weeks of NMES treatments to the quadriceps of
healthy individuals, significances increases in quadriceps strength (+11%, p <
0.001), EMG (+42-44%, p < 0.05), and voluntary activation (+5%, p < 0.05; via
ITT) were observed, but there were no significant changes in quadriceps CSA
(+2%, p > 0.05). Between weeks four and eight, further improvements in
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quadriceps strength (+11%, p < 0.001) were accompanied by changes in
quadriceps CSA (+4%, p < 0.001). Therefore, quadriceps strength improvements
with NMES can be attributed to neural adaptions within the central nervous
system during the early phase of intervention, and muscle hypertrophy during the
later phase.
Perhaps the most compelling evidence supporting the neural adaptive
effect of NMES, is the presence of cross-education in skeletal muscles of the
extremities.111,138,139,508 Although cross-education has been observed with
voluntary exercise,509-512 there is evidence to suggest that NMES may induce
greater cross-education effects than voluntary exercise.138,139 Hortobagyi et al.138
randomized 32 healthy women to a NMES and control groups, and asked them
to perform 840 eccentric contractions (control = voluntary, NMES = stimulated)
over six weeks. Each group was tested before and after six weeks to assess for
changes in eccentric quadriceps strength. Improvements in quadriceps strength
of the trained limb were observed in both groups, but the untrained limb of the
NMES group demonstrated a 60% increase in quadriceps strength, which was
greater than that of the control group. Since the untrained limb did not received
the NMES and was unexercised, the bilateral improvement in quadriceps
strength after a unilateral NMES intervention could only be explained by a neural
adaptation within the central nervous system. This cross-education effect
observed after NMES or exercise has been attributed to both spinal and
supraspinal mechanisms.116,513-516
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The exact neural mechanism underlying the neural adaptations observed
with NMES have yet to be fully comprehended. Based on limited evidence,
NMES does not seem to influence spinal reflexive excitability.117,517 Instead, the
neural adaptations observed with NMES are believed to involve alterations at the
supraspinal level.116,136,137 In a study by Blickenstorfer et al.,136 a single session
of electrical stimulation was applied to wrist extensor and flexor muscles of
healthy individuals, while cerebral activation patterns were being captured with
fMRI. During electrical stimulation, there was significant activation noted in the
contralateral primary motor cortex, primary somatosensory cortex and premotor
cortex, the ipsilateral cerebellum, bilateral secondary somatosensory cortex, the
supplementary motor area, and anterior cingulate cortex. Although, longitudinal
studies are necessary to determine whether neuroplasticity occurs in these
supraspinal centers after NMES interventions, the current cross-sectional
evidence demonstrates that they are at least influenced by NMES.
Hortobagyi and Maffuiletti116 proposed an alternative model in which
heightened afferent input elicited by NMES may explain the neural adaptations
observed with NMES. Since NMES cannot bypass the afferent fibers located
within both the skin and muscle, it is thought to elicit a barrage of afferent input to
the sensory system. As was discussed with TENS, this discharge of sensory
information is thought to trigger supraspinal centers to allow for descending
control motoneurons, which elicits a facilitation of motor output to the involved
muscle. Although this theory has merit, it must be supported by research before it
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can be considered as a legitimate mechanism of the neural adaptations
demonstrated with NMES.
Due to the neural adaptations it elicits in healthy individuals, it is expected
that NMES would be considered as an effective disinhibitory intervention for the
quadriceps in patients after knee injury/surgery. Furthermore, the preferential
recruitment of type II motor units that has been associated with NMES, make it
an attractive modality for patients with ACL injury/surgery, since type II muscle
fibers tend to be most affected in their quadriceps. However, there is conflicting
evidence concerning the disinhibitory effects of NMES on restoring quadriceps
function in a patient population. Several studies have reported improvements in
the voluntary quadriceps activation of patients with NMES interventions.116,118-122
In a case series by Stevens et al.,118 patients were assigned to one of two
interventions, four weeks after receiving bilateral, total knee arthroplasty. Three
patients participated in a 6-week (3 sessions/week), bilateral exercise program
consisting of range-of-motion exercises, lower extremity strengthening exercises,
and functional activities. Five other patients participated in the same exercise
program, while also receiving NMES on the weaker quadriceps. Voluntary
quadriceps activation (via SIB and CAR) was assessed in all patients at baseline,
mid-intervention (3 weeks), post-intervention (6 weeks), and at three and six
months. Due to the small sample size, the authors did not perform a statistical
analysis. However, a recent systematic review calculated the treatment effect
sizes (Cohen’s D) for each group to compare the disinhibitory effect of NMES to
exercise.101 Strong effect sizes were observed at the 3-week (1.66, 95% CI =

‐ 135 ‐

0.10, 2.90), 6-week (1.65, 95% CI = 0.09, 2.89) 3-month (1.71, 95% CI = 0.13,
2.96) and 6-month (1.87; 95% CI = 0.24, 3.13) time points in the NMES group.
Conversely, the effect sizes of the exercise group were weak (-0.08 – 0.-48) and
insignificant (95% CI crossed 0). Thus, it would seem that NMES is an effect
motor-based modality for improving voluntary quadriceps activation in patients.
However, an equal amount of studies have negated the effect NMES has
on improving voluntary quadriceps activation in patients.123-128 Palmieri-Smith et
al.125 randomly assigned 30 patients with radiographic knee OA to NMES (4
weeks; 3 sessions/week) and control groups. The NMES group received NMES
to their quadriceps three times per week, for a total of four week. Whereas, the
control group served as the standard-of-care, and did not receive any treatment.
Voluntary quadriceps activation (via SIB and CAR) was assessed in all patients
at baseline, and one and 16 weeks post-intervention. Compared to the control
group, there were no significant differences in MVIC or CAR changes at 5 weeks
(1 week post-treatment) or 16 weeks (12 weeks post-treatment). The authors
elected to report treatment effect sizes for each group to compare disinhibitory
effects between groups. Unfortunately, weak and insignificant effect sizes were
observed in both the NMES and control groups at five (0.2, 95% CI = -0.53, 0.91
vs. 0.0, 95% CI = -0.78, 0.78) and 15 weeks (0.42, 95% CI = -0.36, 1.18 vs. 0.33,
95% CI = -1.15, 0.51). Therefore, the authors concluded that there was no
additional benefit from NMES for improving voluntary quadriceps activation in
patients with knee OA.
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The conflicting results between these studies may have been due to
different patient populations, but the limitations that are associated with NMES
are most likely to blame. The two main limitations of NMES are the discomfort
experienced with high intensities of surface stimulation,518,519 and the limited
spatial recruitment of motor units.518,520 Coincidentally, stimulation intensity is
believed to directly affect spatial recruitment.518,520,521 NMES applied at a
constant intensity, activates the motor units closest in proximity to the stimulating
electrodes.518 Deeper motor units are targeted by increasing the inter-electrode
distance,520 but this can also be achieved by increasing the stimulation
intensity.521 Thus, it is recommended that NMES intensity be progressed to
prevent against fixed, superficial recruitment.518 However, a new alternative to
conventional NMES, known as multipath NMES, has recently been shown to
elicit better improvements in quadriceps strength due to its advanced spatial
recruitment properties.130 While a single current pathway is applied between an
electrode pair during conventional NMES, multipath NMES distributes its current
to multiple pairs of electrodes within single channels. Furthermore, multipath
NMES has been shown to elicit greater evoked KET from the quadriceps when
compared to conventional NMES.522 These effects are mainly attributed the
higher stimulation intensity that is tolerated with multipath NMES, and the wider
current distribution between multiple pairs of electrodes.
When applying NMES, the stimulation intensity is typically based on the
patient’s tolerance. However, the neuromuscular improvements observed with
lower levels of stimulation intensity are not as large when compared to higher
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levels of stimulation intensity.104,523 Previous reports suggest that the stimulation
intensity of NMES needs to evoke 50 to 60% of an individual’s MVIC in order to
elicit hypertrophy,524,525 and intensities up to 80% MVIC are needed to produce
strength gains.526 Thus, similar principles may apply for voluntary quadriceps
activation. Adams et al.502 developed a formula to predict the activated muscle
cross-sectional area as a function of NMES training intensity. By applying this
formula, it can be found that at the normal ranges of NMES intensity (40–60%
MVC), only 29–43% of the total muscle is being targeted. Therefore, patients
should be familiarized with NMES and encouraged to progress the stimulation
intensity in order to maximize the neuromuscular benefits of NMES.
Further research is needed to determine whether NMES is an effective
disinhibitory intervention, especially in patients who exhibit NQD following ACLr.
In addition, studies need to determine which stimulation parameters elicit the
greatest disinhibitory effects, and whether these effects are greater when NMES
is applied during voluntary relaxation or contraction. The superimposition of
NMES on voluntary muscle contractions has been hypothesized to facilitate
neuromuscular outcomes.130,527-529 Since neural adaptions are found to occur
during the early phase of NMES programs, NMES may be most appropriate
during the early stages of rehabilitation, when patients are immobile and/or
grossly inhibited. Studies are needed to determine whether NMES should be
prescribed to patients based upon neuromuscular status. Lastly, portable NMES
units have demonstrated promising results in regard to restoring neuromuscular
function.129-131 The higher volume of NMES combined with the convenience of
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home-based NMES, make these units attractive modality for postsurgical
patients. Therefore, research is need to determine whether home-based NMES
offers a greater disinhibitory benefit for patients after ACL injury and
reconstruction.
Electromyographic Biofeedback
Electromyographic biofeedback (EMGBF) is another motor-based
modality that is used to re-educate and strengthen muscle. Like NMES, has been
shown to enhance quadriceps strength and activation in both healthy
individuals530-533 and in patients with knee-joint pathology/surgery.127,533-547
However, EMGBF is believed to have a greater effect on patients since they tend
to exhibit large deficits in quadriceps strength and activation.533 Interestingly,
there is evidence to suggest the EMGBF improves quadriceps function more
than NMES in patients after knee-joint surgery.127,538 Biofeedback is used in
rehabilitation to reveal internal, physiological events to patients through external
modalities.548 In other words, EMGBF provides information on the myoelectric
activity of their muscles (internal) through concurrent, external feedback, so that
it may be interpreted on a conscious level.
The methodology behind EMGBF involves surface EMG electrodes which
are applied to the muscle belly of interest. The active electrodes monitor the
myoelectric activity within the muscle, while a reference electrode is used filter
irrelevant stimuli (noise). The EMG signals are transmitted through channels and
transformed into either auditory or visual cues, which provide a quantifiable
representation of the underlying myoelectric activity to the patient.549 These
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external cues are used facilitate neuromuscular control of a muscle by teaching
patients how to modulate their motor output in real-time. EMGBF is hypothesized
to enhance quadriceps strength and activation by improving volitional recruitment
of motor units (temporal and spatial) through corticomotor excitablity.531,550-552 It
has been discovered that when muscular force is produced, there is increased
neuronal activity in the motor cortex of the brain.552 Furthermore, when visual
feedback is provided during a movement task, neuronal activity in the motor
cortex and production of muscular force are symmetrically enhanced.550
Pietrosimone et al.551 discovered that corticomotor excitability is enhanced when
EMGBF is used during an MVIC task. Peak isometric KET (at 90° of knee flexion)
and MEP amplitudes (normalized to M-waves) were assessed in healthy
individuals before and after MVIC tasks, between two conditions: with
(experimental) and without (control) EMGBF being simultaneously applied to the
quadriceps. Compared to the control condition, the EMGBF elicited greater
improvements in both MEP amplitudes and KET, suggesting that EMGBF
enhances quadriceps strength by increasing descending output from the motor
cortex.
The positive neuromuscular effects associated with EMGBF may be
explained by motor learning theories of motor control and development.
Specifically, the rapid neuromuscular facilitation observed with EMGBF is
believed to be based upon the principles of focused feedback. Feedback can be
focused in one of two ways during a motor task: internally or externally. Internally
focused feedback focuses an individual’s attention on their actions used during a
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task (knowledge of performance), whereas externally focused feedback focuses
an individual’s attention on the outcome of their actions used during a task
(knowledge of results).553-555 In other words, internally focused feedback aims to
improve performance by having individuals focus on intrinsic movement patterns,
while externally focused feedback aims to improve performance by having
individuals focus on extrinsic goals related to movement. Evidence has shown
that externally focused feedback is superior to internally focused feedback in
regard to the performance and retention of motor skills.553-557 Therefore, EMGBF
employs an externally focused feedback approach to enhancing neuromuscular
performance, by having patients focus on the external cue of myoelectric activity
from their quadriceps instead of relying on internal cues of a quadriceps
contraction (i.e. muscle tone).
EMGBF was originally introduced in the early 1960s as a therapeutic
modality for neuromuscular dysfunction, after discovering that individuals could
learn to voluntarily control individual motor units by modulating their motor
output.558 Since then, it has been widely used in rehabilitation as a method to
improve neuromuscular control and strength in patients with neuromuscular
dysfunction. As would be expected, EMGBF is regularly used early on in the
rehabilitation of patients following ACLr. The severe quadriceps AMI that is
present in patients acutely after ACLr, often impedes the ability of patients to
observe a visible contraction of their quadriceps. Administering EMGBF allows
these patients to better gauge the contractile behavior of their quadriceps.
Secondly, EMGBF can be used to facilitate motor unit recruitment, by motivating
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patients to maximize their motor output during quadriceps-specific exercises.
Therefore, it is logical to assume that EMGBF may have a disinhibitory effect on
patients who exhibit NQD following ACLr.
Although sensory-based modalities, such as cryotherapy and TENS, are
believed to disinhibit the quadriceps by targeting inhibitory mechanisms
originating at the spinal cord, it is believed that EMGBF is a motor-based
modality that may be able target the supraspinal inhibitory mechanisms
associated with neural NQD. Not only could EMGBF be used disinhibit the
quadriceps of patients after ACLr by reversing the reported decreases in
corticomotor excitability, but it could also do so by overriding the spinal inhibitory
mechanisms with greater control over the descending pathways projecting to the
quadriceps.
Unfortunately, there have been no studies that have assessed whether
EMGBF can increase corticomotor or spinal-reflexive excitability in patients who
exhibit NQD. Although there is evidence demonstrating that EMGBF enhances
quadriceps activation in these patients, 127,534,539-541,545,547,559,560 only one of these
studies540 used a force-based measure of voluntary quadriceps activation (ITT),
whereas the other used EMG measures. Krebs534 was the first to demonstrate a
disinhibitory effect in the quadriceps of a patient population through the use of
EMGBF. A total of 26 patients were randomized to EMGBF and/or exercise
interventions following meniscectomy (20 min/day, 3 days). Both groups
performed 20 minutes of isometric quadriceps exercises a day for three
consecutive days, while the EMGBF group also applied EMGBF to their
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quadriceps while exercising. Peak EMG amplitudes were assessed before and
after the 3-day intervention period. When comparing the results between the two
groups, peak EMG amplitude was found to increase 2.5 μV/day in the exercise
only group, whereas it improved 25 μV per day in the EMGBF group (p<0.001).
Furthermore, a multiple regression analysis revealed that group membership was
a significant predictor of the variance in peak EMG changes (β = 0.68, p < 0.01),
with the EMGBF intervention significantly explaining the improvements in peak
EMG.
The lone study that used a force-based measure of voluntary quadriceps
activation was that of Maitland et al.540 Although the results were only derived
from one patient, making it difficult to generalize to a population, they were quite
astounding. A 34 year old patient who was eight months removed from ACLr,
and experiencing knee-joint instability, underwent 12 weeks of isometric
quadriceps exercises (seated and standing at 20° of knee flexion) and leg press
exercises (3 x 10 repetitions) using EMGBF (24 sessions, 2 hours/session). Peak
isometric KET (at 90° knee flexion) and voluntary quadriceps activation (via ITT)
were measured on the patient before and after the 12-week intervention period.
After 12 weeks, left knee MVIC increased by 209%, and quadriceps activation
decreased by 22%.
These results offer a glimpse of the disinhibitory potential EMGBF may
have on patients after ACLr, but more studies using the recommended
techniques to assess NQD (i.e. TMS, H-reflex, ITT, SIB, etc.) are needed to
determine its full potential as a disinhibitory intervention. Furthermore, a greater
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retention of disinhibitory effects in the quadriceps of patients may be elicited
through EMGBF if a “fading-schedule” is administered during rehabilitation. A
fading-schedule involves applying more EMGBF early in a patient’s rehabilitation,
and then tapering it later on when you have observed discernible improvements
in quadriceps function. Winstein and Schmidt561 used a fading-schedule on
individuals for a skill acquisition task (feedback on half of the trials), and
compared their performance to that of a group who received constant feedback
(every trial). At the end of the intervention, no differences performance were
observed between the groups, but the group who received feedback on a fadingschedule had better performance scores on a delayed-retention test. They
hypothesized that the differences in retention between groups were because the
fading-schedule forced individuals to rely on other cognitive processes to achieve
the same outcome, whereas constant feedback may have produced a
dependency in individuals, where their performance could not be sustained
without feedback. Therefore, it may be beneficial for patients to perform
quadriceps-specific exercise without EMGBF immediately after each
rehabilitation session to foster retention of neuromuscular facilitation.
Furthermore, the neural and motor learning characteristics of EMGBF indicate
that neuroplasticity within the CNS may be induced to account for retained
disinhibitory effects.562
Eccentric Exercise
Traditional rehabilitation programs consisting of isometric or concentric
modes of exercise to enhance quadriceps strength in patients after ACLr have

‐ 144 ‐

been largely ineffective.98,99 The lack of quadriceps strength gains that is
observed in these patients after rehabilitation can be at least partially attributed to
the limiting effects of concurrent NQD. The inability to fully activate a muscle
during exercise, it prevents the neuromuscular components from being
sufficiently overloaded, and the resulting strength improvements are minimal due
to a lack of neural adaptations and hypertrophy. However, eccentric exercise is
an alternative mode of exercise that has been shown to be more effective than
either concentric or isometric exercise for restoring both quadriceps strength and
hypertrophy in patients after ACLr.290,563-570
A muscle is eccentrically exercised either when an external force exceeds
the internal force of a contracted muscle, or when the external force is
decelerated by the internal force of a contracted muscle; thus, causing the
contracted muscle to lengthen (also referred to as negative work). Eccentric
muscle contractions have been shown to produce two to three times greater
force than either isometric or concentric muscle contraction.571,572 Therefore, it is
suggested that the large quadriceps strength gains observed in patients after
eccentric exercise is due to its ability to overload the peripheral components of a
muscle to a greater extent. However, applying eccentric exercise to the surgical
limbs of patients during the early phases ACLr rehabilitation was once
contraindicated in the practice of sports medicine, because clinicians believed
that it may overstress the graft or damage muscle fibers. Recent evidence has
demonstrated the early eccentric exercise is a safe and effective mode of
quadriceps strengthening in patients after ACLr, when the external forces are
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gradually progressed,566,567 and exercises are performed in the closed kinetic
chain.563
Interestingly, eccentric exercise has been shown to facilitate voluntary
quadriceps activation in patients after ACLr,290,570 thus demonstrating its potential
as a disinhibitory intervention. In a study by Brasileiro et al.,570 nine patients, 9 to
10 months removed from ACLr, were prescribed 12 weeks (2 sessions/week) of
eccentric quadriceps training. The EMG activity of the vastus lateralis and vastus
medialis were assessed at baseline, mid-training (6 weeks), and post-training (12
weeks). The EMG activity of the vastus lateralis and vastus medialis increased at
mid-training (213±107 to 289±81 μV, p=0.04 and from 207±65 to 229±69 μV,
p=0.04, respectively), and these activity levels were maintained at post-training.
More recently, Lepley and colleagues290 aimed to compare the disinhibitory
effects between eccentric exercise and NMES. The assigned 36 patients to
either NMES, Eccentric, NMES+Eccentric, or control groups following ACLr. All
groups received standard ACL rehabilitation. The NMES group began their 6week NMES intervention immediately after their first post-operative rehabilitation
visit, the Eccentric group began their 6-week eccentric exercises six weeks postACLr, and the NMES+Eccentric groups received both interventions (6 weeks of
NMES, followed by 6 weeks of eccentric exercise), beginning at the same time
as the NMES group. The control group served as a standard-of-care comparison.
Voluntary quadriceps activation (via SIB and ITT) was assessed in all patients at
pre-ACLr, 12 weeks post-ACLR, and at the time they returned to play (RTP). No
significant group differences were present at pre-ACLr (p = 0.61) or between pre-
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ACLR to 12 weeks post-ACLr time points (p = 0.21). From pre-ACLr to RTP, the
Eccentric group (2.6 ± 4.1) demonstrated greater improvements in voluntary
quadriceps activation than both the NMES (-3.4 ± 7.3%, p < 0.05) and control
groups (-3.2 ± 5.0%, p < 0.05). No differences were observed between the
Eccentric and NMES+Eccentric (+1.6 ± 3.9%) groups (p = 0.63), but the
NMES+Eccentric only demonstrated greater quadriceps activation improvements
than the control group (p = 0.04). Although there were no group differences
observed during the first 12 weeks, the differences at RTP suggest that eccentric
exercise is more effective at restoring voluntary quadriceps activation in patients
after ACLr compared to NMES, and that the neural function of the quadriceps is
in a better condition when eccentric exercise is administered in rehabilitation.
The neural mechanisms involved with the quadriceps activation
improvements observed in patients following ACLr have yet to be understood. It
has been hypothesized that quadriceps activation is enhanced with eccentric
exercise due to the preferential effect it has been shown to have on Type II
muscle fibers.290,573 Given that high threshold (type II) motor units are thought to
be selectively inhibited in patients after ACL reconstruction (via gamma loop
dysfunction), it is plausible to believe that eccentric exercise may serve to
disinhibit these patients’ quadriceps by facilitating the activation of type II motor
units. Secondly, unilateral eccentric exercise interventions have been shown to
produce bilateral improvements in quadriceps strength and activation.510,511,574
The cross-education effect of eccentric exercise is pertinent to clinicians when
treating patients with acute, unilateral knee-joint injuries, or patients who have
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recently undergone unilateral knee-joint surgery. Most of these patients are not
permitted to perform eccentric exercise on their involved limbs, but they are have
gross AMI of their quadriceps that needs to be addressed. Until these patients
are cleared to perform eccentric exercise on their involved limbs, the crosseducation effect of eccentric exercise allows them to perform eccentric exercise
on their uninvolved limbs to facilitate quadriceps activation on their involved
limbs. Given that cross-education seems to be a characteristic of most of the
disinhibitory interventions discussed in this review, it provides further support for
eccentric exercise as a disinhibitory intervention. However, the evidence of
cross-education with eccentric exercise has only been from a healthy population.
More research is needed determine if eccentric exercise can induce crosseducation of quadriceps function in patients after knee-joint injury/surgery.
Furthermore, additional studies are needed to support the early evidence of
eccentric exercise as a disinhibitory intervention for patients following ACLr.
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CHAPTER 3: METHODOLOGY

3.1

RESEARCH DESIGN
This study was a single-blind (orthopaedic surgeon) randomized clinical

trial (1:1 sample ratio) that was conducted at the University of Kentucky. Patients
were recruited from the UK Healthcare Sports Medicine Clinic located in
Lexington, Kentucky. All assessments were conducted on the University of
Kentucky’s campus, in the Musculoskeletal Laboratory of the Charles T.
Wethington building. This randomized clinical trial was registered on
clinicaltrials.gov (NCT02058862).

3.2

PARTICIPANTS
Patients between the ages of 14-40 years who sought care for a primary

ACL injury (diagnosed via magnetic resonance imaging) and were scheduled to
undergo unilateral ACL reconstruction were recruited for this study. Potential
participants were identified by their treating physician and/or physician’s assistant
during their clinical visit. To have been eligible to participate in this study, patients
must have sustained their initial ACL injury within the previous six months leading
up to their clinical visit with an orthopaedic surgeon. Patients who had a previous
surgery to either their involved or contralateral hip, knee, or ankle were excluded
from the study. Furthermore, patients were excluded if they had an injury to their
involved or contralateral hip, knee, or ankle within the past six months. Patients
who were currently being treated for low back pain were also be excluded from
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the study. This was included in the exclusion criteria because of recent evidence
showing that low back pain alters volitional quadriceps activation.575,576 For safety
reasons, patients who had heart condition/pacemaker, were planning to get
pregnant within the next six months (females), or had a history and/or family
history of seizures/epilepsy were deemed ineligible to participate in the study.
Those with vestibular or other balance disorders that might affect their test
performance during a single leg standing task were also excluded. There were
no exclusions based on sex, race, or other demographic characteristics.
Potential participants were prospectively identified during their initial
clinical visit by three orthopaedic surgeons at the UK Healthcare Sports Medicine
Clinic, Darren Johnson, MD, Christian Lattermann, MD, and Mary Lloyd Ireland,
MD. Patients that meet the eligibility criteria were then approached by study
personnel and invited to participate in the study. Informed consent and HIPPA
authorization was provided to eligible patients after they reviewed the study
objectives, procedures, and potential risks of participation. Informed written
consent was obtained from those patients who agreed to participate in the study.
For those participants who were minors (< 18 years of age), informed written
consent was obtained from a legal parent/guardian, and informed written assent
was obtained from the minor. Approval for this study was granted by Institutional
Review Board at the University of Kentucky (IRB #13-0776-F2L).
3.2.1 Randomization
Participants were allocated to either the treatment (home-based NMES)
group or control (standard-of-care) group via block randomization using a
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computer-generated randomization program. Randomization was further
stratified by the time-from-injury (TFI) to baseline testing, and the autograft type
used to reconstruct the ACL. Each of the stratification factors had two levels (TFI:
≤ 4 weeks vs. > 4 weeks, and autograft: bone-patellar tendon-bone vs.
semitendinosus-gracilis tendon). These stratification factors were chosen
because they have both previously been shown to influence quadriceps function
in patients after ACLr.577,578
3.2.2 Power Analysis
An a priori power analysis (using nQuery software program) was
completed for voluntary quadriceps activation levels to determine the sample size
with an alpha level of α = 0.05. At the time of this study, there were no studies
that investigated the effect of NMES on improving voluntary quadriceps activation
in patients after ACLr. Therefore, the parameters used for the power analysis
were taken from observational data on patients before and after. Based on the
literature,32 the participants’ CARs were expected to be approximately 0.75 (±
0.12 SD) prior to ACLr. The participants in the treatment group were
hypothesized to improve their CAR to approximately 0.90 (± 0.12) 12 weeks
post-surgery, and the control group was hypothesized to improve to
approximately 0.85 (± 0.12) 12 weeks post-surgery. To achieve a power level of
at least 0.80, the sample size of at least 40 participants (20 per group) were
needed based upon a 2-sided power analysis using the above parameters. This
would allow for a 5% chance of committing a type I error, and a 20% chance of
committing a type II error.
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3.3

PROTOCOL
3.3.1 Timeline
After informed written consent was received and the participant was

enrolled in the study, baseline measures were assessed by the primary
investigator before their scheduled ACLr. These assessments included isometric
quadriceps strength, voluntary quadriceps activation, and corticomotor excitability
(see section 3.4 for detailed a description of the outcome measures). After
baseline testing, each participant was randomly allocated to either the treatment
group or control group. After ACLr, each group was advised to attend physical
therapy visits as recommended by their orthopaedic surgeon, and to perform
their assigned home-based programs (NMES or standard-of-care) in addition to
their standardized postoperative rehabilitation protocol. The groups were not to
begin their assigned home-based programs until the third day after ACLr, and
were told to continue their assigned programs for 12 weeks. At the completion of
their home-based programs (3 months post-ACLr), the outcome measures were
reassessed by the primary investigator. The participants were then asked to
return at six months following their ACLr for a final assessment of the outcome
measures, with the addition of lower extremity postural control and self-reported
knee function. Each participant was provided the option to review his/her data at
the completion of the study. See Figure 3.1 for a flowchart of the protocol
timeline.
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Figure 3.1. Flowchart of the protocol timeline.

3.3.2 Interventions
The participants in the treatment (Home-NMES) group received a thigh
sleeve that has a NMES unit (EMPI Phoenix, DJO Global, Vista, CA) embedded
into the garment that they controlled during the home-NMES program (see
Figure 3.2).131,579,580 Superimposed electrical stimuli were delivered
percutaneously to artificially contract the quadriceps of the treatment
group.107,123,131,580 Participants were instructed to maintain maximal knee
extension during the home-NMES treatment. The first two minutes of the HomeNMES treatment was a warm-up period to get the participants accustomed to the

‐ 153 ‐

Figure 3.2. Portable neuromuscular electrical stimulation (NMES) sleeve given to
the intervention group. (A) NMES thigh sleeve displaying the controller and
electrode pads, and (B) NMES thigh sleeve assembled and secured to the right
quadriceps.

stimulation. After the warm-up period, a 15-minute exercise period followed.
During the exercise period, the stimulation was delivered to the rectus femoris,
vastus lateralis, and vastus medialis muscles at a frequency of 75Hz (300 μs
pulse duration) with a duty cycle of four seconds on and 10 seconds off. The
treatment group was instructed to perform an isometric quadriceps contraction
throughout each 4-second stimulation period, and relax their muscles during the
10-second rest period.130 Beginning on the third day post-operatively, the
treatment group was instructed to perform their assigned Home-NMES program
three sessions a day for 15 minutes, and five days a week for 12 weeks.130
Participants in the treatment group were encouraged to progressively increase
the intensity of NMES to maximal toleration (max intensity = 100 mA) throughout
the 12-week Home-NMES program in order to appropriately overload the muscle.
The participants in the Home-NMES group were blinded to an internal monitor
within the Home-based NMES unit, which was used to assess total dosage (in
minutes) at the completion of the study.
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The control group was treated according to the current standard-of-care,
performing a home-based treatment of volitional isometric quadriceps
contractions without the addition of NMES beginning on the third day postoperatively. Participants performed 15 minutes of quadriceps contractions
holding each contraction for four seconds followed by a rest time of 10 seconds
between each contraction. Like the treatment group, the control group were
instructed to perform their home-exercise program three sessions a day for 15
minutes, and five days a week for 12 weeks. This was intended to make the
exercise volume of the control group comparable to that of the Home-NMES
group.

3.4

OUTCOME MEASURES
3.4.1 Isometric Quadriceps Strength
Isometric quadriceps strength was assessed on both legs of each

participant. An isokinetic dynamometer (Cybex Norm, Humac 2014 System,
Computer Sports Medicine Inc., Stoughton, MA) was used to measure isometric
KET. The participants were seated and secured into a stationary chair with their
hips fixed at 85° flexion and knee fixed at 90° flexion. The knee being tested was
aligned with the axis of the dynamometer and a resistance pad attached to the
lever arm was fastened to the front of the lower third of their shin (~ two inches
superior to the medial malleolus). Participants performed three maximal voluntary
isometric contraction (MVIC) trials of their quadriceps by pushing their lower leg
against the resistance pad. The highest isometric KET observed from the first
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three MVICs was recorded and used as the target torque level during the
voluntary quadriceps activation testing. To account for the relationship between
muscle mass and strength, peak KET was normalized to each participant’s body
weight (Nm/kg). A 60-second rest period was provided to the participants after
each MVIC trial and before performing voluntary quadriceps activation testing.
3.4.2 Voluntary Quadriceps Activation
Voluntary quadriceps activation was measured on both legs of each
participant. The same dynamometer used to assess isometric quadriceps
strength was used for voluntary quadriceps activation testing, and participants
were seated and secured into the dynamometer chair in the same position as
described above. Volitional quadriceps activation was assessed on participants
using a superimposed burst (SIB) technique. The SIB technique involves
superimposing a brief train of percutaneous electrical stimulation during an MVIC
of a muscle. A square wave stimulator (Grass S48, Natus Neurology, W.
Warwick, RI) and stimulation isolation unit (SIU8T, W. Warwick, RI) with a 100
ms train of 10 stimuli delivered at 100 pulses per second, a pulse duration of 0.6
ms with a 0.01 ms pulse delay, and a stimulation intensity of 650 mA delivered at
150 V was used to create the SIB.381 Two, 7x13 cm self-adherent surface
electrodes (Dura-Stick Plus Chattanooga, DJO Global, Vista, CA) positioned on
the proximal vastus lateralis and distal vastus medialis were used to deliver the
electrical stimulus to the quadriceps. Figure 3.3 depicts the participant positioning
and electrode placement for voluntary quadriceps activation testing. The SIB was
then used to calculate the central activation ratio (CAR), which compares the
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Figure 3.3. Participant positioning (A) and electrode placement (B) for
superimposed burst (SIB) testing (proximal = vastus lateralis, distal = vastus
medialis).
amount of superimposed torque produced from the SIB to that of the MVIC
torque measured just prior to the SIB (CAR = MVIC/superimposed MVIC). To
familiarize the participants with the stimulation, a graded stimulation warm-up
was provided prior to the voluntary quadriceps activation test. Participants were
instructed to perform three submaximal isometric contractions at approximately
25%, 50%, and 75% of their perceived MVIC. During each of these submaximal
contractions, a corresponding submaximal electrical stimulus (25%, 50%, and
75% of 150 V, respectively) was delivered to the quadriceps in attempt to
acclimate the participants to the stimulation. For the SIB test, participants
performed one MVIC of their quadriceps and a brief automated stimulus (150 V)
was triggered once the participants reached their peak knee extension torque
(derived from their isometric quadriceps strength trials). To provide participants
with visual feedback of their torque output, a monitor was placed in front of the
participants during the SIB test with a target torque level set at 120% of their
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peak MVIC. This target torque level was used to further motivate the participants
and ensure that they were providing maximal effort. Refer to Figure 3.4 for
description of SIB protocol and CAR calculation.

Figure 3.4. Depiction of torque graph from the superimposed burst (SIB) test.
The dashed line was set on the screen and represents the peak MVIC produced
during the quadriceps strength testing. The top, solid black line represents 120%
of the peak maximal voluntary isometric contraction (MVIC) and serves as the
target torque level. Participants are instructed to attempt to reach the solid black
line to ensure maximal effort. An automated stimulus was delivered once the
torque output reached the dotted line. If the participant was unable to reach the
dotted line during the trial, the stimulus was never delivered and more rest was
provided between trials. MVIC values and superimposed burst torque values
were used to calculate a central activation ratio (CAR) as seen by the equation in
the figure.
3.4.3 Corticomotor Excitability
For cortical excitability testing, the participants were seated in the same
position on the dynamometer as the strength and activation tests. All participants
were fitted with a swim cap so the investigator could mark (with a semipermanent marker) specific anatomical landmarks to determine the ideal
placement of the magnetic coil for eliciting an MEP of the quadriceps. Quartersized areas on the skin over the vastus medialis and the medial malleolus of the
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ankle were gently abraded with fine-grade sandpaper and cleaned with an
isopropyl alcohol pad. This step was necessary to remove any oils, lotions, and
dry skin that may impede the recording of myoelectrical potentials. Surface EMG
electrodes were then placed over the cleaned areas of the distal quadriceps to
record MEPs and a ground electrode was placed on the medial malleolus. The
vastus medialis electrodes were placed approximately 4 cm superior and 3 cm
medial to the superomedial border of the patella and oriented 55° to the
vertical.581 These electrodes were secured in place using self-adhesive tape (see
Figure 3.5).

Figure 3.5. Placement of surface
electromyography (EMG) electrodes
for corticomotor excitability testing. The
red and white wires correspond to the
active and reference electrodes at the
vastus medialis (respectively), and the
black wire corresponds to the ground
electrode at the medial malleolus.
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Transcranial magnetic stimulation (TMS) was delivered using the
MagStim2002 unit synchronized with the Myopac system for amplification and
filtering. A double-cone coil connected to the MagStim2002 was used to deliver a
single electromagnetic impulse to the primary motor cortex of the cerebral
hemisphere contralateral to the limb being used to record MEPs. To find the ideal
placement of the double-coned coil for each participant, the coil was moved
anterior to posterior over the vertex (1 cm increments) of the skull while the
primary investigator applied an electromagnetic impulse (50% of maximal TMS
output) until the largest MEP is elicited in the quadriceps. This area (“hot spot”)
was indicated on each participant’s swim cap with a marker for every testing
session. The coil was held in place during testing by the primary investigator (see
Figure 3.6).

Figure 3.6. Depiction of the equipment and participant setup employed during
corticomotor excitability testing. (A) The “hot spot” was marked with marker (red)
on a swim cap, and the posterior border of the double-coned coil overlaid the
marked spot (B) to elicit motor evoked potentials (MEP) at the vastus medialis
and determine the active motor threshold (AMT).
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To find the active motor threshold (AMT) of the quadriceps, participants
performed an isometric knee extension at a normalized intensity of 5% of their
MVIC observed during isometric quadriceps strength testing. A monitor was
placed in front of the participants to provide visual feedback of their torque
output. TMS was first delivered at 50% of the maximum stimulator output (110 –
120 V)61,296,451 with the stimulating coil placed over the primary motor cortex area
of the cerebral hemisphere contralateral to the limb being used to record the
MEPs. The active motor threshold was defined as the minimum stimulus intensity
at which an electrical response of at least 100 μV is achieved. Active motor
threshold was obtained by first decreasing the magnetic stimulus by 5% until six
out of 10 trials had an MEP amplitude of <100 μV.
The percentage of stimulator intensity was then gradually increased until
five out of 10 consecutive stimuli produced an MEP of equal to or greater than
100 μV (see Figure 3.7). The stimulator intensity (% TMS output) used to achieve
this value was recorded as the active motor threshold for each participant.442

Figure 3.7. Representation of
transcranial magnetic stimulation
(TMS) impulse and resultant motor
evoked potential (MEP) recorded
via surface electromyography
(EMG) from the vastus medialis
muscle. The TMS intensity (% TMS
output) needed to achieve an MEP
equal to 100 μV represents a
participant’s active motor threshold.
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3.4.4 Lower Extremity Postural Control
The Y-balance testTM (YBT; FunctionalMovement.com, Danville, VA) was
used to assess the patients’ lower extremity postural control at 6 months postACLr. The YBT is the commercialized version of the Star Excursion Balance Test
(SEBT) that was developed to improve its reliability.582 Both the YBT and the
SEBT assess an individual’s ability to move from a position of bilateral stance to
a position of unilateral stance whereby the contralateral limb is used to reach
maximally in three different directions (anterior, posterolateral, and
posteromedial) without compromising their balance. Although some evidence
suggests the YBT and SEBT require different kinematic strategies to achieve
maximal reach distances,583,584 the two tests continue to be strongly correlated.
Furthermore, anterior reach distance has been shown to predict lower extremity
injuries in athletes,585,586 and the integrated EMG activity of the quadriceps is the
highest with the anterior reach.587 Therefore, the anterior reach direction was
preferentially assessed in participants of this study.
The anterior reach distance on the YBT (YBT-A) was measured on both
limbs of each participant. Participants were instructed to stand unilaterally on the
center platform of the Y-balance device, and to place their hands on their hips.
While balancing on the stance limb, the participants were encouraged to slide the
anterior block with their contralateral limb as far away from the center platform as
possible while maintaining their balance (see Figure 3.8). Once they achieved
their maximal reach distance, they returned their contralateral limb to the starting
position and were allowed to step off of the platform. If the anterior block was
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Figure 3.8. Representation of the Y-balance
test for anterior reach (YBT-A) procedure
used to assess lower extremity postural
control.

kicked, the stance foot moved, a hand was removed from the hip, or the
participant lost balance during any point of the trial, the trial was discarded and
another was allotted until a total of three clean trials were recorded for both
limbs. Participants were given three practice trials before the recorded trials in
attempt to neutralize a learning effect. The average reach distance for the three
recorded trials were normalized to each participant’s respective leg length
measured from the anterior superior iliac spine to the medial malleolus (anterior
reach distance/leg length).
3.4.5 Self-Reported Knee Function
The Knee Injury and Osteoarthritis Outcome Score (KOOS) was used to
assess the self-reported knee function of the participants at six months post-
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ACLr (see Appendix). The KOOS is a questionnaire intended to assess both the
short-term and long-term consequences of knee injury or surgery.193 It has
demonstrated excellent validity and reliability in patients after ACLr.190-193
Compared to other patient-reported knee questionnaires, the KOOS is meant for
younger, and more physically active patients who have sustained a knee injury or
have undergone knee surgery.588 The KOOS consists of 42 questions that are
separated and scored into five domains [Symptoms, Pain, Activities of Daily
Living (ADLs), Quality of life (QOL), and Function in Sports/Recreational
Activities (Sports/Rec)]. Each question includes a Likert scale answer format
scored from 0 (No Problems) to 4 (Extreme Problems). It takes patients
approximately 5-10 minutes to complete the entire KOOS questionnaire. Once
completed, the sum of the item scores for each domain were calculated and
transformed on a 0-100 scale (0 = lowest function, 100 = highest function).
Of the five domains, the QOL and Sports/Rec domains have
demonstrated the most unidimensionality,589 and are the most sensitive to
changes over time in patients after ACLr.193 Therefore, the QOL and Sports/Rec
domains were preferentially assessed in the participants of this study.

3.5

STATISTICAL ANALYSES
Statistical analyses were performed using SAS software (version 9.3, SAS

Institute, Inc., Cary, NC) Shapiro-Wilk tests were performed on all demographics
and outcome measures to confirm the normality of baseline data (pre-ACLr). All
of the variables were deemed to possess normal distribution, except for
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quadriceps CAR. Therefore, quadriceps CAR was transformed
(arcsin√[CAR/100]) to achieve normal distribution during statistical analyses, but
it was untransformed to the original units (%) when reporting it in the results
(sin[transformed CAR2]*100).
3.5.1 Group Characteristics
Independent (Student’s) t-tests were performed on age, height (cm),
weight (kg), number of concomitant knee injuries, TFI (days), and time from
surgery (TFS) to 3-month and 6-month testing (months) to assess for
demographic differences between the treatment and control groups. Fisher’s
Exact tests were used to assess for demographic differences in sex and
autograft type between groups. Independent t-tests were also used to detect for
differences in the outcome measures between groups at baseline. Means and
standard deviations were reported to represent central tendency and variability of
the continuous variables. Alpha level was set a priori at P ≤ 0.05.
3.5.2 Specific Aim 1
A 2x3 (limb x time) mixed model, analyses of variance (ANOVA) with
repeated measures was performed in the control group to assess differences
between the involved limb and the uninvolved limb in isometric quadriceps
strength (peak KET), and voluntary quadriceps activation (CAR) from baseline to
three months post-ACLr, baseline to six months post-ACLr, and three months
post-ACLr to six months post-ACLr. A one-way mixed model, ANOVA with
repeated measures was performed in the control group to assess differences in
corticomotor excitability (AMT) over time (baseline, 3 months post-ACLr, and 6
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months post-ACLr). Post-hoc comparisons with simulated P-value adjustments
were performed when appropriate.590 Model estimates and 95% confidence
intervals were reported to represent the results. Alpha level was set a priori at P
≤ 0.05.
3.5.3 Specific Aim 2
Means and standard deviations were calculated for the lower extremity
functional outcome measures of the control group at six months post-ACLr.
Separate, mixed model, linear regression analyses were performed in the control
group (involved limb) to determine the effect that isometric quadriceps strength
(normalized peak KET), voluntary quadriceps activation (CAR), and corticomotor
excitability (AMT) measures assessed at baseline and three months post-ACLr,
had on lower extremity postural control (YBT-A) and self-reported knee function
(KOOS-QOL and KOOS-Sports/Rec) assessed at six months post-ACLr. Beta
estimates and 95% confidence intervals were reported for each baseline and 3month post-ACLr neuromuscular variable, corresponding with each 6-month
lower extremity functional outcome measure. Alpha level was set a priori at P ≤
0.05.
3.5.4 Specific Aim 3
A 2x2x3 (group x limb x time) mixed model, ANOVA with repeated
measures was performed to assess group differences between the involved limb
and the uninvolved limb in isometric quadriceps strength (peak KET), and
voluntary quadriceps activation (CAR) from baseline to three months post-ACLr,
baseline to six months post-ACLr, and 3 months post-ACLr to six months post-
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ACLr. A 2x3 (group x time) mixed model, ANOVA with repeated measures was
performed to assess group differences in corticomotor excitability (AMT) over
time (baseline, 3 months post-ACLr, and 6 months post-ACLr). Post-hoc
comparisons with simulated P-value adjustments were performed when
appropriate.590 Model estimates and 95% confidence intervals were reported to
represent the results. Alpha level was set a priori at P ≤ 0.05.

Copyright © Conrad M. Gabler 2016
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CHAPTER 4: RESULTS

4.1

GROUP CHARACTERISTICS
4.1.1 Demographics
A total of 50 patients with ACL injuries volunteered to participate in this

study (25 Home-NMES group, 25 control group). Baseline group demographic
data can be found in Table 4.1. There were no statistically significant
demographic differences between the groups at baseline (p > 0.05).

Table 4.1. Baseline Group Demographics (Means ± SD)
Demographic
Home-NMES
Control
Group
Group
(n = 25)
(n = 25)
Sex (Males/Females)
6/19
11/14
Age (years)
18.9 ± 5.4
19.4 ± 4.5
Height (cm)
170.8 ± 9.7
171.1 ± 11.5
Weight (kg)
74.6 ± 18.5
70.7 ± 11.9
Time from injury to baseline
28.0 ± 20.0
24.9 ± 18.5
testing (days)
Time from ACLr to 3-month
3.7 ± 0.3
3.4 ± 0.4
testing (months)
Time from ACLr to 6-month
6.5 ± 0.7
6.3 ± 0.5
testing (months)
Graft Choice (BPTB/STG)
18/7
19/6

P-value
0.23
0.71
0.90
0.40
0.56
0.06
0.18
1.00

Home-NMES, home-based neuromuscular electrical stimulation program; ACLr,
anterior cruciate ligament reconstruction; BPTB, bone-patellar tendon-bone autograft;
STG, semitendinosus-gracilis autograft.

4.1.2 Outcome Measures
All 50 patients reported for baseline testing. Baseline outcome group
measures can be found in Table 4.2. There were no group differences between
baseline outcome measures (p > 0.05), except for normalized peak KET in the
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uninvolved limb (p = 0.02). Thirty nine patients (78%) were available for 3-month
postoperative testing (20 Home-NMES group, 19 control group), and 42 patients
(84%) were available for 6-month post-operative testing (23 Home-NMES group,
19 control group).

Table 4.2. Baseline Group Outcome Measures (Means ± SD)
Outcome Measure
Home-NMES
Control
Group
Group
(n = 25)
(n = 25)
Normalized Peak KET (Nm/kg) 2.6 ± 0.7
2.9 ± 0.9
Involved
Normalized Peak KET (Nm/kg) 2.9 ± 0.6
3.3 ± 0.7
Uninvolved
CAR (%) - Involved
94.6 ± 5.5
91.3 ± 8.3
CAR (%) - Uninvolved
89.5 ± 8.4
87.7 ± 9.7
AMT (%) - Involved
33.9 ± 7.2
39.1 ± 10.2

P-value
0.19
0.02*
0.12
0.51
0.06

Home-NMES, home-based neuromuscular electrical stimulation program; KET, knee
extension torque; CAR, central activation ratio; AMT, active motor threshold; YBT-A,
Y-balance test-anterior reach (reach distance/leg length); KOOS, Knee Injury and
Osteoarthritis Outcome Score; Sports/Rec, sports and recreation; QOL, quality of life.
*Significant difference between groups (P ≤ 0.05)

4.2

SPECIFIC AIM 1
4.2.1 Descriptive Statistics
Model estimates and 95% confidence intervals for the temporal

neuromuscular quadriceps outcome measures in patients before and after ACLr
(control group) can be found in table 4.3.
4.2.2 Isometric Quadriceps Strength
A significant limb by time interaction was discovered for normalized peak
KET (F2,18.6 = 29.7, P < 0.001) in patients. Patients demonstrated lower
normalized peak KET on their involved limbs compared to their uninvolved limbs
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Table 4.3. Model estimates (95% CI) of temporal neuromuscular outcome measures
between limbs (control group).
Measure
Time Point
Involved limb
Uninvolved limb
Normalized Peak KET
(Nm/kg)

CAR (%)**

AMT (%)

Baseline (pre-ACLr)

2.87 (2.52, 3.22)*

3.36 (3.07, 3.65)

3-month (post-ACLr)

1.67 (1.31, 2.03)*†

3.23 (2.94, 3.51)

6-month (post-ACLr)

1.97 (1.58, 2.36)*†‡

3.06 (2.71, 3.40)†

Baseline (pre-ACLr)

93.4 (90.2, 96.0)

91.0 (87.8, 93.8)

3-month (post-ACLr)

94.1 (91.1, 96.5)

91.8 (88.1, 94.9)

6-month (post-ACLr)

92.7 (88.1, 96.2)

90.1 (84.4, 94.6)

Baseline (pre-ACLr)

39.1 (34.5, 43.8)

N/A

3-month (post-ACLr)

39.2 (34.3, 44.1)

N/A

6-month (post-ACLr)

39.7 (35.6, 43.7)

N/A

95% CI, 95% confidence interval (lower bound, upper bound); Home-NMES, home-based
neuromuscular electrical stimulation program; KET, knee extension torque; CAR, central
activation ratio; AMT, active motor threshold; TMS, transcranial magnetic stimulation; ACLr,
anterior cruciate ligament reconstruction
*Significant difference compared to the uninvolved limb (p ≤ 0.05)
†Significant difference compared to baseline (pre-ACLr) time point (p ≤ 0.05)
‡Significant difference compared to 3-month (post-ACLr) time point (p ≤ 0.05)
**Significant main effect for limb (p ≤ 0.05)

at baseline (-0.49 Nm/kg, p = 0.015), three months post-ACLr (-1.56 Nm/kg, p <
0.001), and six months post-ACLr (-1.09 Nm/kg, p < 0.001). Normalized peak
KET progressively decreased in the involved limbs of patients from baseline to 3
months post-ACLr (-1.20 Nm/kg, p < 0.001), baseline to six months post-ACLr (0.90 Nm/kg, p = 0.002), and increased from three months to six months postACLr (0.30 Nm/kg, p = 0.016). Normalized peak KET was also decreased in the
uninvolved limbs of patients from baseline to six months post-ACLr (-0.30 Nm/kg,
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p = 0.016). No other time-based differences were detected in the uninvolved limb
(p > 0.05). Refer to Figure 4.1 for visual representation of normalized peak KET
model estimates.

Figure 4.1. Model estimates and 95% confidence intervals of normalized peak
KET (Nm/kg) for the involved and uninvolved limbs at baseline, 3 months postACLr, and 6 months post-ACLr.
*Significant difference compared to the uninvolved limb (p ≤ 0.05)
†
Significant difference compared to baseline (pre-ACLr) time point (p ≤ 0.05)
‡
Significant difference compared to 3-month (post-ACLr) time point (p ≤ 0.05)

4.2.3 Voluntary Quadriceps Activation
There was a significant main effect for limb observed with quadriceps CAR
(F1,24 = 4.68, p = 0.04) in patients, but there was no main effect for time (F2,17.1 =
0.57, p = 0.58) or limb by time interaction. Irrespective of when it was assessed,
quadriceps CAR was approximately 2.4% higher (on average) in the involved
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limbs of patients compared to their uninvolved limbs (p = 0.04). Refer to Figure
4.2 for visual representation of quadriceps CAR model estimates.

Figure 4.2. Model estimates and 95% confidence intervals of quadriceps CAR
(%) for the involved and uninvolved limbs at baseline, 3 months post-ACLr, and 6
months post-ACLr.
*Significant main effect for limb (p ≤ 0.05)

4.2.4 Corticomotor Excitability
There was no main effect for time (F2,16.1 = 0.08, p = 0.93) observed for
quadriceps AMT in the involved limbs of patients (p > 0.05).

4.3

SPECIFIC AIM 2
4.3.1 Descriptive Statistics
Means and standard deviations for the lower extremity functional outcome
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measures of patients at six months after ACLr (control group) can be found in
table 4.4. The beta estimates and 95% confidence intervals from the linear
regression analyses for each baseline and 3-month post-ACLr neuromuscular
variable, corresponding with each 6-month lower extremity functional outcome
measure, can be found in table 4.5.

Table 4.4. Means (± SD) of lower extremity functional outcome measures in
patients six months after ACLr (control group).
Measure
6-month Outcome
YBT-A (%) - Involved

62.6 ± 8.0

KOOS-Sports/Rec (/100)

77.7 ± 17.5

KOOS-QOL (/100)

63.5 ± 18.7

YBT-A, Y-balance test-anterior reach; KOOS, Knee Injury and Osteoarthritis
Outcome Score; Sports/Rec, sports and recreation; QOL, quality of life.

4.3.2 Effect of Early Neuromuscular Quadriceps Outcome Measures
on 6-month Lower Extremity Functional Outcome Measures
The normalized peak KET of patients at three months post-ACLr had a
significant positive effect on their 6-month YBT-A performance (t16 = 12.29, p =
0.04) and KOOS-QOL score (t17 = 2.14, p = 0.047). For every 1 Nm/kg increase
in normalized peak KET at three months post-ACLr, an estimated 5.1% increase
in YBT-A reach distance was expected at six months post-ACLr. Likewise, for
every 1 Nm/kg increase in normalized peak KET at three months post-ACLr, an
estimated 8.9 point increase in KOOS-QOL score was expected at 6-months
post-ACLr. Normalized peak KET at three months post-ACLr did not have an
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Table 4.5. Regression analyses to determine effect of baseline and 3-month post-ACLr neuromuscular variable on
lower extremity functional outcomes at six months post-ACLr (control group).
6-month Outcome Variable
Time Point
Beta Estimate (95% CI)
P-value
YBT-A - Involved
(%)
Normalized Peak KET
Baseline
1.9 (-2.9, 6.7)
0.42
3-month
5.1 (0.4, 9.8)*
0.04
CAR
Baseline
-13.5 (-39.5, 12.6)
0.29
3-month
10.7 (-8.0, 29.4)
0.24
AMT
Baseline
0.2 (-0.3, 0.6)
0.40
3-month
0.2 (-0.3, 0.6)
0.38
KOOS-Sports/Rec
(/100)
Normalized Peak KET
Baseline
1.7 (-8.1, 11.5)
0.72
3-month
5.3 (-3.5, 14.1)
0.22
CAR
Baseline
1.2 (-5.2, 7.6)
0.70
3-month
-2.4 (-6.1, 1.3)
0.18
AMT
Baseline
0.1 (-0.7, 1.0)
0.74
3-month
0.3 (-0.6, 1.2)
0.50
KOOS-QOL
(/100)
Normalized Peak KET
Baseline
0.8 (-9.7, 11.3)
0.88
3-month
8.9 (0.1, 17.7)*
0.047
CAR
Baseline
-0.4 (-7.3, 6.4)
0.90
3-month
0.6 (-3.5, 4.7)
0.76
AMT
Baseline
-0.5 (-1.3, 0.4)
0.24
3-month
-0.6 (-1.5, 0.3)
0.19
ACLr, anterior cruciate ligament reconstruction; 95% CI, 95% confidence interval (lower bound, upper bound); YBT-A, Y-balance
test (anterior reach); KOOS, Knee Injury and Osteoarthritis Outcome Score; Sports/Rec, sports and recreation; QOL, quality of
life; KET, knee extension torque; CAR, central activation ratio; AMT, active motor threshold
*Significant association with 6-month outcome (p ≤ 0.05)
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effect on 6-month KOOS-Sport/Rec score (p > 0.05). Neither quadriceps CAR or
AMT (at baseline or 3-month post-ACLr) had a significant effect on any of the 6month lower extremity function outcome measures (p > 0.05).

4.4

SPECIFIC AIM 3
4.4.1 Descriptive Statistics
Model estimates and 95% confidence intervals for the temporal

neuromuscular quadriceps outcome measures in both the Home-NMES group
and control group can be found in table 4.6.
4.4.2 Isometric Quadriceps Strength
There was a significant main effect for group observed with normalized
peak KET (F1,46.4 = 4.5, p = 0.04) in the control group. Irrespective of limb or
when it was assessed, normalized peak KET was 0.36 Nm/kg higher (on
average) in the control group compared to the Home-NMES group (p = 0.04). A
significant limb by time interaction was discovered for normalized peak KET
(F2,40.3 = 52.17, P < 0.001), regardless of group assignment. Both groups
demonstrated lower normalized peak KET on their involved limbs compared to
their uninvolved limbs at baseline (-0.32 Nm/kg, p < 0.001), three months postACLr (-1.35 Nm/kg, p < 0.001), and six months post-ACLr (-0.95 Nm/kg, p <
0.001). Normalized peak KET progressively decreased in the involved limbs of
both groups from baseline to three months post-ACLr (-1.07 Nm/kg, p < 0.001)
and baseline to six months post-ACLr (-0.75 Nm/kg, p < 0.001), and increased
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Table 4.6. Model estimates (95% CI) of temporal neuromuscular outcome measures between groups and limbs
Measure
Time Point
Home-NMES
Home-NMES
Control
Control uninvolved
involved limb
uninvolved limb
involved limb
limb
Normalized Peak
KET (Nm/kg)**

CAR (%)

AMT (%)

Baseline
(pre-ACLr)
3-month
(post-ACLr)
6-month
(post-ACLr)

2.55 (2.27, 2.82)*

2.94 (2.70, 3.19)

2.91 (2.63, 3.18)*

3.30 (3.06, 3.55)

1.48 (1.21, 1.74)*†

2.83 (2.59, 3.07)

1.84 (1.57, 2.11)*†

3.19 (2.95, 3.44)

1.80 (1.51, 2.08)*†‡

2.75 (2.49, 3.01)

2.16 (1.87, 2.45)*†‡

3.11 (2.84, 3.38)

Baseline
(pre-ACLr)
3-month
(post-ACLr)
6-month
(post-ACLr)

95.5 (93.1, 97.5)*

91.7 (88.5, 94.4)

93.4 (90.6, 95.7)*

88.9 (85.3, 92.0)

95.0 (91.6, 97.6)

92.5 (89.4, 95.1)

92.7 (88.8, 95.9)

89.8 (86.2, 92.9)

92.5 (88.7, 95.5)

92.2 (88.7, 95.0)

89.8 (85.5, 93.4)

89.4 (85.5, 92.8)

Baseline
(pre-ACLr)
3-month
(post-ACLr)
6-month
(post-ACLr)

34.6 (30.8, 38.3)

N/A

38.5 (34.8, 42.1)

N/A

35.8 (31.8, 39.8)

N/A

39.8 (35.8, 43.7)

N/A

36.2 (32.5, 39.9)

N/A

40.2 (36.5, 43.8)

N/A

95% CI, 95% confidence interval (lower bound, upper bound); Home-NMES, home-based neuromuscular electrical stimulation
program; KET, knee extension torque; CAR, central activation ratio; AMT, active motor threshold; TMS, transcranial magnetic
stimulation; ACLr, anterior cruciate ligament reconstruction
*Significant difference compared to the uninvolved limb (p ≤ 0.05)
†Significant difference compared to baseline (pre-ACLr) time point (p ≤ 0.05)
‡Significant difference compared to 3-month (post-ACLr) time point (p ≤ 0.05)
**Significant main effect for group (p ≤ 0.05)
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from three months to six months post- ACLr (0.32 Nm/kg, p < 0.001). Normalized
peak KET was also decreased in the uninvolved limbs of both groups from
baseline to six months post-ACLr (-0.19, p = 0.02 unadjusted), but this decrease
did not achieve statistical significance after the simulated adjustment (p = 0.13).
No other time-based differences were detected in the uninvolved limb for either
group (p > 0.05). Refer to figure 4.3 for visual representation for normalized peak
KET model estimates.

Figure 4.3. Model estimates and 95% confidence intervals of normalized peak
KET (Nm/kg) for the involved and uninvolved limbs of both the Home-NMES and
control groups at baseline, 3 months post-ACLr, and 6 months post-ACLr.
*Significant difference compared to the uninvolved limb (p ≤ 0.05)
†
Significant difference compared to baseline (pre-ACLr) time point (p ≤ 0.05)
‡
Significant difference compared to 3-month (post-ACLr) time point (p ≤ 0.05)
**Significant main effect for group (p ≤ 0.05)
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4.4.3 Voluntary Quadriceps Activation
There was no main effect observed for group with quadriceps CAR (F1,48.3
= 1.83, p = 0.18). Regardless of group assignment, there was a significant limb
by time interaction (F1,32.6 = 4.52, p = 0.02). At baseline, quadriceps CAR was
approximately 4.2% higher (on average) in the involved limbs of both groups
compared to their uninvolved limbs (p = 0.003). No other limb differences were
observed in either group at three or six months post-ACLr (p > 0.05). Quadriceps
CAR decreased in the involved limbs of both groups from baseline to six months
post-ACLr (3.3%, p = 0.02 unadjusted), but this decrease did not achieve
statistical significance after the simulated adjustment (p = 0.11). No other timebased differences were detected in the involved limb or uninvolved limb for either
group (p > 0.05). Refer to Figure 4.4 for visual representation of quadriceps CAR
model estimates.
4.4.4 Corticomotor Excitability
There were no main effects for group (F1,40.2 = 2.25, p = 0.14) or time (F2,33
= 1.45, p = 0.25) observed with quadriceps AMT in the involved limbs of either
group (p > 0.05).

178

Figure 4.4. Model estimates and 95% confidence intervals of quadriceps CAR
(%) for the involved and uninvolved limbs of both the Home-NMES and control
groups at baseline, 3 months post-ACLr, and 6 months post-ACLr. The dashed
red line corresponds to the healthy normative quadriceps CAR (95%) reported by
Park and Hopkins, 2013, International Journal of Neuroscience, 123 (1), 5559.404
*Significant difference compared to the uninvolved limb (p ≤ 0.05)
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CHAPTER 5: DISCUSSION

5.1

SPECIFIC AIM 1
5.1.1 Modifications in Quadriceps Strength
Involved Limb
As was hypothesized, the group of patients who received the standard-of-

care after ACLr (control group) demonstrated significantly lower quadriceps
strength on their involved limbs compared to their uninvolved limbs at baseline
(pre-ACLr), three months post ACLr, and six months post-ACLr. Secondly, the
magnitude of this side-to-side difference was different depending on when
quadriceps strength was assessed in these patients. The largest side-to-side
difference in normalized peak KET was observed at three months post-ACLr (1.56 Nm/kg); with the 6-month post-ACLr time point having the second largest
difference (-1.09 Nm/kg), and the baseline having the least difference (-0.49
Nm/kg). A criterion that is regularly used by clinicians when determining whether
a patient is ready to return to activity/sport after ACLr, is if their quadriceps
strength LSI is equal to or greater than 90%.8,28,68,180,181 If our limb model
estimates reported for normalized peak KET at baseline, three months postACLr, and six months post-ACLr were converted into quadriceps strength LSI,
they would correspond to 85%, 51%, and 64%, respectively. Although the 6month quadriceps strength LSI of the ACLr patients in our study looks to be lower
than what has been reported in the ACLr literature,98,132 there are several studies
that have reported asymmetries of 30% or more in patients at six months postACLr.50,143,146,154,156,160,162,173,174,177
180

The variability of 6-month quadriceps strength LSI that has been reported
in patients at six months post-ACLr is most likely attributed to methodological
differences in measurement and surgical techniques between studies.
Quadriceps strength can be assessed isometrically or isokinetically (concentric or
eccentric), and at different knee-joint angles or velocities, respectively. Several
studies have reported insufficient quadriceps strength LSI (≤90%) in patients
after ACLr when isokinetically testing (concentrically) at an angular velocity of
60°/s, but when angular velocities of 120°/s or faster were used, these same
patients meet the criterion (LSI ≥90%).30,31,57,132,133,142,168,178,179 Hsiao et al.31
recently assessed quadriceps strength LSI in patients after ACLr using a variety
of angular velocities (isokinetic) as well as knee-joint angles (isometric). When
compared to the pre-ACLr values, significant decreases in quadriceps strength
LSI were only observed at the slower angular velocities (concentric at 50°/s and
100°/s) and the larger knee flexion angles (70° and 90°). Current evidence
suggests that quadriceps strength should be tested isometrically at 70-90° of
knee flexion,31 or isokinetically at an angular velocity of 60°/s (concentric) in order
to detect asymmetries in patients following ACLr.98,132 Quadriceps strength of the
patients in our study was assessed isometrically at 90° of knee flexion. Secondly,
studies use different units to assess quadriceps strength LSI, which can alter the
LSI value that is reported. Quadriceps strength can be recorded as force (i.e.,
Newtons, pounds, etc.) or torque (i.e., Nm, ft·lbs, etc.), or normalized to a
patient’s bodyweight (i.e., Nm/kg, ft·lbs/lb, %bodyweight, etc.). If quadriceps
strength is recorded as force, it assumes that the force is applied in a linear
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direction. However, since quadriceps force is applied across a joint (knee), it
produces an angular force (torque). Therefore, recording quadriceps strength as
KET is more valid than force. Furthermore, individuals who are heavier in weight
are generally able to produce more KET due to higher quadriceps muscle mass.
Therefore, it is recommended that a patient’s peak KET be normalized to their
bodyweight, such as what was done in this study. Lastly, the type of autograft
used to reconstruct a patient’s ACL has been shown to effect postoperative
quadriceps strength.132,591 A recent systematic review and meta-analysis
assessed quadriceps strength differences between patients after ACLr, based on
the type of autograft they received.591 At 12 months post-ACLr, the quadriceps
strength of patients who received hamstring tendon autografts was an average of
9% higher than those patients who received bone-patellar tendon-bone
autografts. As a result, patients who receive hamstring tendon autografts for
ACLr may have higher quadriceps strength LSI than those who receive bonepatellar tendon-bone autografts. In our study, the majority of patients (78%) in the
control group received bone-patellar tendon-bone autografts, which may explain
the large side-to-side quadriceps strength difference observed at six months
post-ACLr. However, there were not enough patients who received hamstring
tendon autografts in our study to determine whether autograft type had an effect
on normalized peak KET outcomes. Methodological differences in quadriceps
strength assessments between studies must be considered when comparing the
results of quadriceps strength LSI in patients following ACLr.
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The temporal pattern of side-to-side quadriceps strength differences can
be easily attributed to the unilateral quadriceps strength changes observed over
time in the involved limb of the patients. We originally hypothesized that
quadriceps strength would decrease in the involved limbs of patients at three
months post-ACLr compared to baseline, and then return to baseline values at
six months post-ACLr. Compared to baseline, quadriceps strength decreased in
patients at three months post-ACLr (-1.20 Nm/kg), and then increased at six
months post-ACLr (+0.30 Nm/kg), but this increase did not reach baseline value
(-0.90 Nm/kg); thus, rejecting our hypothesis. These changes can all be
described as true change that occurred beyond measurement error (MDC95 =
0.30 Nm/kg).592 In other words, we are 95% confident that true clinical changes
occurred with quadriceps strength in the involved limb after ACLr. The V-shaped
pattern (see Figure 4.1) of quadriceps strength changes observed in our study is
consistent with what has been reported in a previous study that longitudinally
assessed quadriceps strength in the involved limb of patients before and after
ACLr. Zech and colleagues24 assessed the (isometric) quadriceps strength of
patients before ACLr, and at multiple time points after ACLr, up until 48 weeks
post-ACLr. At 12 weeks (3 – 4 months) post-ACLr, the patients’ peak KET values
were 12% (± 14) lower than their pre-ACLr values. However, there were no
differences between preoperative and postoperative peak KET values observed
in patients after 24 weeks (5 – 6 months) post-ACLr. Several longitudinal studies
have supported these authors’ findings of quadriceps strength being restored to
(or surpassing) preoperative values in the involved limb of patients at
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approximately six months post-ACLr.149,158,186 Conversely, there are other studies
that have reported similar results to our study,27,28 with the involved limb having
less quadriceps strength at six months compared to baseline (pre-ACLr). In a
recent study by Lepley et al.,27 they reported significantly lower normalized
(isometric) peak KET in the involved limb of patients at seven months post-ACLr
(2.2 Nm/kg ± 0.6) compared to their preoperative values (2.5 Nm/kg ± 0.7). Even
with their post-ACLr time point being a month longer than our study (7.2 months
vs. 6.3 months), a pre-to-post-ACLr deficit in quadriceps strength was still
present in the involved limb of patients.
As stated previously, the contrasting results observed between studies
concerning time-based differences in ipsilateral quadriceps strength of patients
after ACLr may be due to methodological variances in measurement and surgical
techniques. However, the combination of limb asymmetry and persistent
weakness observed in the involved limb of patients at six months post-ACLr,
warrants a more conservative approach when clearing patients to return to
competitive or recreational sport activities. The current timeframe for a patient to
expect to return to sport is between six and 12 months following their ACLr,593,594
but if quadriceps strength deficits are still present in the involved limbs of patients
at six or seven months, this timeframe may need to be extended closer to 12
months post-ACLr. In our study, the control group consisted of high school
athletes (15), college athletes (2), and recreational athletes (8). Only one
(recreational athlete) of the 25 patients was cleared by a physician to return to
unrestricted sport activity at the 6-month assessment time point. Therefore, this
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information may help physicians be better informed and possibly employ a more
conservative approach when deciding when to return patients to unrestricted
sport activities after ACLr, and providing more time for patients to recover their
quadriceps strength.
Although the rate of recovery after ACLr is unique to each patient, and
other outcomes (i.e., SLH tests, step-down tests, YBT/SEBT, KOOS/IKDC,
psychological readiness to return to sport, etc.) are necessary when making the
clinical decision to clear a patient to return to sport, quadriceps strength is an
important factor to asses from both a performance and health standpoint.
Restoring quadriceps strength in patients after ACLr is not only beneficial to their
performance during sport activities, but it can reduce risk of patients developing
early knee OA. Individuals who have a history of ACL injury and/or ACLr are
reported to be at a higher risk of developing early knee OA than healthy
individuals.195,196 Furthermore, evidence has shown that although ACLr is a
successful treatment for restoring knee-joint stability in these patients, patients
who undergo ACLr are found to have a 29% higher odds of developing knee OA
compared to those who are ACL-deficient.23 Within the first decade after ACLr, it
has been reported that over one third of patients develop knee OA, and this
prevalence approaches 50% by the second decade.23 Interestingly, there is
growing evidence demonstrating that quadriceps weakness contributes to the
onset and progression of knee OA in patients.73-75,197 During normal gait, three to
four times the bodyweight of a healthy individual is transmitted through their
knee-joint.73 To limit excessive joint loading, the quadriceps serve as the primary
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shock absorber for the knee-joint. During ground contact (weight acceptance),
the quadriceps contract eccentrically to absorb the majority of external forces at
the knee.73-75 As a result, the forces transmitted through the knee-joint become
dissipated, and minimal stress is placed on articular cartilage.76,77 Therefore,
quadriceps weakness is thought to allow higher loads to be transmitted at the
knee-joint, and expose the articular cartilage to more contact forces.
Within the past decade, there have been a handful of longitudinal studies
that have been able to demonstrate that quadriceps weakness is a significant
contributor to the onset of knee OA in patients.78-82 Tourville and colleagues79
assessed tibiofemoral joint space narrowing and isokinetic KET (concentric at 60
deg/s) in 38 patients prior to ACLr (baseline) and 4 years postoperatively. After
follow-up testing, the authors separated patients into narrow and normal joint
space groups based upon their 4-year radiographs. They also compared the
ACLr patients’ quadriceps strength to that of 32 healthy controls of similar age,
body mass index, and physical activity level. At baseline, the quadriceps strength
in both ACLr groups was lower than that of healthy controls (p < 0.001).
However, the quadriceps strength of the narrow ACLr group’s peak KET was
also significantly lower than that of the normal ACLr group. Four years after
ACLr, the quadriceps strength of the normal ACLr group (95 ± 10.3% LSI)
improved and was not significantly different compared to healthy controls (99 ±
11.6% LSI, p > 0.05), while the narrow ACLr group’s quadriceps strength (83 ±
23.1% LSI) remained lower than both the normal ACLr group (p = 0.04) and
healthy controls (p = 0.01). A more recent systematic review and meta-analysis
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by Oiestad et al.78 reported that early quadriceps weakness increased the odds
of patients developing knee OA (radiographic and/or symptomatic) by 65% (OR =
1.65, CI = 1.23-2.21). Therefore, the quadriceps weakness that was observed at
six months post-ACLr in the patients of our study may place them at risk for
developing knee OA if these strength deficits continue to persist. This is
especially true for those patients who plan to return to sport activity, because
their knee will be exposed to higher ground reaction forces during sports
compared to activities of daily living. Furthermore, these patients may develop
knee OA at a very young age, with the average age of patients in the control
group being 19.4 (± 4.5) years. Since one third of patients are predicted to
develop knee OA within the first decade after ACLr, at least eight of the 25
patients can be expected to develop knee OA. However if patients also
demonstrate persistent quadriceps weakness after ACLr, it may expedite the
onset of knee OA and/or exacerbate the severity of cartilage degradation. The
potential for this unfortunate sequence of events supports the significance of
restoring quadriceps strength in patients during post-ACLr rehabilitation as a
strategy better protect the knee-joint cartilage from further damage.
Uninvolved Limb
Perhaps the most significant findings from our study were the
neuromuscular quadriceps changes that occurred in the uninvolved limb of
patients after unilateral ACLr. We hypothesized that the quadriceps strength in
the uninvolved limb would gradually decrease up until six months after ACLr. Our
results confirmed this hypothesis, revealing that quadriceps strength was
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significantly decreased in the uninvolved limb of patients at six month post-ACLr
when compared to their baseline values. As observed in Figure 4.1, quadriceps
strength in the uninvolved limb does not follow the same V-shaped temporal
pattern as the involved limb. The temporal pattern of quadriceps strength in the
uninvolved limbs tended to have a more gradual decline than that of the involved
limb. However, instead of improving between three and six months post-ACLr
like what was observed in the involved limb, quadriceps strength continued to
decrease. This decrease in quadriceps strength from baseline to six months
post-ACLr (-0.30 Nm/kg) can be described as true change beyond measurement
error;592 thus, we are 95% confident that a clinical decrease in quadriceps
strength occurred in the uninvolved limb of patients at six months post-ACLr.
Although the quadriceps strength deficits observed in the uninvolved limb
of patients were not as large as those observed in the involved limb, this finding
still holds significant clinical value. Based on our knowledge of current literature,
this would be the first study to report time-based quadriceps strength deficits in
the uninvolved limb of patients after unilateral ACLr. However, there have been
several studies that have reported cross-sectional strength deficits in the
uninvolved limb of patients before and after ACLr when compared to healthymatched controls.32,42,45,51,52 Chung and colleagues45 recently assessed the
longitudinal changes in bilateral isokinetic (concentric) quadriceps strength of 75
patients at three, six, 12, and 24 months after unilateral ACLr. In addition to
comparing strength values between limbs, they also compared the peak KET
values of the ACLr patients to 75 healthy controls who were of equal age, sex,
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height, weight, and pre-injury physical activity level. In the ACLr group, the
uninvolved limb’s peak KET was significantly higher than that of the involved limb
at three months (266.1 ± 43.7 Nm vs. 178.8 ± 51.2 Nm), six months (276.4 ± 42.7
Nm vs. 224.2 ± 58.5 Nm), 12 months (276.7 ±44.9 Nm vs. 235.4 ± 56.9 Nm), and
24 months (276.6 ± 42.8 Nm vs. 242.8 ± 55.5 Nm) after ACLr. Interestingly, when
these values were compared to that of the healthy control group (290.9 ± 40.1
Nm), both the involved and uninvolved limbs of ACLr group demonstrated
significantly lower peak KET at each follow-up time point. Although more
research is needed to understand the manifestation of contralateral quadriceps
weakness in patients after unilateral ACLr, the results of our study combined with
prior evidence is enough to deserve clinical consideration.
This evidence suggests that using the uninvolved limb as the reference
when assessing quadriceps strength in patients after unilateral ACLr may
underestimate the magnitude of quadriceps strength deficits. Therefore, using
quadriceps strength LSI as an indicator of recovery should not be heavily relied
upon by physicians when making the decision of returning a patient to sport
activity after ACLr. Quadriceps strength LSI could mask residual quadriceps
weakness in the involved limb and deceive clinicians when making the decision
to return patients to their pre-injury activity after ACLr. For example, a patient
may demonstrate greater than 90% quadriceps strength LSI, but if the
quadriceps strength of their uninvolved limb has also declined since the initial
ACL injury, then the recovery of quadriceps strength on the involved limb may
have been overestimated by the LSI. Clearing a patient to return to their pre-
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injury activity prior to restoring bilateral quadriceps strength may place both of
their limbs at risk for subsequent knee-joint injury, and expose the knee to
increased contact forces due to the decreased force absorption capabilities from
the quadriceps.
To unmask the quadriceps strength deficits in the involved limbs of
patients, we recommend that clinicians should not depend on a LSI when
assessing the recovery of quadriceps strength in patients after unilateral ACLr.
Alternatively, it is recommended that clinicians compare the quadriceps strength
of their ACLr patients to those of healthy individuals who are of similar age and
stature (preferably normalized to bodyweight). If data from healthy individuals is
not available to clinicians, the second best alternative is to compare the
postoperative quadriceps strength of the involved limb to the patient’s
preoperative quadriceps strength of their uninvolved limb recorded prior to ACLr.
If we use model estimates in our study (see Table 4.3) as an example, the 6month quadriceps strength LSI is 64%. However, if the 6-month peak KET of the
involved limb is compared to the baseline value of the uninvolved limb, the LSI
equates to 59%. Although acute ACL injury is known to elicit deficits in ipsilateral
quadriceps strength, there is no evidence to suggest that acute ACL injury affects
quadriceps strength in the contralateral limb. However, we encourage clinicians
to assess the quadriceps strength on the uninvolved limb of patients as soon as
possible after ACL injury to account for the possibility of a crossover effect from
developing in the uninvolved limb later on. Using these alternative comparison
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strategies provides clinicians with a clearer representation of quadriceps strength
recovery in the involved limbs of patients after ACLr
We believe that it is also important for clinicians to account for the
potential quadriceps strength deficits that are present in uninvolved limb of
patients after unilateral ACLr. We agree that in order to improve a patient’s
function and prevent them from sustaining a subsequent injury upon return to
sport activity, improving quadriceps strength in involved limb of patients is one of
the most important goals during post-ACLr rehabilitation. However, neglecting
potential quadriceps strength deficits in the uninvolved limb could also put
patients at risk upon return to sport activity. In a study by Schmitt et al.,67 they
reported that external biomechanical forces during a drop-jump task were
distributed differently between the limbs of patients at the time of return to sport
activity after unilateral ACLr. The authors divided patients into high and low
quadriceps strength groups, and compared biomechanical data to that of agematched, healthy participants. Compared to the patients with high quadriceps
strength and healthy participants, the patients with low quadriceps strength
demonstrated greater asymmetry in peak external knee flexion moments, peak
vertical ground reaction forces, and peak loading rates. Specifically, all three
biomechanical measures were significantly lower in the involved limbs and higher
in the uninvolved limbs of patients with low quadriceps strength. Whereas, there
were no significant differences between those patients with high quadriceps
strength and the healthy participants in regard to biomechanical limb symmetries.
The asymmetrical distribution of external forces between limbs of patients who
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exhibit quadriceps weakness after ACLr has been theorized to place both kneejoints at risk for subsequent knee-joint injury.67,194 While the quadriceps
weakness exhibited in the involved limb of patients after unilateral ACLr may
decrease their ability to absorb shock at the surgical knee-joint, their increased
reliance on the uninvolved limb combined with a potential quadriceps strength
deficit may also overload the nonsurgical knee-joint. Therefore, we believe that
clinicians should begin to incorporate a bilateral approach when treating
quadriceps strength deficits in patients after unilateral ACLr.
There is compelling evidence supporting the effectiveness of crossexercise on improving neuromuscular quadriceps function.111,138,139,509-512,574
Cross-exercise is the practice of training unilaterally to achieve bilateral
improvements based on a neural phenomenon known as cross-education.116,513516

Cross-education through cross-exercise has been observed with both

exercise509-512,574 and NMES interventions.111,138,139 However, only one study to
date has investigated the effect of cross-exercise on the bilateral quadriceps
strength of patients after ACLr.509 A total of 42 patients were randomized to the
standard-of-care (control) or cross-exercise group after ACLr. The patients in the
cross-exercise group performed eccentric exercises (3-5 days/week) on the
uninvolved limb for eight weeks. Quadriceps strength (isometric) was assessed
in patients before surgery and nine weeks post-ACLr. Compared to the control
group, post-ACLr quadriceps strength was 4-8% higher in the uninvolved
(trained) limb of patients who performed cross-exercise. Quadriceps strength in
the involved limb still decreased in all patients post-ACLr, but this decrease was
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21-31% greater in control group. Clinicians should be encouraged to incorporate
a cross-exercise rehabilitation protocol such as this when treating patients who
have recently undergone unilateral ACLr. During the first couple months after
surgery, most patients are not permitted to perform high-intensity quadriceps
exercises on their involved limbs to protect the graft; yet these patients have
gross atrophy and inhibition of their quadriceps that needs to be addressed to
preserve and restore quadriceps strength. Therefore, until patients are cleared to
perform high-intensity quadriceps exercises on their involved limb, cross-exercise
can be performed on their uninvolved limb to facilitate quadriceps strength in the
uninvolved limb, and mitigate strength deficits in the involved limb. Even
afterwards, clinicians should continue to incorporate bilateral quadriceps strength
training during rehabilitation as a way to maximize neuromuscular outcomes and
improve the protection of both joints.
5.1.2 Modifications in Neural Quadriceps Dysfunction
Voluntary Quadriceps Activation
An unexpected outcome of this study was the lack the neural quadriceps
dysfunction in the involved limb of patients after ACLr. We hypothesized that
voluntary quadriceps activation in the involved limb of patients would follow the
same V-shaped temporal pattern as what was observed with quadriceps
strength. However, voluntary quadriceps activation in the involved limb remained
unchanged in patients after ACLr. Secondly, the degree of quadriceps inhibition
present in the involved limb before and after ACLr was quite unremarkable.
Although the quadriceps CAR in the involved limb of patients ranged from 60% to
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100%, the model estimates at baseline, three and six months, were 93.4%,
94.1% and 92.7%, respectively. Unfortunately, we are unable to discuss whether
these estimates are lower than the patients’ quadriceps CAR values of when they
were healthy, prior to ACL injury. Therefore, we can only compare our results on
voluntary quadriceps activation to what has been established in the literature.
Park and Hopkins88 assessed voluntary quadriceps activation levels of 91 healthy
individuals without a history of knee injury or surgery, and reported an average
quadriceps CAR value of 95%. Therefore, a quadriceps CAR value of greater
than or equal to 95% has been generally accepted as the threshold for
determining whether or not a patient has neural inhibition of their quadriceps after
ACLr.89,90 In our study, each of the quadriceps CAR estimates fell below this
threshold (< 95%), but the only time point where the quadriceps could be defined
as being inhibited beyond measurement error (SEM = 2%),404 was at six months
post-ACLr (CAR = 92.7%). However, the 95% confidence interval of this 6-month
estimate (88.1, 96.2) crosses the voluntary quadriceps activation threshold of
95%, and true change beyond measurement error was not reached (MDC =
2.8%); thus, we cannot be confident that true quadriceps inhibition was present
at this time point.
Based upon the last 20 years of research in this area, the average
voluntary quadriceps activation in the involved limb of patients, both before and
after ACLr, has been reported to be as low as 75% to 77%,32,145,289 and as high
as 99%.24 However, these studies assessed voluntary quadriceps activation in
patients using different measurement techniques (ITT and %ACT) compared to
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our study (SIB and CAR), which have been known to provide different
results.385,395,595-597 Therefore, we felt that it was necessary to only compare our
results to studies that assessed voluntary quadriceps activation in patients using
the same measurement techniques. The majority of studies have reported
average quadriceps CAR values that were at 95% in the involved limb of patients
before ACLr (90 – 95%).27,89,172,232,290 Lepley et al.51 is the only study that has
reported a quadriceps CAR value in the involved limb that was below 90% (83.1
± 8.1%) before ACLr. Conversely, the average quadriceps CAR values that have
been reported in the involved limb of patients after ACLr vary anywhere between
75-92%.27,34,48,51,55,91,97,290-293 Interestingly, the lowest quadriceps CAR value
(75.2 ± 13.4%) was reported in a study whose patients were four years removed
from ACLr,292 and the highest quadriceps CAR values (91.7 ± 6.4% and 91.8 ±
4.6%) were reported in a study whose patients were three and seven months
post-ACLr (respectively).292 The results from the later study are similar to those
of our study, with high quadriceps CAR estimates (>92%) being observed in
patients at both three and six months post-ACLr. It can be expected that a high
degree of quadriceps inhibition is present in patients immediately after ACLr
based on the principles of AMI. During this acute stage after ACLr, the effusion,
pain, and inflammation present within the knee-joint is sufficient to inhibit the
involved limb’s quadriceps. However, force-based measures of voluntary
quadriceps activation are typically contraindicated in the involved limb of patients
within the first two months after ACLr due to increased pain, inadequate rangeof-motion, and/or postoperative guidelines that are enforced to protect the graft
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from being stressed prematurely. After this acute stage, AMI may begin to
resolve in the quadriceps of patients during the first few months after ACLr, with
voluntary quadriceps activation approaching normal levels up until one year postACLr. However, a decline in voluntary quadriceps activation may be apparent in
patients who are years removed from ACLr. Quadriceps inhibition that persists in
patients years after ACLr may be defined as QAF. Alternatively, a relapse of
quadriceps inhibition years later may be a reoccurrence of quadriceps AMI that is
due to the insidious onset of a subsequent knee-joint pathology, such as knee
OA. Similar patients after ACL injury or reconstruction, patient with knee OA have
been reported to exhibit deficits in voluntary quadriceps activation.295 However,
further research is need to explore this theory, and to determine whether deficits
in voluntary quadriceps activation after ACLr are truly time-dependent.
The most significant finding observed with the voluntary quadriceps
activation of patients after ACLr was not in that of the involved limb, but in that of
the uninvolved limb. We originally hypothesized that voluntary quadriceps
activation would be lower in the involved limb compared to the uninvolved limb at
each time point; however, the exact opposite was observed in our results. There
was a significant main effect for limb observed with quadriceps CAR in patients.
Regardless of when it was assessed, quadriceps CAR estimate was
approximately 2.4% lower (on average) in the uninvolved limbs of patients
compared to their involved limbs. A bilateral voluntary quadriceps activation
deficits after ACL injury and subsequent ACLr has been consistently reported in
the literature, and is now considered to be a regular phenomenon in
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patients.34,51,84,85,91 Furthermore, the amount of neural inhibition present within
the quadriceps of the contralateral limb is equivalent to that of the ipsilateral
(involved) limb following unilateral ACLr. In a recent study by Thomas et al.,91
voluntary quadriceps activation was assessed bilaterally in the limbs of patients
who were seven months removed from ACLr. The mean quadriceps CAR value
of the patients’ involved limbs was 87%, while the uninvolved limbs demonstrated
a quadriceps CAR value of 85% (see Table 4.3). However, our findings were
unique because the voluntary quadriceps activation in the uninvolved limb of
patients was actually lower than that of their involved limb. Although we can
conclude that this difference was beyond measurement error (SEM = 2%), but
we cannot confidently say that this difference was true due to the confidence
intervals of our estimates and the MDC (2.8 – 5.5%) for quadriceps CAR.404
Compared to baseline, no temporal changes were observed with voluntary
quadriceps activation in the uninvolved limb of patients after ACLr. This finding
was similar to what was observed in the involved limb of patients after ACLr.
However, true quadriceps inhibition was more apparent in the uninvolved limb of
patients before and after ACLr compared to the involved limb. The quadriceps
CAR estimates at baseline (91%), three months (91.8%), and six months (90.1%)
post-ACLr were all below the 95% threshold value for determining whether a
patient has quadriceps inhibition.89,90 These estimates were not only below the
measurement error for quadriceps CAR (SEM = 2%),404 but their 95% confidence
intervals did not cross the 95% threshold. Furthermore, true quadriceps inhibition
can be assumed with more confidence at the 6-month post-ACLr time point
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(MDC90 = 4.65%) compared to baseline and the 3-month post-ACLr time point
(MDC = 2.83%).404 However, we are unable to determine whether the pre-injury
voluntary quadriceps activation levels of our patients would have met the 95%
threshold that has been previously reported in healthy individuals;88 we can only
assume that the quadriceps CAR estimates reported in the uninvolved limb of our
patients reflected quadriceps inhibition, based on the 95% threshold criterion.
The joint trauma present within the surgically reconstructed knee-joint of
patients after ACL injury and/or reconstruction seems to be modulating the
voluntary quadriceps activation of their uninvolved limb. Scientists have yet to
fully understand the reason for the bilateral quadriceps inhibition that is observed
in patients after unilateral ACLr. The most popular explanation is that of a neural
crossover effect that occurs in the central nervous system due to altered afferent
information being transmitted from the involved knee-joint.42,145,272 Due to this
bilateral deficit, clinicians are cautioned when using a patient’s uninvolved limb
as a comparison when assessing the recovery of neuromuscular quadriceps
function in the involved limb and making return-to-activity decisions after ACLr.
Consequently, clinicians should be advised to consider a healthy-matched
control as a comparison, and clinicians should place further attention on the
uninvolved limb during the rehabilitation of patients following ACLr.
Corticomotor Excitability
Like voluntary quadriceps activation, temporal changes in corticomotor
excitability at the quadriceps were not observed in the involved limb of patients
after ACLr. As a reminder, a lower quadriceps AMT value (%TMS output)
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corresponds to higher corticomotor excitability at the quadriceps. The only study
that has assessed quadriceps AMT in the involved limb of patients prior to ACLr
was that of Lepley et al.51 They assessed quadriceps AMT in their patients at an
average of 35 days after ACL injury, and reported an average AMT of 39.9%.
This value is very similar to the quadriceps AMT estimate that we reported in our
patients (39.7%) who were assessed an average of 25 days after ACL injury.
However, the postoperative quadriceps AMT estimates in our study were
relatively low compared to what has been previously reported in patients after
ACLr.34,51,61,84,97 The quadriceps AMT estimates of our patients were 39.1% and
39.2% at three and six months post-ACLr, respectively (see Table 4.3). The
majority of studies have reported average quadriceps AMT values that fall
between 44% and 62% in patients after ACLr.34,51,84,97 It must be noted that most
of these studies assessed quadriceps AMT in patients who were more than two
years removed from ACLr.34,84,97 However, Lepley et al.51 assessed quadriceps
AMT in patients at a time point similar to our study (6 months post-ACLr), but
their AMT value was higher (46.1% vs. 39.2%). There has been one study that
has reported low quadriceps AMT values (33.2%) in patients after ACLr,61 but
their assessment was performed at a time point (33.2 months post-ACLr) much
later than our study.
It is not clear why the quadriceps AMT estimates of our patients were
different than when they were healthy (prior to ACL injury). Therefore, we can
only compare our results to what has been reported for healthy individuals. Of
the aforementioned studies that assessed corticomotor excitability in patients
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before and/or after ACLr, most of them assessed quadriceps AMT in a group of
healthy individuals as comparison. The majority of these studies reported
quadriceps AMT values between 36% and 38% in healthy controls.34,51,97
However, Kuenze et al. reported quadriceps AMT values in healthy controls that
were greater than 60%. Although the inconsistent results between studies may
be due to methodological variances, more studies are needed to determine the
normative values of quadriceps AMT that can be expected in healthy individuals.
Secondly, due to the limited evidence of corticomotor excitability changes in
patients before and after ACLr, more longitudinal studies are needed to confirm
whether corticomotor excitability at the quadriceps is altered in patients after ACL
injury and reconstruction, and to what extent these alterations exist. Furthermore,
other supraspinal areas (i.e., sensory cortex, cerebellum, brainstem, etc.) should
be explored to determine the systemic effect that ACL injury and reconstruction
have on the neural function of CNS.

5.2

SPECIFIC AIM 2
5.2.1 Early Neuromuscular Effects on Lower Extremity Function
Outcomes
Lower Extremity Postural Control
We originally hypothesized that the patients’ quadriceps strength

assessed at baseline and three months post-ACLr would be associated with their
lower extremity postural control at six months post-ACLr. The YBT-A was used to
assess lower extremity postural control in patients at six months post-ACLr. We
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chose the anterior reach direction of the YBT, because quadriceps EMG activity
has been reported to be the highest in that direction.587 The normalized peak
KET of patients at three months post-ACLr was the only variable that
demonstrated a significant positive association with 6-month YBT-A reach
distance (see Table 4.5). For every 1 Nm/kg increase in normalized peak KET at
three months post-ACLr, an estimated 5.1% increase in normalized YBT-A reach
distance could have been expected at six months post-ACLr. If we use the
results from Specific Aim 1 as an example (Table 4.3), the model estimate for
normalized peak KET of patients at three months post-ACLr was 1.67 Nm/kg.
Therefore, if the patients increased their normalized peak KET to 2.67 Nm/kg
between three and six months post-ACLr, they would see a 5.1% increase in
their normalized YBT-A reach distance at six months post-ACLr, which would
signify an improvement in their postural control. However, we are only able to
conclude that this 5.1% increase is statistically significant, and not beyond
measurement error or a true increase in lower extremity postural control,
because no study has determined the MDC of the normalized YBT-A reach
distance.
Our results were similar to those reported by Kline and colleagues.72 They
found that the 3-month postoperative isometric quadriceps strength of ACLr
patients was significantly correlated their knee flexion excursion and internal
knee extension moment observed with running at six months post-ACLr. Knee
flexion excursion and internal knee extension moments are biomechanical
measures that are believed to be controlled by the activity of quadriceps,68 and
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they have previously been found to be correlated with quadriceps strength in
patients at the time of return-to-sport after ACLr.63 However, the problem is that
most studies choose to assess these correlations in patients cross-sectionally
after they have returned to sport activity, and are unable to determine whether
earlier quadriceps strength deficits can explain the reduced function and/or poor
biomechanics that are observed in patients around the time that they have
returned to sport activity. The results of our study combined with those of Kline et
al.,72 have begun to fill this void by demonstrating that quadriceps strength of
patients at three months post-ACLr have a direct influence on their lower
extremity function and biomechanics at six months post-ACLr. Therefore, these
results demonstrate the importance for clinicians to focus on quadriceps
strengthening during the early stages of ACLr rehabilitation in order to provide
patients the opportunity for better outcomes around the time that they are cleared
to return to sport activity.
Other studies have also reported significant associations between
quadriceps strength and lower extremity functional performance in patients after
ACLr.3,4,7-9,28,39,53-59 Keays and colleagues28 sought to determine whether
quadriceps strength was correlated with SLH performance before and after ACLr.
They assessed the isokinetic (concentric) peak KET, single hop for distance, and
triple hop for distance of 31 patients before unilateral ACLr and at their 6-month
postoperative follow-up. Prior to surgery, significant correlations were observed
between isokinetic quadriceps strength and performance on the SLH tests (r =
0.53 – 0.59). However, stronger correlations were observed at six months post-
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ACLr between quadriceps strength and the SLH (r = 0.62 – 0.74). The results of
our study not only demonstrated a significant association between postoperative
quadriceps strength and lower extremity postural control, but that the amount of
quadriceps strength a patient has earlier after ACLr has a direct effect on the
degree of postural control they will have months later.
The anterior reach component of the YBT has been shown to predict
lower extremity injuries in athletes.585 A recent study by Smith et al.585 assessed
the bilateral YBT-A reach distance of 184 Division-1 collegiate athletes during
their pre-participation physical examinations. These athletes were then followed
throughout their respective sport seasons, and the number of lower extremity
non-contact injuries were recorded. A total of 81 athletes sustained a lower
extremity non-contact injury during their sport season. The authors found that
greater limb asymmetry with the pre-participation YBT-A significantly increased
the odds of athletes sustaining a lower extremity non-contact injury during their
sport season (OR = 2.33; 95% CI = 1.15 – 4.76). Therefore, the results of our
study carry great clinical significance from an injury prevention standpoint. More
focus should be made to enhancing quadriceps strength in patients during the
early months after ACLr as a proactive attempt to improve their lower extremity
postural control and reduce the odds of them sustaining a subsequent lower
extremity injury upon return to sport activity. However, more research is needed
to explore the effect that early postoperative quadriceps strength has on other
measures of lower extremity functional performance, and whether these
measures can predict subsequent knee-joint injuries.
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Self-Reported Knee Function
We also hypothesized that the patients’ quadriceps strength assessed at
baseline and three months post-ACLr would be associated with self-reported
knee function at six months post-ACLr. The Sport/Rec and QOL domains of the
KOOS were used to assess self-reported knee function in patients at six months
post-ACLr. The normalized peak KET of patients at three months post-ACLr was
not found to be associated to their 6-month postoperative KOOS-Sport/Rec
score. Similar to what was reported with 6-month YBT-A outcomes, the
normalized peak KET of patients at three months post-ACLr was the only
variable that demonstrated a significant positive association with any of the 6month KOOS domains (see Table 4.5). The 6-month postoperative KOOS-QOL
score of patients was the only domain that was influenced by their 3-month
postoperative quadriceps strength. For every 1 Nm/kg increase in normalized
peak KET at three months post-ACLr, an estimated 8.9 point increase in KOOSQOL score could have been expected at 6-months post-ACLr. This 8.9 point
increase in KOOS-QOL score would be defined as true change beyond
measurement error because it surpasses the MDC associated with that KOOS
domain (MDC95 = 7.2 pts).192
The fact that 3-month postoperative quadriceps strength effected 6-month
postoperative KOOS-QOL scores, but not KOOS-Sport/Rec scores may be
explained by the different aspects of knee function that are addressed by the two
domains. For the KOOS-Sport/Rec domain, there are five questions that pertain
to five different activities/movements (squatting, running, jumping,
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twisting/pivoting, and kneeling). Patients are asked to think of the degree of
difficulty that they experience (within the past week) with their knee for each
question. Difficulty is graded on a 5-point Likert scale, ranging from no difficulty to
extreme difficulty. Conversely, for the KOOS-QOL domain, there are four
questions that pertain knee function from a broader level of QOL instead of
activities/movements. Rather than asking patients the degree of difficulty that
they have with their knee, patients are asked to think of the frequency and
degree of difficulty that they experience with their knee. Again, the answers are
graded on a 5-point Likert scale, ranging from either never-to-constantly, or from
none/not at all-to-extreme/totally. As stated earlier, only one of the 25 patients in
our study was cleared by a physician to return to unrestricted sport activity at the
6-month assessment time point. Therefore, the KOOS-Sport/Rec score that was
observed in patients at six months post-ACLr may not have been accurate,
because the majority of them were not exposed to sport activities at that time
point; thus, they did not have a valid reference to relate to when answering
questions form that domain. Unlike our study, Ithburn et al.63 reported that the
KOOS Sport/Rec scores observed in patients after ACLr (~ 8 months post-ACLr)
were different depending on their levels of isometric quadriceps strength.
Compared to patients with high quadriceps strength (LSI ≥ 90%), patients with
low quadriceps strength (LSI < 85%) also demonstrated lower KOOS-Sport/Rec
scores (89.5 ± 11.7 pts vs. 79.6 ± 15.5 pts). The primary difference between our
study and theirs, is that their patients completed the KOOS-Sport/Rec after they
were cleared to return to sport activity (~ 7 months post-ACLr), whereas the
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majority of our patients had not returned to sport activity prior to completing the
6-month KOOS-Sport/Rec. Although hypothetical, if our patients were exposed to
sport activity prior to completing the KOOS-Sport/Rec domain at six months postACLr, more accurate scores may have been evidenced, and significant
associations may have resulted with 3-month postoperative quadriceps strength.
Since the KOOS-QOL domain does not pertain to sport activities, but rather a
broader construct of knee function, it may explain why a significant association
was observed with that self-reported functional outcome measure.
In addition to the KOOS, several studies have demonstrated significant
associations between IKDC scores and the quadriceps strength of patients
following ACLr.8,55,60-62 Perhaps the most impressive study that demonstrated this
association was that of Pietrosimone and colleagues.61 They assessed isometric
peak KET and IKDC scores in 15 patients who were an average of 54 months
removed from ACLr, and performed a linear regression analysis to determine the
amount of variability in self-reported knee function that could be explained by
their quadriceps strength. Remarkably, they discovered that isometric quadriceps
strength predicted over 60% (r2 = 0.61) of the variance in the IKDC scores of
patients who have a history of ACLr; thus, demonstrating that the majority of
IKDC scores can be explained by a patient’s quadriceps strength after ACLr, and
that quadriceps weakness can severely limit their self-perceived function. We
may have observed more and/or greater associations between early
postoperative quadriceps and 6-month self-reported knee function if we used the
IKDC, however, the KOOS-Sport/Rec and KOOS-QOL were intentionally chosen
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to represent the self-reported knee function in our sample of patients. Compared
to other self-reported outcome measures, the KOOS is meant for younger, and
more physically active patients who have sustained a knee injury or have
undergone knee surgery.588 Furthermore, of the five domains in the KOOS, the
QOL and Sports/Rec domains have demonstrated the most unidimensionality,589
and are the most sensitive to changes over time in patients after ACLr,193 thus,
justifying our rationale for choosing to preferentially assess those two domains in
our study. That being said, further investigations should performed to determine
whether early postoperative quadriceps strength has an effect on other selfreported outcome measures (i.e., IKDC, Cincinnati Knee Score, Knee Outcome
Survey, etc.) at the time of return to sport activity.
Lack of Associations with Neural Measures
Neither quadriceps CAR or AMT (at baseline or 3-months post-ACLr) had
a significant effect on any of the 6-month lower extremity function outcome
measures. Based on our original hypotheses, we expected that corticomotor
excitability would not have a significant influence on the patients’ lower extremity
function, because quadriceps AMT has been previously shown to be minimally
correlated with the quadriceps strength of patients after ACLr,61,97 and as
evidenced in our study, quadriceps strength has been consistently reported to
influence lower extremity function in patients after ACLr. Therefore, since
voluntary quadriceps activation has been reported to explain nearly 40% of
quadriceps strength in patients after ACLr (r2 = 0.37),97 we hypothesized that it
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would influence the lower extremity function of our patients at six months postACLr, yet this not supported in our results.
Although we hoped to observe an association between voluntary
quadriceps activation and lower extremity function in patients after ACLr, the
absence of this finding is not surprising. To date, only one study has reported on
the association between voluntary quadriceps activation and lower extremity
function in patients following ACLr.48 Kuenze and colleagues48 used receiveroperator-characteristic (ROC) curves as a method to establish clinical thresholds
for voluntary quadriceps activation (CAR) associated with self-reported knee
function (KOOS) in patients who were at least six months removed from
unilateral ACLr. They found that quadriceps CAR LSI greater than 99.2% (area
under curve = 0.67) was the most effective in identifying a patient with a total
KOOS score similar to that of healthy individuals (96 pts). However, there are
several limitations associated with this study, which questions the clinical
significance of its findings. To begin, quadriceps CAR LSI is not commonly
assessed, and as was mentioned earlier, LSI may underestimate the amount
quadriceps dysfunction present in patients after ACLr. Secondly, reporting the
total KOOS score, which is the sum of the scores for each domain is not advised.
This is because the intention of the KOOS is to allow clinicians to analyze and
interpret each domain separately. This is one advantage the KOOS has over
other self-reported knee outcome measures.
The correlation between voluntary quadriceps activation and lower
extremity function may be too low to reach statistical significance. However,
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voluntary quadriceps activation may serve to moderate the relationship between
quadriceps strength and lower extremity function in patients with knee OA.134
Fitzgerald et al.134 assessed quadriceps activation and strength, and lower
extremity function (Western Ontario and McMaster Universities Osteoarthritis
Index combined with Get Up and Go test) in 105 patients with radiographic knee
OA. After performing regression analysis, the authors found that adding the
quadriceps activation by strength interaction to the regression model resulted in
the highest explanation of variance for lower extremity function (r2 = 0.22); thus,
quadriceps inhibition was believed to serve as a moderator between quadriceps
strength and function. For example, patients who exhibited higher levels of
quadriceps weakness and quadriceps inhibition, had lower levels of function than
those with comparable strength and less inhibition. Conversely, patients who
exhibited lower levels of quadriceps weakness and higher levels of quadriceps
inhibition, had higher levels of function compared to those of comparable
strength and less inhibition. Although the authors could not explain why stronger
patients with more quadriceps inhibition had higher levels of function, they
hypothesized that if a patient has good quadriceps strength, the presence or
absence of quadriceps inhibition may not play an important role in affecting their
function.134 If a patient has enough strength to function well, they may not need
to fully activate their quadriceps. In contrast, if a patient has significant
quadriceps weakness and quadriceps inhibition, the combination of the two may
be sufficient enough to affect their function. Regardless, the effect that voluntary
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quadriceps activation has on quadriceps strength alone, makes it an important
outcome for clinicians to consider when treating patients after ACLr.

5.3

SPECIFIC AIM 3
5.3.1 Group Patterns
Isometric Quadriceps Strength
We hypothesized that those patients who were randomly allocated to the

Home-NMES group would demonstrate greater bilateral improvements in
quadriceps strength, voluntary activation, and corticomotor excitability at both
three and six months post-ACLr compared to patients in the control group.
However, the only significant group difference that was observed in our
randomized clinical trial was with the isometric quadriceps strength outcome
measure (see Table 4.6). A main effect for group was reported with isometric
quadriceps strength, with the control group having an average of 0.36 Nm/kg
higher normalized peak KET than that of the Home-NMES group (irrespective of
limb and time). However, this group difference was not because the HomeNMES group had a negative treatment effect from the home-based NMES
program, but because group differences in normalized peak KET were present at
baseline. Although the only statistically significant group difference that was
present at baseline was with normalized peak KET on the uninvolved limb being
higher in the control group (see Table 4.2), a trend was also observed in the
involved limb, with the control group again being higher than the Home-NMES
group. The mixed model analyses may have accounted for this trend, causing
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the model estimates for normalized peak KET to be significantly higher in the
control group at baseline, regardless of limb. Even if normalized peak KET was
the same bilaterally between groups at baseline, we do not foresee that the
Home-NMES group would have demonstrated a greater bilateral improvement in
isometric quadriceps strength than the control group at either three or six months
post-ACLr, due to the differences in model estimates for limb and time being
identical between both groups. Therefore, the isometric quadriceps strength
deficits observed in Home-NMES group followed the same pattern as the control
group after ACLr, but they happened to begin with weaker quadriceps at
baseline.
Regardless of group allocation, significant limb by time interaction that
was demonstrated in the results of Specific Aim 3. Similar to the results of
Specific Aim 1, there was a side-to-side difference in isometric quadriceps
strength between limbs at each time-point. For both groups, the normalized peak
KET of the involved limb was significantly lower than that of the uninvolved limb
at baseline, three months, and six months post-ACLr. Again, the largest
difference between limbs was observed at three months post-ACLr (-1.35
Nm/kg), with the next largest difference occurring at six months post-ACLr (-0.95
Nm/kg), and the smallest difference between limbs was observed at baseline (0.32 Nm/kg). Furthermore, if we convert the 6-month model estimates for
normalized peak KET (see Table 4.6) into quadriceps strength LSIs, they fall
below the 90% LSI return-to-sport criterion in both groups (Home-NMES =
65.5%; control = 69.5%) post-ACLr. Thankfully, only one patient in both the

211

Home-NMES group (high-school athlete) and control group (recreational athlete)
was cleared by a physician to return to sports activity before the 6-month postACLr time point; thus, the majority of the patients in this clinical trial were not
exposing their surgical knees to the increased external forces associated with
sport activities, prior to achieving an acceptable limb symmetry in quadriceps
strength. However, as stated earlier in this chapter, when interpreting a patient’s
quadriceps strength LSI after unilateral ACLr, it is important to consider the
possibility of bilateral deficits in quadriceps strength. When available, we
recommended that clinicians compare the quadriceps strength of their ACLr
patients to those of healthy individuals, and if healthy data is not available, the
second best alternative is to compare the postoperative quadriceps strength of
the involved limb to the patient’s preoperative quadriceps strength of their
uninvolved limb recorded as soon as possible after ACL injury. These alternative
comparison strategies to LSI will provide clinicians with a more accurate
representation of the recovery of quadriceps strength in patients after ACLr.
Like the results of Specific Aim 1, a V-shaped curve was observed with
quadriceps strength changes for both groups. Compared to baseline, quadriceps
strength decreased in patients at three months post-ACLr (-1.07 Nm/kg), and
then increased at six months post-ACLr (+0.32 Nm/kg), but this increase did not
reach baseline value (-0.75 Nm/kg); thus, rejecting one component of our
hypothesis. These changes can all be described as true change that occurred
beyond measurement error (MDC95 = 0.30 Nm/kg),592 making us 95% confident
that true clinical changes in quadriceps strength occurred in the involved limb of
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both groups after ACLr. Unlike the results of Specific Aim 1, there were no
statistically significant changes with quadriceps strength in the uninvolved limb
for either group. However, this was most likely due to larger mixed model
analysis used for Specific Aim 2. Before post-hoc adjustments, normalized peak
KET was significantly decreased from baseline to six months post-ACLr an
average of 0.19 Nm/kg in the uninvolved limbs of both groups (unadjusted p =
0.02), but after adjusting for multiple comparison, this decrease in peak KET on
the uninvolved limb did not achieve statistical significance (adjusted p = 0.13). In
addition, the 95% confidence intervals of the 6-month peak KET estimates
crossed the baseline estimates in both groups, and only 65% confidence can be
had that true change occurred in quadriceps strength from baseline to six months
post-ACLr (MDC = 0.16 Nm/kg).592 The inclusion of the group variable adjusted
the model estimates for normalized peak KET observed in the uninvolved limb of
the control group (see Tables 4.3 and 4.6). Since the normalized peak KET
estimate of the uninvolved limb was lower in the Home-NMES group than the
control group at baseline, it may have decreased the likelihood of observing a
statistically significant postoperative decrease in the uninvolved limb. Greater
responsiveness to change after ACLr can be expected with higher normalized
peak KET estimates, but since the Home-NMES started with lower normalized
peak KET, the likelihood of a statistically significant decrease after ACLr is
reduced; thus, explaining why no temporal changes were observed in the
uninvolved limb of the control group. Regardless, we still believe that clinicians
should account for potential bilateral deficits in the quadriceps strength of
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patients after unilateral ACLr, by incorporating bilateral quadriceps strengthening
interventions during rehabilitation.
Voluntary Quadriceps Activation
As observed with Specific Aim 1, there was a significant difference in
voluntary activation observed between limbs at baseline. Regardless of group
membership, the baseline quadriceps CAR estimate in the uninvolved limb of
patients was on average 4.2% lower than that of the involved limb. However, a
limb difference in quadriceps CAR was not significant in either group at three or
six months post-ACLr. The lack of statistically significant limb differences in
quadriceps CAR of the control group at three and six months post-ACLr are likely
do to the larger mixed model analysis used for Specific Aim 3 compared to
Specific Aim 1. The estimated 4.2% difference in quadriceps CAR between limbs
(involved limb > uninvolved limb) at baseline was greater than what was reported
in Specific Aim 1 (2.4%). Furthermore, this difference was beyond measurement
error (SEM = 2%), and can be considered as true change with 68% confidence
(MDC = 2.8%). As discussed earlier, a bilateral deficit in voluntary quadriceps
activation of patients after unilateral ACLr has been previously demonstrated in
the literature,34,51,84,85,91 which is likely the result of a neural crossover
effect.42,145,272 This bilateral deficit further rejects the practice of relying on LSI
measurements when assessing the recovery of neuromuscular quadriceps
function in the involved limb and making return-to-activity decisions for patients
after ACLr, and supports the inclusion of bilateral interventions during the
rehabilitation of patients following unilateral ACLr.
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Although there were no other statistically significant findings observed in
this clinical trial concerning voluntary quadriceps activation, a case can be made
that quadriceps inhibition was present in both groups of patients (see Table 4.6).
Since quadriceps CAR was not assessed in the groups prior to ACL injury, we
are unable to determine whether the injury and/or ACLr elicited decreases in
voluntary quadriceps activation. By using the 95% voluntary quadriceps
activation threshold established in the literature to determine the presence of
quadriceps inhibition,88-90 we can see that several quadriceps CAR estimates in
both groups fall below this 95% threshold. In the involved limb, quadriceps
inhibition was present beyond measurement error at three and six months postACLr in the control group, and at six months post-ACLr in the Home-NMES
group (SEM = 2%).404 However a true difference (with 90% confidence) to the
95% threshold was only observed with quadriceps CAR estimate at six months
post-ACLr (89.8%) in the control group (MDC90 = 4.6%).404 In the uninvolved
limb, quadriceps inhibition was present beyond measurement error at each time
point in both groups, but unlike the control group, true difference to the 95%
threshold could only be seen at baseline (91.7%) and six months (92.2%) postACLr in the Home-NMES group. Furthermore, only 68% confidence can be given
to the quadriceps inhibition (quadriceps CAR < 95%) that was present in the
Home-NMES group at baseline and six months post-ACLr (MDC = 2.8%);
whereas, 90% confidence (MDC90 = 4.6%) can be given to the quadriceps
inhibition that was present in the control group at three months (quadriceps CAR
= 89.8%) post-ACLr, and 95% confidence (MDC95 = 5.5%) to the quadriceps
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inhibition present at baseline (quadriceps CAR = 88.9%) and six months
(quadriceps CAR = 89.4%) post-ACLr.
Perhaps this point can be made clearer by observing the 95% confidence
intervals (error bars) associated with the quadriceps CAR estimate (columns) for
each group. Figure 4.4. The dashed red line in Figure 4.4 corresponds to the
healthy normative quadriceps CAR (95%) reported by Park and Hopkins,404
which is also used as the threshold for determining the presence of quadriceps
inhibition. In the Home-NMES group, the only confidence interval that did not
cross the 95% CAR threshold was seen with uninvolved limb at baseline (95% CI
= 88.5%, 94.4%). Conversely, in the control group, the confidence intervals for all
time points in the uninvolved limb were below the 95% CAR threshold, and even
the confidence intervals for the 6-month quadriceps CAR estimate in the involved
limb fell below this threshold (95% CI = 85.5%, 93.4%). Regardless of the
observation that less inhibition was observed in the Home-NMES group than the
control group, we cannot conclude that the home-based NMES treatment was
effective at improving voluntary quadriceps activation in patients after ACLr. This
observed difference between groups can be explained by the greater quadriceps
inhibition observed in the control group at baseline, since no significant changes
in quadriceps CAR were observed in either group over time. However, the main
observation of this clinical trial was the presence of quadriceps inhibition in the
uninvolved limb of patients before and after ACLr. This finding suggests that
disinhibitory interventions may need to be applied bilaterally in patients after
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unilateral ACLr as an attempt to maintain quadriceps activation and foster
quadriceps strength gains during rehabilitation.
Corticomotor Excitability
In agreement with Specific Aim 1, no temporal changes in corticomotor
excitability were observed in either group after ACLr, and no differences were
found between groups at either time point. Since the quadriceps AMT estimates
of both groups did not change postoperatively, and are similar to the quadriceps
AMT values that have been reported in healthy individuals,34,51,97 we believe that
ACLr may not effect corticomotor excitability as much as what has been reported
in earlier studies. Due to the limited evidence of corticomotor excitability changes
in patients after ACLr, more studies are needed to determine the extent that
these alterations exist. In addition, other supraspinal areas should be explored to
determine the systemic effect that ACLr has on the CNS.
5.3.2 Explaining the Lack of Treatment Effect in the Home-NMES
Group
Quadriceps Strength
The most disappointing finding of this randomized clinical trial was the lack
of a treatment effect observed with the home-based NMES for any of the
outcome measures pertaining to neuromuscular quadriceps function. Based on
the time points in which quadriceps strength was assessed in our study, we
expected that both groups would demonstrate a V-shaped pattern with temporal
quadriceps strength changes. However, we hypothesized that the decreases in
quadriceps strength at three and six months post-ACLr would be less extreme in
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the Home-NMES group compared to the control, due to the superior treatment
effects that have been reported with NMES. NMES has been well established in
the literature as an effective modality for restoring quadriceps strength in patients
after ACLr.70,104-110,598 In a systematic review conducted in 2010, Kim et al.105
assessed the effect sizes of six randomized clinical trials that compared the
effect of NMES interventions on improving quadriceps strength in patients after
ACLr, to that of other strengthening interventions (i.e., exercise, EMGBF, etc.).
Of the seven clinical trials, six of them had effect sizes which favored the NMES
interventions, and half of those demonstrated significant effect sizes (95%
confidence intervals did not cross 0). From a physiological standpoint, NMES is
effective at improving quadriceps strength in patients ACLr because it
preferentially recruits type II (fast-twitch) muscle fibers,115,503,504 which are
thought be more effected in the quadriceps of patients after ACLr.56,65,86,241-243
Therefore, since type II muscle fibers are responsible for high muscle force
production, it is logical that NMES would be an effective modality for improving
quadriceps strength.
Furthermore, NMES has demonstrated cross-education capabilities after
unilateral application.111,138,139,508 Although cross-education has been typically
reported with exercise,509-512 there is evidence to suggest that NMES may induce
an even greater cross-education effect.138,139 Hortobagyi et al.138 randomized 32
healthy women to a NMES and control groups, and asked them to perform 840
eccentric contractions (control = voluntary, NMES = stimulated) over six weeks.
Each group was tested before and after six weeks to assess for changes in
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eccentric quadriceps strength. Improvements in quadriceps strength of the
trained limb were observed in both groups, but the untrained limb of the NMES
group demonstrated a 60% increase in quadriceps strength, which was greater
than that of the control group. Since the untrained limb did not received the
NMES and was unexercised, the bilateral improvement in quadriceps strength
after a unilateral NMES intervention could only be explained by a neural
crossover effect within the central nervous system.116,513-516
Lastly, there have been a handful of recent studies that have also
demonstrated significant outcomes in patients with the use of home-based
NMES devices.129-131 The main benefit of home-based NMES is that a larger
dosage of NMES can be provided to patients after ACLr. Although the control
group in this study received NMES treatments on their quadriceps at physical
therapy during the 12-week intervention period (average of 2-3 visits/week), the
Home-NMES group was allowed more exposure to NMES within the same time
window. Because of the convenience and higher NMES dosage that is
associated with home-based NMES devices, we hypothesized that the HomeNMES group would demonstrate better quadriceps strength outcomes.
The reason why we did not observe a treatment effect in the Home-NMES
group with quadriceps strength may have been due to the different treatment
procedures used in our study, compared to those studies that have reported
significant quadriceps strength improvements with NMES.70,104,107,110 In our study,
we had the Home-NMES group perform their NMES treatments with their knees
in full/maximal extension. However, the most effective NMES protocols used for
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improving quadriceps strength require patients to position their knees at 60° to
90° of flexion when applying NMES to achieve a quadriceps contraction that is at
least 50% of their MVIC.70,98,104,107,110 Although, there have also been studies
have demonstrated positive quadriceps strength outcomes in patients when
applying NMES in full knee extension.108,130 Secondly, even though a greater
training intensity can be provided by applying NMES in knee flexion, it tends to
be more uncomfortable for patients, and difficult to attain during home-based
NMES treatments.
Another reason as to why we did not observe superior quadriceps strength
outcomes in the Home-NMES group may have been due to the length of our
intervention. Our study consisted of a 12-week intervention period, which is
longer compared to most studies that have shown positive quadriceps strength
outcomes with NMES.105 In the aforementioned systematic review, 105 the three
randomized clinical trials that demonstrated significant effects sizes in favor of
NMES for improving quadriceps strength, also had the shortest intervention
periods (mean = 4.3 weeks).70,110,598 Thus, the authors concluded that longer
NMES interventions after ACLr may not be as effective in patients. However,
their conclusion is interesting since quadriceps strength increases observed
within the first few weeks of an NMES intervention have been attributed to neural
adaptations, while those observed in the later weeks have been attributed to
muscle hypertrophy. 111-114 Therefore, NMES interventions may be more effective
at increasing quadriceps strength via neural adaptations instead of muscle
hypertrophy. In our study, the soonest our physicians allowed us to assess
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postoperative quadriceps strength in patients was at 12 weeks post-ACLr;
therefore, even if a shorter NMES intervention period was used in the HomeNMES group, we would have been unable to determine whether neural
adaptations moderated quadriceps strength deficits in patients within the first few
weeks after ACLr.
To date, there have been a total of two studies which have assessed the
effectiveness of home-based NMES for improving quadriceps strength in patients
following ACLr.104,130 Most recently, Feil et al.130 assessed the effectiveness of
three home-based interventions at restoring quadriceps strength in patients after
ACLr by conducting a randomized clinical trial. A total of 131 patients were
randomly allocated into one of three groups after ACLr: control group, Polystim
group, or Kneehab group. The Polystim and Kneehab interventions were both
home-based NMES interventions with identical stimulation parameters (50 Hz, 0
– 70 mA), but the Polystim intervention was a traditional two-channel NMES
device with a single current pathway that is applied between an electrode pair,
whereas the Kneehab intervention is a multipath NMES device that distributes its
current to multiple pairs of electrodes within single channels. Both NMES groups
began their interventions three days post-ACLr, and continued them for a total of
12 weeks (20 min/day, 5 days/week). The control group received the standard-ofcare, but similar to our study, they performed isometric quadriceps contractions
of the same duration and frequency as the home-based NMES groups, as a
method to equalize the exercise volume. Isokinetic (concentric) quadriceps
strength was assessed prior to ACLr, and every six weeks after ACLr, up to 24
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weeks. The authors reported that the Kneehab group demonstrated significant
increases from baseline to 24 weeks post-ACLr that were greater than both the
Polystim and control groups. However, there were no significant differences
observed between the Polystim and control groups in regard to quadriceps
strength outcomes. The authors concluded the Kneehab group demonstrated
better improvements in quadriceps strength because multipath NMES allowed for
more spatial recruitment than the traditional NMES that was used in the Polystim
group.130
Multipath NMES has been shown to elicit greater evoked KET from the
quadriceps when compared to traditional NMES.522 Maffiuletti et al.522 attributed
these effects to both the higher stimulation intensity that is tolerated with
multipath NMES, and the wider current distribution between multiple pairs of
electrodes. Compared to the study by Feil et al.,130 the home-based NMES
device used in our randomized clinical trial was more similar to the Polystim
group than it was to the Kneehab group. Like the Polystim group, our traditional,
home-based NMES device consisted of a two channel, single current pathway
that was applied between a pair of electrodes. Therefore, the lack of quadriceps
strength improvements observed in the Home-NMES group of our study may
have been due to the limitation of traditional NMES.
However, traditional, home-based NMES has also been shown to be less
effective at restoring quadriceps strength in patients after ACLr than traditional,
clinic-based NMES.104 In an earlier randomized clinical trial, Synder-Mackler and
colleagues104 randomly allocated 52 patients to either a clinic-based NMES
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group or a home-based NMES group following ACLr. The patients in the clinicbased NMES group received traditional NMES treatments to their quadriceps
during their physical therapy visits (3 days/week); whereas the patients in the
home-based NMES group administered traditional NMES treatments to their
quadriceps using a portable device (15 mins/treatment, 4 treatments/day, 5
days/week). Both groups began their respective interventions two weeks postACLr, and continued them for the following four weeks. The stimulation
parameters were the same for clinic-based and home-based NMES (75 Hz, 300
μs, 50 – 100 mA), and each group was encouraged to increase the NMES
intensity to maximal toleration. The contraction intensity was monitored weekly
by assessing the evoked KET (%MVIC) on the uninvolved limb with each
patients’ maximally tolerated NMES intensity. After four weeks, isometric
quadriceps strength was assessed in both groups. The clinic-based NMES group
was reported to train with higher contraction intensities, and had greater
quadriceps strength recovery than the home-based NMES group. Furthermore,
there was a significant correlation observed between contraction intensity and
quadriceps strength recovery in the clinic-based NMES group, but not in the
home-based NMES group. Interestingly, the home-based NMES group in their
study trained at a higher average NMES intensity (83 mA) than the clinic-based
NMES group (55 mA). However, the traditional, clinic-based NMES was able to
elicit greater contraction intensities in patients after ACLr. This observation is
odd, because the evoked KET from NMES is known to be linearly related with
spatial recruitment of the quadriceps, and NMES intensity is believed to directly
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affect the evoked force of the quadriceps.518,520,521 Therefore, the higher NMES
intensity used by the home-based NMES group in this study should have
produced a high contraction intensity, resulting in greater quadriceps strength
recovery than what was reported.
The absence of this observation suggests that traditional NMES my only
be effective with clinic-based devices, due to a limitation associated with portable
NMES devices. With portable NMES devices, the electrodes are usually housed
in a garment that is wrapped around the thigh, like the one used in our HomeNMES group. However, the distances between electrodes are confined to the
surface area of the garment, which may restrict the degree of spatial recruitment
NMES has within the quadriceps. Although spatial recruitment can be improved
by increasing NMES intensity,521 deeper motor units can also be targeted by
increasing the inter-electrode distance.520 Conversely, clinic-based NMES
devices are not restricted to a specific inter-electrode distance. Therefore, the
lower evoked KET observed in the home-based NMES group of the above
study,104 may be due to the limited inter-electrode distance of portable NMES
devices.
However, this potential limitation of portable NMES devices may be
corrected if multipath NMES is used instead of traditional NMES. As stated
above, multipath NMES is believed to allow for more spatial recruitment with the
quadriceps compared to traditional NMES.130 Furthermore, patients have also
reported experiencing less discomfort with multipath NMES compared to
traditional NMES. Since three randomized clinical trials have now failed to
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demonstrate significant quadriceps strength recovery with traditional, homebased NMES, multipath NMES seems to be the more attractive home-based
modality for restoring quadriceps strength in patients after ACLr. Regardless,
more studies are needed to determine whether multipath, home-based NMES is
as effective as clinic-based NMES for restoring quadriceps strength in patients
after ACLr.
Irrespective of the potential limitations associated with the home-based
NMES device used in our study, we believe that the main reason why quadriceps
strength improvements were not observed in the Home-NMES group, was
because of their poor treatment compliance. Compliance has previously been
shown to be strongly associated with improved functional outcomes and an
increased likelihood of returning to sport in athletes after ACLr.599 We
recommended the Home-NMES group to administer the portable NMES device
to their quadriceps three times a day, five days a week, for 12 weeks following
ACLr, with each treatment session lasting 15 minutes. Therefore, the targeted
treatment duration for the Home-NMES group totaled to 45 hours over the 12week intervention. However, after extracting the logged minutes from the
portable NMES devices, only one of the 25 patients randomized to the HomeNMES group meet the targeted treatment duration (48 hours, 10 minutes), and
the average treatment duration of the entire group was just below 11 hours.
Based on this average, the treatment compliance of the Home-NMES group was
24%. This observation was discouraging, based upon the treatment compliance
that has been reported with other home-based NMES studies.104,130 Of the two
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previous studies that assessed the effectiveness of home-based NMES on
restoring quadriceps strength in patients after ACLr,104,130 both demonstrated far
better treatment compliance than the Home-NMES group of our study. In the
study by Feil et al.,130 the targeted treatment duration for the Polystim and
Kneehab groups was a total of 60 hours over 12 weeks. Although the Polystim
group registered less total hours (mean = 39 hours, 18 minutes) than the Knee
group (mean = 45 hours, 20 minutes), they had nearly three times the treatment
compliance of our Home-NMES group (65% and 75%, respectively). Likewise,
the targeted treatment duration for the home-based NMES group in the study by
Synder-Mackler et al.,104 was a total of 20 hours over four weeks. They
registered an average treatment duration of 18 hours and 41 minutes, which
equates to over 93% treatment compliance.
Except for minor differences in the prescribed treatment duration and
frequency, these studies mentioned no other factors that may have explained the
higher treatment compliance compared to our study. Like Snyder-Mackler et
al.,104 patients in the Home-NMES group were contacted on several occasions
during the intervention period to insure that they were performing the prescribed
home-based NMES treatments. Although we did not expect the Home-NMES
group to achieve 100% compliance, we hoped that they would be similar to
previous home-based NMES studies. We believe that the age of our patients
may explain why our patients had lower treatment compliance compared to the
other two home-based NMES studies. The average age of patients in our HomeNMES group was 19 years, with the majority of them being high school-aged.
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Conversely, the average age of patients in the two previous studies ranged from
25 to 35 years.104,130 Due to these age differences, it is likely that immaturity
contributed to the low treatment compliance observed in our Home-NMES group.
If this group consisted of patients whose ages were similar to those of the other
two studies, we may have observed higher treatment compliance, which would
have allowed us to better determine the effectiveness of our home-based NMES
intervention on restoring quadriceps strength in patients following ACLr. In
conclusion, because of the low treatment compliance observed in this
randomized clinical trial, we were unable to reject or support the effectiveness of
our home-based NMES intervention.
Voluntary Quadriceps Activation
We hypothesized that voluntary quadriceps activation would be more
improved in the Home-NMES group after ACLr, based on the neural adaptions
that are associated with NMES. Although improvements in muscle strength are
easily attributed to the muscle hypertrophy that develops during NMES
interventions,111-115 neural adaptations elicited by NMES are also responsible for
these increases in muscle strength.111-113,116,117 Gondin and colleagues113
reported that after 4-weeks of NMES treatments to the quadriceps of healthy
individuals, significances increases in quadriceps strength (+11%,, EMG (+4244), and voluntary activation (+5%) were observed, but there were no significant
changes in quadriceps CSA. However, between weeks four and eight, further
improvements in quadriceps strength (+11%) were accompanied by changes in
quadriceps CSA (+4%). The neural adaptations demonstrated in this study
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supports NMES as a potentially effective disinhibitory intervention for the
quadriceps of patients following ACLr.
However, there is conflicting evidence concerning the disinhibitory effects
of NMES on restoring quadriceps function in a patient population. Several studies
have reported improvements in the voluntary quadriceps activation of patients
with NMES interventions.116,118-122 In a case series by Stevens et al.,118 patients
were assigned to one of two interventions, four weeks after receiving bilateral,
total knee arthroplasty. Three patients participated in a 6-week (3
sessions/week), bilateral exercise program consisting of range-of-motion
exercises, lower extremity strengthening exercises, and functional activities. Five
other patients participated in the same exercise program, while also receiving
NMES on the weaker quadriceps. Voluntary quadriceps activation was assessed
in all patients at baseline, mid-intervention (3 weeks), post-intervention (6
weeks), and at three and six months. Due to the small sample size of patients,
the authors chose to not report statistics, but a recent systematic review
calculated the treatment effect sizes for each group to compare the disinhibitory
effect of NMES to exercise.101 Strong effect sizes were observed at the 3-week
(1.66, 95% CI = 0.10, 2.90), 6-week (1.65, 95% CI = 0.09, 2.89) 3-month (1.71,
95% CI = 0.13, 2.96) and 6-months (1.87; 95% CI = 0.24, 3.13) time points in the
NMES group. Conversely, the effect sizes of the exercise group were weak (0.08 – 0.-48) and insignificant (95% CI crossed 0). Thus, it would seem that
NMES is an effective motor-based modality for improving voluntary quadriceps
activation in patients.
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Conversely, there have been an equal number of studies which report less
favorable effects of NMES for improving voluntary quadriceps activation in
patients.123-128 Palmieri-Smith et al.125 randomly assigned 30 patients with
radiographic knee OA to NMES (4 weeks; 3 sessions/week) and a control group.
The NMES group received NMES to their quadriceps three times per week, for a
total of four weeks. Whereas, the control group served as the standard-of-care,
and did not receive any treatment. Voluntary quadriceps activation was assessed
in all patients at baseline, one week, and 16 weeks post-intervention. Compared
to the control group, there were no significant differences in quadriceps CAR
changes at either post-intervention time point. The authors reported treatment
effect sizes for each group to compare disinhibitory effects between groups.
Unfortunately, weak and insignificant effect sizes were observed in both the
NMES and control groups at five (0.2, 95% CI = -0.53, 0.91 vs. 0.0, 95% CI = 0.78, 0.78) and 15 weeks (0.42, 95% CI = -0.36, 1.18 vs. 0.33, 95% CI = -1.15,
0.51). Therefore, they concluded that there was no additional benefit from NMES
for improving voluntary quadriceps activation in patients with knee OA.
In addition to the mixed evidence pertaining to the effectiveness of NMES
as a disinhibitory intervention for the quadriceps of patients, the potential
limitations of the home-based NMES device used in our study, combined with the
poor treatment compliance of the Home-NMES group (discussed above), may
have contributed to the lack of voluntary quadriceps activation improvements of
observed in patients after the 12-week home-based NMES intervention.
Furthermore, minimal quadriceps inhibition was observed in the limbs of patients
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in the Home-NMES both before and after ACLr. Therefore, a potential ceiling
effect with voluntary quadriceps activation may have prevented us from
observing a disinhibitory effect with home-based NMES. However, this is the first
known study that has investigated the disinhibitory effectiveness of NMES for the
quadriceps of patients following ACLr.
Corticomotor Excitability
We believed that changes in corticomotor excitability would be
demonstrated in the patients randomized to the Home-NMES group, because the
neuromuscular improvements that have been previously reported with NMES are
believed to involve alterations at the supraspinal level.116,136,137 In a study by
Blickenstorfer et al.,136 a single session of electrical stimulation was applied to
wrist extensor and flexor muscles of healthy individuals, while cerebral activation
patterns were being captured with fMRI. During electrical stimulation, there was
significant activation noted in the contralateral primary motor cortex, primary
somatosensory cortex and premotor cortex, the ipsilateral cerebellum, bilateral
secondary somatosensory cortex, the supplementary motor area, and anterior
cingulate cortex. Additionally, Hortobagyi and Maffuiletti116 proposed an
alternative model in which heightened afferent input elicited by NMES may
explain the neural adaptations observed with NMES. Since NMES cannot bypass
the afferent fibers located within both the skin and muscle, this barrage of
afferent impulses may be transmitted to the sensory system. This sensory
discharge is thought to trigger supraspinal centers to allow for descending control
of motoneurons, which elicits a facilitation of motor output to the involved muscle.
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Therefore, the home-based NMES intervention used in our study was thought to
elicit corticomotor excitability changes in the Home-NMES group through the
above mechanisms.
The fact that no changes in corticomotor excitability were observed in the
Home-NMES group after the home-based NMES intervention was not particularly
surprising. The quadriceps AMT of the Home-NMES group was similar to that
which has been reported in healthy individuals, and there were no changes
observed at any of the postoperative time points. Therefore, a floor-effect with
quadriceps AMT may have prevented a treatment effect from being observed in
the Home-NMES group. Furthermore, to our knowledge, this is the first study to
investigate whether an NMES intervention can elicit changes in the corticomotor
excitability measured via quadriceps AMT. Since there was no previous evidence
to compare to, our hypothesis was generated through inductive reasoning.

5.4

LIMITATIONS AND DELIMITATIONS
5.4.1 Limitations
There were several limitations in this study that were beyond the control of

the investigators. The a priori power analysis was performed for voluntary
quadriceps activation. Since there has been no study that has investigated the
effect of NMES on improving voluntary quadriceps activation in patients after
ACLr, we had to base our power analysis on observational data from patients
before and after ACLr.32 This procedure may have incorrectly estimated the
sample size needed to achieve statistical power. Secondly, the poor treatment
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compliance of the Home-NMES group was disappointing, and it may have
prevented us from observing a treatment effect with any of the neuromuscular
outcome measures.
5.4.2 Delimitations
There were also several delimitations in this study that were within the
investigators’ control. A healthy-matched control group was not included in this
study; thus, we were forced to compare the results of Specific Aims 1 and 3 to
that of previously reported data on healthy individuals. The group differences in
peak KET at baseline was an observation of this study that could have been
prevented by using a different randomization protocol. In addition to stratifying
patients by autograft type and TFI, we could have included baseline peak KET as
a stratification factor. Alternatively, we could have performed our statistical
analyses by using the baseline outcome measures of the groups as a covariate.
However, the similar limb and time patterns that were observed with peak KET
between groups after ACLr suggests that this limitation did not confound our
results substantially. Secondly, the lack of a healthy-matched control group
prevented us from comparing our patient outcome measures to healthy
individuals who were assessed using the same equipment and procedures.
Although inter-rater reliability was established with the majority of outcome
measures used in this study, we cannot not be fully confident that our techniques
were exactly the same as those of other investigators. Therefore, comparing our
results to those of data on healthy individuals collected from other investigators
was not ideal. Thirdly, unlike other neuromuscular outcome measures, we did not
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assess the corticomotor excitability in the uninvolved limb of patients. We chose
not to assess quadriceps AMT in both limbs of patients because this measure
requires the most, and with several other outcome measures being collected, we
wanted limit the duration of the testing session for our patients. Lastly, we did not
monitor the contraction intensity used with the home-based NMES device for
those patients randomized to the Home-NMES group. This delimitation is
important, because the contraction intensity elicited by NMES is known to be
linearly related with spatial recruitment and the recovery of quadriceps strength in
patients after ACLr.104,518 Monitoring the contraction intensity in the Home-NMES
group would have allowed us to determine the exercise load that was being
applied to the quadriceps via the home-based NMES device, and whether this
load was high enough to expect neuromuscular improvements in quadriceps
function. Contraction intensity could have been determined by assessing the KET
output of each patient’s selected NMES intensity on a weekly basis.
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CHAPTER 6: CONCLUSION

Our purpose was to determine the temporal neuromuscular quadriceps
deficits that develop in patients after ACLr, the effect that early deficits have on
the lower extremity function of patients at six months post-ACLr, and whether a
home-based NMES intervention could be used to reduce the extent of these
deficits in patients following ACLr. Our results from Specific Aim 1 indicate that
although quadriceps weakness is more apparent in the involved limb of patients
after ACLr, the quadriceps strength of their uninvolved limb is also affected,
demonstrating reductions at six months post-ACLr. Due to this observation,
clinicians are encouraged to not rely on quadriceps strength LSI when making
return-sport-decisions for their patients after recovering from ACLr. In addition,
the quadriceps inhibition in the involved limb of patients was not as significant as
what has been previously reported in patients after ACL injury and
reconstruction. However, the quadriceps in the uninvolved limb of patients
demonstrated more inhibition, which may explain the quadriceps strength deficits
observed in the uninvolved limb of patients following ACLr. To reduce the risk of
subsequent injury upon return-to-sport and protect against the development of
knee OA, we recommend that clinicians incorporate bilateral interventions aimed
at restoring quadriceps strength and disinhibiting the quadriceps.
Our results from Specific Aim 2 indicate that the early postoperative
quadriceps strength of patients around three months after ACLr are associated
with the lower extremity function of these patients at six months post-ACLr. More
specifically 3-month quadriceps strength was associated with 6-month lower
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extremity postural control and self-reported quality of life. These findings
demonstrate the importance of intensive quadriceps strengthening in the early
stages of ACLr rehabilitation, so that both lower extremity postural control and
knee-related quality of life of patients can be improved later on. Although the
neural measures of quadriceps function in patients did not demonstrate
significant associations with postoperative lower extremity function, the effect that
NQD has on quadriceps strength is sufficient for it to be considered during the
rehabilitation of these patients following ACLr.
Lastly, we are unable to prove or disprove the effectiveness of homebased NMES as a modality for restoring quadriceps strength and activation in
patients after ACLr based on the results from Specific Aim 3. Although the lack of
treatment effect observed with home-based NMES may be contributed to
limitations that are associated with portable NMES devices, we believe that poor
treatment compliance was the main contributor to the lack of treatment effect
observed in this study. Home-based NMES provides patients with the ability to
receive higher doses of NMES to the quadriceps. However, before portable
NMES devices can be prescribed to patients after ACLr, it must be determined
whether these devices can elicit similar contraction intensities to that of clinicbased NMES, and if treatment compliance in patients can be enhanced.
Furthermore, more randomized clinical trials are needed to determine whether
NMES and other motor-based modalities have disinhibitory effects in the involved
limb of patients who exhibit quadriceps inhibition after ACLr, and if these
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modalities possess the capabilities to elicit a crossover effect in the uninvolved
limb of patients.
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APPENDIX: KNEE INJURY AND OSTEOARTHRITIS OUTCOME SCORE

KOOS KNEE SURVEY
Today’s date:

/

/

Date of birth:

/

/

Name:
INSTRUCTIONS: This survey asks for your view about your knee. This
information will help us keep track of how you feel about your knee and how
well you are able to perform your usual activities.
Answer every question by ticking the appropriate box, only one box for each
question. If you are unsure about how to answer a question, please give the
best answer you can.
Symptoms
These questions should be answered thinking of your knee symptoms during
the last week.

Stiffness
The following questions concern the amount of joint stiffness you have
experienced during the last week in your knee. Stiffness is a sensation of
restriction or slowness in the ease with which you move your knee joint.
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Pain
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Function, daily living
The following questions concern your physical function. By this we mean your
ability to move around and to look after yourself. For each of the following activities
please indicate the degree of difficulty you have experienced in the last week
due to your knee.
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Function, sports and recreational activities
The following questions concern your physical function when being active on a
higher level. The questions should be answered thinking of what degree of
difficulty you have experienced during the last week due to your knee.
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Quality of Life

Thank you very much for completing all the questions in this
questionnaire.
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